
<html lang="en"     class="pb-page"  data-request-id="42e0d941-98f2-4563-8809-08d8a6210a95"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm701267q;issue:issue:10.1021/jmcmar.2008.51.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents" /></meta><meta name="dc.Creator" content="Nicola Antonio  Colabufo" /></meta><meta name="dc.Creator" content="Francesco  Berardi" /></meta><meta name="dc.Creator" content="Roberto  Perrone" /></meta><meta name="dc.Creator" content="Simona  Rapposelli" /></meta><meta name="dc.Creator" content="Maria  Digiacomo" /></meta><meta name="dc.Creator" content="Michael  Vanni" /></meta><meta name="dc.Creator" content="Aldo  Balsamo" /></meta><meta name="dc.Description" content="Starting from lead compounds 12b and 28b, previously characterized as P-glycoprotein (P-gp) modulating agents, two series of new compounds were investigated. Compounds 14a,b and 15a,b displayed hig..." /></meta><meta name="Description" content="Starting from lead compounds 12b and 28b, previously characterized as P-glycoprotein (P-gp) modulating agents, two series of new compounds were investigated. Compounds 14a,b and 15a,b displayed hig..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 8, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701267q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701267q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701267q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701267q" /></link>
        
    
    

<title>Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701267q" /></meta><meta property="og:title" content="Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0009.jpeg" /></meta><meta property="og:description" content=" Starting from lead compounds 12b and 28b, previously characterized as P-glycoprotein (P-gp) modulating agents, two series of new compounds were investigated. Compounds 14a,b and 15a,b displayed high P-gp modulating activity in the submicromolar range (EC50 values from 0.25 to 0.80 µM). Moreover, amino derivatives 23–27 showed EC50 values ranging from 0.085 to 0.90 µM. In the pyridyl series, the best result has been obtained for 4-pyridyl derivative 17b (EC50 = 0.85 µM). The best P-gp modulating agents 14a,b, 15a,b, and 23–27 also have been studied for determining their breast cancer resistance protein (BCRP) inhibition activity. The results demonstrated that only the amino derivatives 23–27 displayed moderate BCRP inhibition activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701267q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701267q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701267q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701267q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701267q&amp;href=/doi/10.1021/jm701267q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1415-1422</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701087n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701303z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicola+Antonio++Colabufo">Nicola Antonio Colabufo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Berardi">Francesco Berardi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Perrone">Roberto Perrone</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simona++Rapposelli">Simona Rapposelli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Digiacomo">Maria Digiacomo</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Vanni">Michael Vanni</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aldo++Balsamo">Aldo Balsamo</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. (N.A.C.) Phone: +39-0805442727 . Fax: +39-0805442231. E-mail: <a href="/cdn-cgi/l/email-protection#74171b18151601121b3412150619171c1d195a011a1d16155a1d00"><span class="__cf_email__" data-cfemail="94f7fbf8f5f6e1f2fbd4f2f5e6f9f7fcfdf9bae1fafdf6f5bafde0">[email protected]</span></a>. (S.R.) Phone: +39-0502219582 . Fax: +39-0502219605. E-mail: <a href="/cdn-cgi/l/email-protection#3a485b4a4a49537a5c5b4857144f54534a5314534e"><span class="__cf_email__" data-cfemail="31435041414258715750435c1f445f5841581f5845">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Universitá degli Studi di Bari.</div><div class="corresp-fn" id="afn2">‡Università di Pisa.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701267q&amp;href=/doi/10.1021%2Fjm701267q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1415–1422</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 8, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 October 2007</li><li><span class="item_label"><b>Published</b> online</span>8 February 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 March 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701267q" title="DOI URL">https://doi.org/10.1021/jm701267q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1415%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNicola%2BAntonio%2BColabufo%252C%2BFrancesco%2BBerardi%252C%2BRoberto%2BPerrone%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D5%26contentID%3Djm701267q%26title%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2B%2528Hetero%2529Arylmethyloxy-%2Band%2BArylmethylamine-phenyl%2BDerivatives%2Bas%2BPotent%2BP-glycoprotein%2BModulating%2BAgents%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1422%26publicationDate%3DMarch%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701267q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">555</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701267q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;Antonio Colabufo&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Berardi&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Perrone&quot;},{&quot;first_name&quot;:&quot;Simona&quot;,&quot;last_name&quot;:&quot;Rapposelli&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Digiacomo&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Vanni&quot;},{&quot;first_name&quot;:&quot;Aldo&quot;,&quot;last_name&quot;:&quot;Balsamo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1415-1422&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701267q&quot;},&quot;abstract&quot;:&quot;Starting from lead compounds 12b and 28b, previously characterized as P-glycoprotein (P-gp) modulating agents, two series of new compounds were investigated. Compounds 14a,b and 15a,b displayed high P-gp modulating activity in the submicromolar range (EC50 values from 0.25 to 0.80 µM). Moreover, amino derivatives 23–27 showed EC50 values ranging from 0.085 to 0.90 µM. In the pyridyl series, the best result has been obtained for 4-pyridyl derivative 17b (EC50 = 0.85 µM). The best P-gp modulating agents 14a,b, 15a,b, and 23–27 also have been studied for determining their breast cancer resistance protein (BCRP) inhibition activity. The results demonstrated that only the amino derivatives 23–27 displayed moderate BCRP inhibition activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701267q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701267q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701267q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701267q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701267q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701267q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701267q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701267q&amp;href=/doi/10.1021/jm701267q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701267q" /></input><a href="/doi/pdf/10.1021/jm701267q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (255 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701267q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701267q%26sid%3Dliteratum%253Aachs%26pmid%3D18257545%26genre%3Darticle%26aulast%3DColabufo%26date%3D2008%26atitle%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2B%2528Hetero%2529Arylmethyloxy-%2Band%2BArylmethylamine-phenyl%2BDerivatives%2Bas%2BPotent%2BP-glycoprotein%2BModulating%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D5%26spage%3D1415%26epage%3D1422%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Starting from lead compounds <b>12b</b> and <b>28b</b>, previously characterized as P-glycoprotein (P-gp) modulating agents, two series of new compounds were investigated. Compounds <b>14a</b>,<b>b</b> and <b>15a</b>,<b>b</b> displayed high P-gp modulating activity in the submicromolar range (EC<sub>50</sub> values from 0.25 to 0.80 µM). Moreover, amino derivatives <b>23</b>–<b>27</b> showed EC<sub>50</sub> values ranging from 0.085 to 0.90 µM. In the pyridyl series, the best result has been obtained for 4-pyridyl derivative <b>17b</b> (EC<sub>50</sub> = 0.85 µM). The best P-gp modulating agents <b>14a</b>,<b>b</b>, <b>15a</b>,<b>b</b>, and <b>23</b>–<b>27</b> also have been studied for determining their breast cancer resistance protein (BCRP) inhibition activity. The results demonstrated that only the amino derivatives <b>23</b>–<b>27</b> displayed moderate BCRP inhibition activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ATP-binding cassette (ABC) transporters are a transmembrane (TM) family of proteins<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> that extrudes various molecules across all cell membranes by using the ATP hydrolysis energy. These transporters efflux compounds from the cytoplasm to the outside of the cell or into an intracellular compartment such as the endoplasmic reticulum (ER), the mitochondria, or the peroxisome.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">In humans, 49 ABC genes, organized into seven subfamilies (A−G), have been reported,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and many of these genes are involved in human genetic diseases<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> and in multidrug resistance (MDR).<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9-12)</a></div><div class="NLM_p">MDR is an important cause of failure of cancer treatment with chemotherapeutic agents.<a onclick="showRef(event, 'ref10 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref13">(10, 13)</a> The mechanism of MDR is mainly the cell overexpression of some ABC transporters localized in the cell membrane such as P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), multidrug resistance protein 1-7 (MRP1-7), and lung resistance protein (LRP). These transporters, involved in MDR, determine this pharmacological effect by effluxing a variety of chemotherapeutic drugs from tumor cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">A potential strategy to reverse MDR could be the coadministration of a chemotherapeutic agent with an efflux pump inhibitor, although such reversal agents might actually increase the side effects of chemotherapy by blocking physiological anticancer drug efflux from normal cells.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> In recent years, many drugs have been investigated for reversing MDR,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> such as the calcium channel blocker verapamil and the antisteroids tamoxifen (first generation), biricodar (second generation), and tariquidar, elacridar, and zosuquidar (third generation), as depicted in Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Third Generation P-gp Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At the present, clinical trials reported elacridar<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and zosuquidar<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in phase I while tariquidar reached phase III, even if recently it was terminated because of an increased incidence of side effects.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Recently, we developed a new class of small molecules having arylmethyloxyphenyl structure that displayed moderate P-gp modulating activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Among these previously studied derivatives, compounds <b>12b</b> (EC<sub>50</sub> = 17.2 µM) and <b>28b</b> (EC<sub>50</sub> = 27.5 µM), depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, have shown the best results in modulating P-gp activity. Previous studies evidenced that the P-gp inhibition activity was influenced by the presence of a methoxy group on the C-ring. In the present work, compounds <b>11a</b>,<b>b</b>, <b>13a</b>,<b>b</b>−<b>17a</b>,<b>b</b>, and <b>22</b>–<b>27</b> have been synthesized in order to investigate the following: (i) the influence of the extent of methoxylation on the C-ring for P-gp modulating activity (compounds <b>11a</b>,<b>b</b> and <b>13a</b>,<b>b</b>−<b>16a</b>,<b>b</b>), (ii) the effect of the methoxy substituent on the A-ring (<b>11b</b>, <b>13b</b>−<b>16b</b>, and <b>17b</b>), (iii) the effect of the position of the pyridyl nitrogen on the P-gp activity (<b>17a</b>,<b>b</b>), and (iv) the effect of the isosteric substitution of the oxygen in the spacer between the B-ring and C-ring with a NH group (compounds <b>22</b>–<b>27</b>).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compounds <b>12b</b> and <b>28b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The P-gp inhibition activity for each compound was studied by three combined biological assays: (i) inhibition of [<sup>3</sup>H]-vinblastine transport, (ii) ATP cell depletion, and (iii) apparent permeability (<i>P</i><sub>app</sub>) in a Caco-2 cells monolayer. By these assays, it was possible to determine the structural requirements that favor P-gp inhibition and the mechanism involved in P-gp modulation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Moreover, the best P-gp modulators have been tested for both their BCRP activity and cytotoxicity.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Compounds <b>10a</b>,<b>b</b>−<b>17a</b>,<b>b</b> were prepared by alkylation of phenols <b>1a</b>,<b>b</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with the appropriate substituted benzyl halide (<b>2</b>–<b>8</b>) or with 4-chloromethylpyridine (<b>9</b>) in the presence of KOH, as reported in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The aniline derivatives <b>22</b>–<b>27</b> were synthesized starting from the phosphonium salt <b>18</b>, which was submitted to Wittig’s reaction with 2-nitrobenzaldehyde (<b>19</b>) to give 1-[2-(3-methoxyphenyl)vinyl]-2-nitrobenzene (<b>20</b>) as a mixture of <i>cis</i> and <i>trans</i> isomers (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The subsequent catalytic hydrogenation of <b>20</b> afforded the aniline derivative <b>21</b>. The final compounds <b>22</b>–<b>24</b> were obtained by a microwave reaction with the appropriate methoxybenzylchloride in the presence of a catalytic amount of KI,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> while compounds <b>25</b>–<b>27</b> were obtained by reaction of <b>21</b> with the corresponding dimethoxy-benzaldehydes and subsequent reduction with NaBH<sub>4</sub>. The synthesis of compounds <b>10a</b>,<b>b</b>, <b>12a</b>,<b>b</b>, <b>28a</b>,<b>b</b>, and <b>29a</b>,<b>b</b> was reported in our previous work.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0003.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents: (A) KOH, Δ, DMSO.</p><p class="last"><span class="fn-label">Scheme b</span>Physical properties reported in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0004.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (A) DBU (1,8-diazabicyclic[5.4.0]undec-7-ene), CH<sub>3</sub>CN; (B) H<sub>2</sub>, Pd/C 10%, EtOH; (C) appropriate methoxybenzylchloride, KI, CH<sub>3</sub>CN, microwave; (D) (i) appropriate dimethoxybenzaldehyde, EtOH, reflux, (ii) NaBH<sub>4</sub>, EtOH/H<sub>2</sub>O.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> SAR Studies</h3><div class="NLM_p">The new compounds synthesized (<b>11a</b>,<b>b</b>, <b>13a</b>,<b>b</b>−<b>17a</b>,<b>b</b>, and <b>22</b>–<b>27</b>) were evaluated for their ability to inhibit the P-gp protein. Results are reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, together with those already obtained for the previously described analogues (<b>10a</b>,<b>b</b>, <b>12a</b>,<b>b</b>, <b>28a</b>,<b>b</b>, and <b>29a</b>,<b>b</b>) and the reference drugs (elacridar, verapamil, and cyclosporin A).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Results of Derivatives <b>10a</b>,<b>b</b>−<b>16a</b>,<b>b</b> and <b>22</b>–<b>27</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0005.gif" alt="" id="gr6" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="8.323133414932682%" align="left" /></col><col width="8.323133414932682%" align="left" /></col><col width="8.323133414932682%" align="left" /></col><col width="13.953488372093023%" align="left" /></col><col width="15.299877600979192%" align="left" /></col><col width="17.74785801713586%" align="left" /></col><col width="15.422276621787026%" align="left" /></col><col width="12.607099143206854%" align="left" /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="bottom">compd</th><th class="rowsep1" align="center" valign="bottom">R</th><th class="rowsep1" align="center" valign="bottom">X</th><th class="rowsep1" align="center" valign="bottom">R1</th><th class="rowsep1" align="center" valign="bottom">R2</th><th class="rowsep1" align="center" valign="bottom">[<sup>3</sup>H]-vinblastine transport inhibition, EC<sub>50</sub> ± S.E.M. (µM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th class="rowsep1" align="center" valign="bottom">ATP-ase activation<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th><th class="rowsep1" align="center" valign="bottom">[<i>P</i><sub>app</sub>(B-A)]/[<i>P</i><sub>app</sub>(A-B)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a>]</th></tr></thead><tbody><tr valign="top"><td align="left"><b>10a</b><a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">H</td><td align="left">O</td><td align="left">H</td><td align="left">H</td><td align="left">>1000<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">Y<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>10b</b><a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">OCH<sub>3</sub></td><td align="left">O</td><td align="left">H</td><td align="left">H</td><td align="left">92.8 ± 5.5<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">N<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>11a</b></td><td align="left">H</td><td align="left">O</td><td align="left">2-OCH<sub>3</sub></td><td align="left">H</td><td align="left">20 ± 2.5</td><td align="left">N</td><td align="left">1.4</td></tr><tr valign="top"><td align="left"><b>11b</b></td><td align="left">OCH<sub>3</sub></td><td align="left">O</td><td align="left">2-OCH<sub>3</sub></td><td align="left">H</td><td align="left">12 ± 1.5</td><td align="left">N</td><td align="left">8.7</td></tr><tr valign="top"><td align="left"><b>12a</b><a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">H</td><td align="left">O</td><td align="left">3-OCH<sub>3</sub></td><td align="left">H</td><td align="left">95.6 ± 10.0<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">Y<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>12b</b><a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">OCH<sub>3</sub></td><td align="left">O</td><td align="left">3-OCH<sub>3</sub></td><td align="left">H</td><td align="left">17.2 ± 0.5<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">N<a class="ref internalNav" href="#tbl1-fn4" aria-label="c">c</a></td><td align="left">13</td></tr><tr valign="top"><td align="left"><b>13a</b></td><td align="left">H</td><td align="left">O</td><td align="left">4-OCH<sub>3</sub></td><td align="left">H</td><td align="left">3.1 ± 0.5</td><td align="left">N</td><td align="left">5.1</td></tr><tr valign="top"><td align="left"><b>13b</b></td><td align="left">OCH<sub>3</sub></td><td align="left">O</td><td align="left">4-OCH<sub>3</sub></td><td align="left">H</td><td align="left">5.2 ± 0.50</td><td align="left">N</td><td align="left">7.6</td></tr><tr valign="top"><td align="left"><b>14a</b></td><td align="left">H</td><td align="left">O</td><td align="left">2-OCH<sub>3</sub></td><td align="left">3-OCH<sub>3</sub></td><td align="left">0.80 ± 0.05</td><td align="left">N</td><td align="left">0.95</td></tr><tr valign="top"><td align="left"><b>14b</b></td><td align="left">OCH<sub>3</sub></td><td align="left">O</td><td align="left">2-OCH<sub>3</sub></td><td align="left">3-OCH<sub>3</sub></td><td align="left">0.25 ± 0.05</td><td align="left">Y</td><td align="left">7.8</td></tr><tr valign="top"><td align="left"><b>15a</b></td><td align="left">H</td><td align="left">O</td><td align="left">3-OCH<sub>3</sub></td><td align="left">4-OCH<sub>3</sub></td><td align="left">0.75 ± 0.07</td><td align="left">N</td><td align="left">2.1</td></tr><tr valign="top"><td align="left"><b>15b</b></td><td align="left">OCH<sub>3</sub></td><td align="left">O</td><td align="left">3-OCH<sub>3</sub></td><td align="left">4-OCH<sub>3</sub></td><td align="left">0.65 ± 0.08</td><td align="left">N</td><td align="left">5.1</td></tr><tr valign="top"><td align="left"><b>16a</b></td><td align="left">H</td><td align="left">O</td><td align="left">3-OCH<sub>3</sub></td><td align="left">5-OCH<sub>3</sub></td><td align="left">1.60 ± 0.20</td><td align="left">N</td><td align="left">5.7</td></tr><tr valign="top"><td align="left"><b>16b</b></td><td align="left">OCH<sub>3</sub></td><td align="left">O</td><td align="left">3-OCH<sub>3</sub></td><td align="left">5-OCH<sub>3</sub></td><td align="left">2.5 ± 0.40</td><td align="left">N</td><td align="left">6.7</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left">OCH<sub>3</sub></td><td align="left">NH</td><td align="left">2-OCH<sub>3</sub></td><td align="left">H</td><td align="left">N.D.<a class="ref internalNav" href="#tbl1-fn6" aria-label="e">e</a></td><td align="left">N.D.<a class="ref internalNav" href="#tbl1-fn6" aria-label="e">e</a></td><td align="left">N.D.<a class="ref internalNav" href="#tbl1-fn6" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="left">OCH<sub>3</sub></td><td align="left">NH</td><td align="left">3-OCH<sub>3</sub></td><td align="left">H</td><td align="left">0.48 ± 0.002</td><td align="left">N</td><td align="left">2.9</td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="left">OCH<sub>3</sub></td><td align="left">NH</td><td align="left">4-OCH<sub>3</sub></td><td align="left">H</td><td align="left">N.D.<a class="ref internalNav" href="#tbl1-fn6" aria-label="e">e</a></td><td align="left">N.D.<a class="ref internalNav" href="#tbl1-fn6" aria-label="e">e</a></td><td align="left">N.D.<a class="ref internalNav" href="#tbl1-fn6" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>25</b></td><td align="left">OCH<sub>3</sub></td><td align="left">NH</td><td align="left">2-OCH<sub>3</sub></td><td align="left">3-OCH<sub>3</sub></td><td align="left">0.085 ± 0.02</td><td align="left">N</td><td align="left">5.5</td></tr><tr valign="top"><td align="left"><b>26</b></td><td align="left">OCH<sub>3</sub></td><td align="left">NH</td><td align="left">3-OCH<sub>3</sub></td><td align="left">4-OCH<sub>3</sub></td><td align="left">0.18 ± 0.04</td><td align="left">N</td><td align="left">5.6</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">OCH<sub>3</sub></td><td align="left">NH</td><td align="left">3-OCH<sub>3</sub></td><td align="left">5-OCH<sub>3</sub></td><td align="left">0.90 ± 0.004</td><td align="left">N</td><td align="left">6.9</td></tr><tr valign="top"><td align="left">elacridar</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">2.0<a class="ref internalNav" href="#tbl1-fn5" aria-label="d">d</a></td><td align="left">N<a class="ref internalNav" href="#tbl1-fn5" aria-label="d">d</a></td><td align="char" char="d"><2<a class="ref internalNav" href="#tbl1-fn5" aria-label="d">d</a></td></tr><tr valign="top"><td align="left">cyclosporin A</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">80 ± 7.5</td><td align="left">N</td><td align="left">9.6</td></tr><tr valign="top"><td align="left">verapamil</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">20 ± 1.0</td><td align="left">Y</td><td align="left">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Data are the mean of three independent determinations, samples in triplicate.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Effect measured at 100 µM. Data are the mean of three independent determinations with samples in triplicate.</p></div><div class="footnote" id="tbl1-fn4"><sup>c</sup><p class="last">See ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></div><div class="footnote" id="tbl1-fn5"><sup>d</sup><p class="last">See ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div><div class="footnote" id="tbl1-fn6"><sup>e</sup><p class="last">Not determined (chemically unstable).</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biological Properties of Pyridyl Derivatives <b>28a</b>,<b>b</b>, <b>29a</b>,<b>b</b>, and <b>17a</b>,<b>b</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0006.gif" alt="" id="gr7" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="8.48585690515807%" align="left" /></col><col width="10.482529118136439%" align="left" /></col><col width="11.148086522462561%" align="left" /></col><col width="18.136439267886857%" align="left" /></col><col width="15.141430948419298%" align="left" /></col><col width="36.605657237936775%" align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">R</th><th align="center" valign="bottom">Het</th><th align="center" valign="bottom">[<sup>3</sup>H]-vinblastine transport inhibition, EC<sub>50</sub> ± SEM (µM)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th><th align="center" valign="bottom">ATP-ase activation<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th><th align="center" valign="bottom">[<i>P</i><sub>app</sub>(B-A)]/[<i>P</i><sub>app</sub>(A-B)<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a>]</th></tr></thead><tbody><tr valign="top"><td align="left"><b>28a</b><a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">H</td><td align="left">2-pyridyl</td><td align="left">100 ± 25<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">N<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>28b</b><a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">OCH<sub>3</sub></td><td align="left">2-pyridyl</td><td align="left">27.6 ± 0.2<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">N<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>29a</b><a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">H</td><td align="left">3-pyridyl</td><td align="left">125 ± 15<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">Y<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>29b</b><a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">OCH<sub>3</sub></td><td align="left">3-pyridyl</td><td align="left">>1000<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left">Y<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>17a</b></td><td align="left">H</td><td align="left">4-pyridyl</td><td align="left">18 ± 2.5</td><td align="left">Y</td><td align="left">1.3</td></tr><tr valign="top"><td align="left"><b>17b</b></td><td align="left">OCH<sub>3</sub></td><td align="left">4-pyridyl</td><td align="left">0.85 ± 0.05</td><td align="left">Y</td><td align="left">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are the mean of three independent determinations (samples in triplicate), each with SEM < 10%.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Effect measured at 100 µM. Data are the mean of three independent determinations with samples in triplicate.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">Data are the mean of three independent determinations, samples in triplicate.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">See ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></div></div></div><div class="NLM_p">The results of the <b>12b</b> analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) studied for determining the importance of the presence, the position, and the extent of methoxylation of the C-ring displayed that the unsubstituted derivative <b>10b</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> is a weak P-gp modulating agent (EC<sub>50</sub> = 92.8 µM) with respect to monosubstituted derivatives <b>11b</b>−<b>13b</b> (EC<sub>50</sub> = 12, 17.2, and 5.2 µM, respectively). Compound <b>13b</b>, which had the best activity, had a 4-OCH<sub>3</sub> substituent on the C-ring.</div><div class="NLM_p">In regards to the C-ring dimethoxy-substituted derivatives (<b>14b</b>−<b>16b</b>), all isomers were found to be more active than the monosubstituted ones, in accord with the hypothesis that substituents able to increase the hydrogen bond formation with the P-gp active site might constitute an important structural requirement for improving the P-gp inhibition activity.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> The best results were observed for 2,3- and 3,4-dimethoxy derivatives <b>14b</b> (EC<sub>50</sub> = 0.25 µM) and <b>15b</b> (EC<sub>50</sub> = 0.65 µM), while the 3,5-dimethoxy derivative <b>16b</b> displayed a slightly lower P-gp inhibition activity (EC<sub>50</sub> = 2.5 µM) than those of the corresponding isomers <b>14b</b> and <b>15b</b>. This trend was also confirmed by the data concerning their inferior homologues, lacking the methoxy substituent on the A-ring (<b>10a</b>−<b>16a</b>). In fact, also in this series, the best results were observed for 2,3- and 3,4-dimethoxy derivatives <b>14a</b> and <b>15a</b> (EC<sub>50</sub> = 0.80 and 0.75 µM, respectively), while 3,5-dimethoxy compound <b>16a</b> displayed only moderate P-gp inhibition activity (EC<sub>50</sub> = 1.60 µM).</div><div class="NLM_p">Moreover, with respect to the dimethoxy compounds <b>14a</b>−<b>16a</b>, the monosubstituted derivatives <b>11a</b>−<b>13a</b> displayed lower activity (EC<sub>50</sub> = 20.0, 95.6, and 3.1 µM, respectively), but the latter was more potent than the unsubstituted <b>10a</b> (EC<sub>50</sub> > 1000 µM). Among monomethoxy derivatives, also in this series, the compound bearing 4-OCH<sub>3</sub> on the C-ring, <b>13a</b>, displayed the best activity.</div><div class="NLM_p">Furthermore, comparing the biological results of compounds differing by the presence (<b>10b</b>−<b>16b</b>) or the absence (<b>10a</b>−<b>16a</b>) of the methoxy group on the A-ring, it was evident that this substituent played a modest role on the P-gp inhibition activity, with the exception of compounds <b>10a</b>,<b>b</b> and <b>12a</b>,<b>b</b>. In fact, compound <b>10b</b> is some 10 times more potent than <b>10a</b>, and <b>12b</b> is 5.5 times more potent than <b>12a</b>.</div><div class="NLM_p">The isosteric substitution of oxygen present on the spacer linking the B-ring to the C-ring of the lead compound <b>12b</b> with NH, as in compound <b>23</b>, determined an increase in the P-gp inhibition activity (EC<sub>50</sub> = 17.2 vs 0.48 µM, respectively). The position of the methoxy on the C-ring in this series has been evaluated. Derivatives <b>22</b> and <b>24</b> bearing 2-OCH<sub>3</sub> and 4-OCH<sub>3</sub> on the C-ring, respectively, were chemically unstable when dissolved in EtOH, DMSO, and phosphate buffered saline (PBS), which are the solvents employed in the biological assays. Among the dimethoxy-substituted derivatives <b>25</b>−<b>27</b>, the best P-gp inhibition activity was observed for the 2,3-dimethoxy-substituted compound <b>25</b> (EC<sub>50</sub> = 0.085 µM), while the 3,5-dimethoxy-substituted derivative <b>27</b> displayed a slightly lower P-gp inhibition activity (EC<sub>50</sub> = 0.90 µM). Compound <b>26</b>, bearing a 3,4-dimethoxy substitution on the C-ring, displayed good P-gp inhibition activity (EC<sub>50</sub> = 0.18 µM). These results demonstrated the same trend observed for the corresponding isomers <b>14b</b>−<b>16b</b>, having an oxygen atom in the spacer between the B-ring and the C-ring.</div><div class="NLM_p">Moreover, starting from the lead heteroaromatic compound <b>28b</b>, having a 2-pyridyl moiety, instead of the C-ring, the shifting of the pyridyl linkage from the 2 to the 3 and 4 positions (<b>29b</b> and <b>17b</b>, respectively) has been investigated. The results listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> displayed that the best P-gp inhibition activity was obtained for compound <b>17b</b>, having a 4-pyridyl nucleus (EC<sub>50</sub> = 0.85 µM).</div><div class="NLM_p">Moreover, the P-gp modulating activity dramatically decreased in compound <b>29b</b> where the heteroaromatic was a 3-pyridyl (EC<sub>50</sub> > 1000 µM). The same trend was observed also in the corresponding derivatives lacking a methoxy substituent on the A-ring (<b>28a</b>, <b>29a</b>, and <b>17a</b>). In fact, the 4-pyridyl derivative <b>17a</b> is the best of the series (EC<sub>50</sub> = 18.0 µM), while the 2- and 3-pyridyl derivatives <b>28a</b> and <b>29a</b> displayed weak inhibition activity (EC<sub>50</sub> = 100 and 125 µM, respectively). This finding indicates a marked influence on the P-gp inhibitory activity of the position of the nitrogen atom on the pyridine nucleus.</div><div class="NLM_p last">Comparing <b>17a</b> with <b>17b</b> (EC<sub>50</sub> = 18 vs 0.85 µM, respectively) and <b>28a</b> with <b>28b</b> (EC<sub>50</sub> = 100 vs 27.6 µM, respectively), it was evident that the presence of a methoxy substituent on the A-ring in this series seems to be significantly involved in the P-gp modulation activity. On the other hand, compounds <b>29a</b> and <b>29b</b> were both weakly active.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> P-gp Inhibition Mechanism Investigation</h3><div class="NLM_p">In a monolayer efflux assay, the apparent permeability (<i>P</i><sub>app</sub>) in both basolateral to apical [<i>P</i><sub>app</sub>(B-A)] and apical to basolateral [<i>P</i><sub>app</sub>(A-B)] directions was determined for each compound. The BA/AB ratio is ranging from 0.95 to 2.1 for compounds <b>11a</b>, <b>14a</b>, <b>15a</b>, <b>17a</b>,<b>b</b>, and the reference compounds verapamil and elacridar (BA/AB = 1.2 and 2, respectively), while the other compounds and cyclosporin A displayed BA/AB >2.9.</div><div class="NLM_p">The compounds having BA/AB ratio up to 2.1 were not effluxed by P-gp, while compounds with BA/AB ratio >2.9 were P-gp transported and consequently considered substrates of this pump.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">As regards ATP-ase activation, all compounds were unable to deplete ATP from cells with the exception of <b>10a</b>, <b>12a</b>, <b>14b</b>, <b>17a</b>,<b>b</b>, and <b>29a</b>,<b>b</b>. The compounds that reduced the cell ATP level were considered P-gp substrates, while the compounds with unmodified ATP cell content were not effluxed by P-gp.</div><div class="NLM_p">Combining the results of the biological assays, compounds <b>11a</b>, <b>14a</b>, <b>15a</b>, and the reference compound elacridar were claimed “P-gp inhibitors” because they were not transported by P-gp, they inhibited [<sup>3</sup>H]-vinblastine transport, and they were unable to deplete ATP.</div><div class="NLM_p">Compounds <b>17a</b>,<b>b</b> as well as verapamil were not transported by P-gp; they inhibited [<sup>3</sup>H]-vinblastine transport, but they were able to promote the depletion of ATP so that they were claimed “not transported” P-gp substrates.</div><div class="NLM_p">Compounds <b>11b</b>, <b>13a</b>,<b>b</b>, <b>15b</b>, <b>16a</b>,<b>b</b>, <b>23</b>, and <b>25</b>–<b>27</b> as well as cyclosporin A were effluxed by P-gp; they inhibited [<sup>3</sup>H]-vinblastine transport, and they were unable to deplete ATP so that they were considered “saturating transported” P-gp substrates.</div><div class="NLM_p last">Only compound <b>14b</b> was a P-gp substrate because it was effluxed by P-gp, it inhibited [<sup>3</sup>H]-vinblastine transport, and it depleted ATP.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biological Cell Activity</h3><div class="NLM_p">Since the P-gp modulators should be devoid of cytotoxic activity, we tested compounds <b>14a</b>,<b>b</b>, <b>15a</b>,<b>b</b>, <b>17b</b>, <b>23</b>, and <b>25</b>–<b>27</b>, displaying submicromolar activity values, to establish their intrinsic cytotoxicity in the MCF-7/Adr cell line overexpressing P-gp. As depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, all tested compounds until 50 µM were devoid of cytotoxicity at 48 h, except compounds <b>15a</b> and <b>23</b>, which displayed only moderate cytotoxicity (10%). In contrast, compound <b>17b</b> displayed high cytotoxicity (50%) at 1 µM (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, last bar to the right), so that this result discouraged the development of the pyridyl series as potential MDR reverting agents.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cytotoxic effect of P-gp inhibitors on the MCF-7/Adr cell line at 48 h. The effect of compound <b>17b</b> has been determined at 1 µM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> BCRP Activity</h3><div class="NLM_p">Since the limit of P-gp inhibitors such as elacridar is the poor selectivity toward other ABC transporters, in particular the BCRP pump, the best P-gp modulators, <b>14a</b>,<b>b</b>, <b>15a</b>,<b>b</b>, <b>23</b>, <b>25</b>, and <b>26</b>, were tested for their ability to inhibit [<sup>3</sup>H]-mitoxantrone, a specific BCRP substrate. In Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> are reported the EC<sub>50</sub> values of these compounds. The results showed that oxygen derivatives <b>14a</b>,<b>b</b> and <b>15a</b>,<b>b</b> were weakly active to inhibit the BCRP pump (EC<sub>50</sub> from 58 to 150 µM). In contrast, the amino derivatives <b>23</b>, <b>25</b>, and <b>26</b> showed a good BCRP inhibition activity. In particular, compounds <b>25</b> and <b>26</b> showed micromolar BCRP inhibition activity (EC<sub>50</sub> = 1.5 and 0.5 µM, respectively).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. BCRP Inhibition Evaluation of Derivatives <b>14a</b>,<b>b</b>, <b>15a</b>, <b>23</b>, <b>25</b>, and <b>26</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="bottom">compd</th><th class="rowsep1" align="center" valign="middle" char="±">[<sup>3</sup>H]-mitoxantrone transport inhibition, EC<sub>50</sub> ± SEM (µM)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>14a</b></td><td align="char" char="±">75 ± 5</td></tr><tr valign="top"><td align="left"><b>14b</b></td><td align="char" char="±">120 ± 20</td></tr><tr valign="top"><td align="left"><b>15a</b></td><td align="char" char="±">58 ± 3</td></tr><tr valign="top"><td align="left"><b>15b</b></td><td align="char" char="±">150 ± 25</td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="char" char="±">7.0 ± 0.5</td></tr><tr valign="top"><td align="left"><b>25</b></td><td align="char" char="±">1.5 ± 0.20</td></tr><tr valign="top"><td align="left"><b>26</b></td><td align="char" char="±">0.50 ± 0.02</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Data are the mean of three independent determinations, samples in triplicate.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In our previous work, we studied arylmethyloxyphenyl derivatives displaying P-gp modulating activity, and among them <b>12b</b> and <b>28b</b> were suggested as lead compounds of this new class of small P-gp modulators. Starting from <b>12b</b>, the extent of methoxylation on the C-ring, the effect of a methoxy substituent on the A-ring, and the influence of isosteric substitution have been investigated.</div><div class="NLM_p">Starting from <b>28b</b>, the effect of 3- and 4-pyridyl isomers and the influence of a methoxy substituent on the A-ring have been studied. As expected, the extent of methoxylation on the C-ring improved the P-gp inhibition activity both in the series lacking a methoxy group (<b>14a</b>−<b>16a</b>) and in the corresponding series bearing a methoxy group (<b>14b</b>−<b>16b</b>) on the A-ring. However, the presence of a methoxy on the A-ring slightly potentiated P-gp inhibition activity. Among dimethoxy substitutions on the C-ring, the best results have been obtained for the 2,3- and 3,4-<i>ortho</i>-disubstituted derivatives, while 3,5-disubstituted derivatives were less active in all of the series. The effect of the methoxy position on the C-ring in monosubstituted derivatives has been investigated, demonstrating that the <i>para</i>-substitution determined the best activity toward P-gp in all series, although these compounds were less active than the corresponding disubstituted derivatives. The best results in inhibiting P-gp were obtained for the amino derivatives bearing a methoxy substituent on the A-ring, which are always more potent than the corresponding oxygen derivatives. Also in this series, 2,3- and 3,4-<i>ortho</i>-disubstituted derivatives on the C-ring showed the highest P-gp inhibition values in the nanomolar range (EC<sub>50</sub> = 0.085 µM for compound <b>25</b>). Considering the inhibition activity profile of some reference compounds, elacridar in particular, displaying dual inhibition activity toward P-gp and BCRP pumps, the selectivity of the best P-gp modulators has been investigated. The results displayed that both the oxygen and the amino derivatives had similar potency in inhibiting P-gp, but the oxygen derivatives were more selective toward P-gp with respect to BCRP.</div><div class="NLM_p">In Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, for the best oxygen derivatives, the activity values (pEC<sub>50</sub>) toward P-gp and BCRP have been compared. In Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, for the best amino derivatives, the same comparison has been reported.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison between P-gp (gray bars) and BCRP (white bars) inhibition activity of oxygen derivatives (A) and amino derivatives (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These findings suggest that the presence of a NH group in the side chain of the arylmethylamine derivatives increases the inhibitory activity toward P-gp but in the meantime decreases the selectivity between the two types of extrusion pumps (P-gp vs BCRP). In conclusion, the present paper suggests that suitable chemical manipulations of this new class of P-gp inhibitors may lead to the synthesis of new derivatives endowed of improved inhibitory activity and selectivity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Methods</h3><div class="NLM_p">Melting points were determined on a Kofler hot-stage apparatus and are uncorrected. <sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained with a Varian Gemini 200 MHz spectrometer. Chemical shifts (δ) are reported in parts per million downfield from tetramethylsilane and referenced from solvent references; coupling constants <i>J</i> are reported in hertz; <sup>13</sup>C NMR spectra were fully decoupled. The following abbreviations are used: singlet (s), doublet (d), triplet (t), double-doublet (dd), and multiplet (m).</div><div class="NLM_p last">Mass spectra were obtained on a Hewlett-Packard 5988 A spectrometer by using a direct injection probe and an electron beam energy of 70 eV. The elemental compositions of the compounds agreed to within ±0.4% of the calculated value. Chromatographic separation was performed on silica gel columns by flash (Kieselgel 40, 0.040–0.063 mm; Merck) or gravity column (Kieselgel 60, 0.063–0.200 mm; Merck) chromatography. Reactions were followed by thin-layer chromatography (TLC) on Merck aluminum silica gel (60 F<sub>254</sub>) sheets that were visualized under a UV lamp. Evaporation was performed in vacuo (rotating evaporator). Sodium sulfate was always used as the drying agent. The microwave-assisted procedures were carried out with a CEM Discover LabMate microwave. Commercially available chemicals were purchased from Sigma-Aldrich. The UV–vis spectra of compounds <b>11a</b>,<b>b</b>, <b>13a</b>,<b>b</b>−<b>17a</b>,<b>b</b>, and <b>22</b>–<b>27</b>, and the corresponding calibration curves were recorded with a PerkinElmer LAMBDA BIO-20 spectrophotometer.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedure To Synthesize Final Compounds <b>11a</b>,<b>b</b> and <b>13a</b>,<b>b</b>−<b>17a</b>,<b>b</b></h3><div class="NLM_p">A solution of phenol <b>1a</b> or <b>1b</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (1.0 mmol) in a small amount of DMSO (2 mL) was added to a solution of KOH (174 mg, 3.11 mmol) in DMSO (2.5 mL). The mixture was stirred at room temperature for 15 min, and then a solution of the appropriate arylmethylhalide <b>2</b>–<b>9</b> (1.0 mmol) in DMSO (2 mL) was added dropwise to the solution of potassium 2-(2-phenylethyl)benzenolate. The suspension was stirred at room temperature for 12 h, and then it was diluted with AcOEt and washed with water and brine. The organic layer was dried and concentrated. The resulting residue was purified by chromatography on a silica gel column.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 1-[(2-Methoxybenzyl)oxy]-2-(2-phenylethyl)benzene (<b>11a</b>)</h4><div class="NLM_p last">Purified with hexane/AcOEt (95:5) (55% yield) as a colorless oil. MS <i>m</i>/<i>z</i> 318 (M<sup>+</sup>, 85); 198 (27). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.90–3.02 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.90 (s, 3H, OCH<sub>3</sub>), 5.15 (s, 2H, OCH<sub>2</sub>), 6.85–7.04 (m, 4H, Ar), 7.12–7.36 (m, 8H, Ar), 7.51–7.55 (m, 1H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 156.99, 156.88, 142.71, 130.83, 130.08, 128.79, 128.62, 128.37, 128.31, 127.27, 126.09, 125.78, 120.70, 120.65, 112.05, 110.31, 65.55, 65.37, 36.60, 33.24. Anal. (C<sub>22</sub>H<sub>22</sub>O<sub>2</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 16350.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 1-[(2-Methoxybenzyl)oxy]-2-[2-(3-methoxyphenyl)ethyl]benzene (<b>11b</b>)</h4><div class="NLM_p last">Purified with hexane/AcOEt (95:5) (89% yield) as a colorless oil. MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 62); 227 (38). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.87–3.02 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.75 (s, 3H, OCH<sub>3</sub>), 3.86 (s, 3H, OCH<sub>3</sub>), 5.14 (s, 2H, OCH<sub>2</sub>), 6.72–7.35 (m, 11H, Ar), 7.52 (d, 1H, <i>J</i> = 7.7 Hz, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 159.66, 156.93, 156.82, 144.31, 130.69, 130.07, 129.25, 128.78, 128.31, 127.29, 125.99, 121.04, 120.62, 114.17, 111.97, 111.43, 110.24, 65.31, 55.46, 55.24, 36.63, 33.19. Anal. (C<sub>23</sub>H<sub>24</sub>O<sub>3</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 16350.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-[(4-Methoxybenzyl)oxy]-2-(2-phenylethyl)benzene (<b>13a</b>)</h4><div class="NLM_p last">Purified with hexane/Et<sub>2</sub>O (95:5) to (94% yield) as an oil. MS <i>m</i>/<i>z</i> 318 (M<sup>+</sup>, 16); 121 (100). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.83–3.00 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.83 (s, 3H, OCH<sub>3</sub>), 5.03 (s, 2H, OCH<sub>2</sub>), 6.85–6.95 (m, 4H, Ar), 7.11–7.40 (m, 9H, Ar).<sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 159.42, 156.82, 142.58, 130.80, 130.12, 129.65, 128.94, 128.62, 128.31, 127.25, 125.79, 120.73, 114.07, 111.86, 69.91, 55.46, 36.57, 33.10. Anal. (C<sub>22</sub>H<sub>22</sub>O<sub>2</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 14810.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-[(4-Methoxybenzyl)oxy]-2-[2-(3-methoxyphenyl)ethyl]benzene (<b>13b</b>)</h4><div class="NLM_p last">Purified with hexane/Et<sub>2</sub>O (4:1) (70% yield) as a semisolid. MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 55); 228 (76). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.81–2.97 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.74 (s, 3H, OCH<sub>3</sub>), 3.83 (s, 3H, OCH<sub>3</sub>), 5.02 (s, 2H, OCH<sub>2</sub>), 6.69–6.77 (m, 3H, Ar), 6.85–6.96 (m, 4H, Ar), 7.13–7.23 (m, 3H, Ar), 7.38 (d, 2H, <i>J</i> = 8.6 Hz, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 159.02, 158.79, 156.18, 143.58, 130.09, 129.49, 129.0, 128.60, 128.34, 126.63, 120.40, 120.09, 113.54, 113.43, 111.21, 110.81, 69.28, 54.80, 54.58, 36.00, 32.40. Anal. (C<sub>23</sub>H<sub>24</sub>O<sub>3</sub>) C, H. UV–vis (solvent: PBS) λ = 225 nm, ϵ = 22560.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-[(2,3-Dimethoxybenzyl)oxy]-2-(2-phenylethyl)benzene (<b>14a</b>)</h4><div class="NLM_p last">Purified with CHCl<sub>3</sub> (25% yield) as an oil. MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 65). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.90–2.98 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.89 (s, 3H, OCH<sub>3</sub>), 3.90 (s, 3H, OCH<sub>3</sub>), 5.16 (s, 2H, OCH<sub>2</sub>), 6.85–7.29 (m, 12H, Ar), <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 156.84, 152.63, 146.86, 142.56, 131.46, 130.67, 130.05, 128.58, 128.29, 127.29, 125.76, 124.17, 123.24, 120.71, 112.26, 111.94, 65.21, 61.10, 56.00, 36.56, 33.00. Anal. (C<sub>23</sub>H<sub>24</sub>O<sub>3</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 22560.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 1-[(2,3-Dimethoxybenzyl)oxy]-2-[2-(3-methoxyphenyl)ethyl]benzene (<b>14b</b>)</h4><div class="NLM_p last">Purified by CHCl<sub>3</sub> (24% yield) as an oil. MS <i>m</i>/<i>z</i> 378 (M<sup>+</sup>, 71). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.83–3.00 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.75 (s, 3H, OCH<sub>3</sub>), 3.89 (s, 3H, OCH<sub>3</sub>), 3.90 (s, 3H, OCH<sub>3</sub>), 5.17 (s, 2H, OCH<sub>2</sub>), 6.72–7.26 (m, 11H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 160.33, 157.49, 153.29, 147.52, 144.86, 132.11, 131.29, 130.73, 129.87, 127.96, 127.96, 124.85, 121.70, 121.41, 114.85, 112.90, 112.58, 112.10, 65.87, 61.75, 56.64, 55.88, 37.28, 33.61. Anal. (C<sub>24</sub>H<sub>26</sub>O<sub>4</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 10420.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-[(3,4-Dimethoxybenzyl)oxy]-2-(2-phenylethyl)benzene (<b>15a</b>)</h4><div class="NLM_p last">Purified with hexane/Et<sub>2</sub>O (95:5) (15% yield) as an oil. MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 25); 210 (76). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.88–3.03 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.84 (s, 3H, OCH<sub>3</sub>), 3.91(s, 3H, OCH<sub>3</sub>), 5.04 (s, 2H, OCH<sub>2</sub>), 6.86–7.02 (m, 6H, Ar), 7.11–7.31 (m, 6H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 156.78, 149.34, 148.94, 142.49, 130.82, 130.20, 130.11, 128.51, 128.31, 127.27, 125.81, 120.84, 119.93, 111.99, 111.43, 110.99, 70.19, 56.15, 56.00, 36.54, 33.00. Anal. (C<sub>23</sub>H<sub>24</sub>O<sub>3</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 15250.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-[(3,4-Dimethoxybenzyl)oxy]-2-[2-(3-methoxyphenyl)ethyl]benzene (<b>15b</b>)</h4><div class="NLM_p last">Purified with CHCl<sub>3</sub> (16% yield) as an oil. MS <i>m</i>/<i>z</i> 378 (M<sup>+</sup>, 38); 227 (85). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.83–3.02 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.74 (s, 3H, OCH<sub>3</sub>), 3.84 (s, 3H, OCH<sub>3</sub>), 3.90 (s, 3H, OCH<sub>3</sub>), 5.03 (s, 2H, OCH<sub>2</sub>), 6.70–6.78 (m, 3H, Ar), 6.86–7.01 (m, 5H, Ar), 7.13–7.24 (m, 3H, Ar), <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 160.33, 157.42, 149.96, 149.56, 144.73, 131.37, 130.75, 129.85, 127.89, 121.57, 121.46, 120.57, 114.89, 112.61, 112.06, 111.96, 111.65, 70.81, 56.75, 56.64, 55.80, 37.21, 33.53, 31.57. Anal. (C<sub>24</sub>H<sub>26</sub>O<sub>4</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 11350.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-[(3,5-Dimethoxybenzyl)oxy]-2-(2-phenylethyl)benzene (<b>16a</b>)</h4><div class="NLM_p last">Purified with hexane/CHCl<sub>3</sub> (1:1) (26% yield) as an oil. MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 50); 198 (67). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.89–3.02 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.77 (s, 6H, OCH<sub>3</sub>), 5.04 (s, 2H, OCH<sub>2</sub>), 6.42 (t, 1H, <i>J</i> = 2.1 Hz, Ar), 6.62 (d, 2H, <i>J</i> = 2.1 Hz, Ar), 6.86–6.93 (m, 2H, Ar), 7.12–7.30 (m, 7H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 161.79, 157.35, 143.15, 140.69, 131.42, 130.82, 129.22, 128.96, 127.94, 126.47, 121.53, 112.57, 105.71, 100.61, 70.71, 56.13, 37.21, 33.68. Anal. (C<sub>23</sub>H<sub>24</sub>O<sub>3</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 15377.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-[(3,5-Dimethoxybenzyl)oxy]-2-[2-(3-methoxyphenyl)ethyl]benzene (<b>16b</b>)</h4><div class="NLM_p last">Purified with hexane/CHCl<sub>3</sub> (3:7) (43% yield) as an oil. MS <i>m</i>/<i>z</i> 378 (M<sup>+</sup>, 22); 227 (93). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.86–3.05 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.75 (s, 3H, OCH<sub>3</sub>), 3.77 (s, 6H, OCH<sub>3</sub>), 5.04 (s, 2H, OCH<sub>2</sub>), 6.42 (t, 1H, <i>J</i> = 2.3 Hz, Ar), 6.62 (d, 2H, <i>J</i> = 2.3 Hz, Ar), 6.71–6.93 (m, 4H, Ar), 7.12–7.21 (m, 4H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 161.79, 160.39, 157.35, 144.77, 140.67, 131.40, 130.84, 129.89, 127.96, 121.66, 121.57, 114.87, 112.59, 112.14, 105.73, 100.59, 70.75, 56.11, 55.87, 37.28, 33.60. Anal. (C<sub>24</sub>H<sub>26</sub>O<sub>4</sub>) C, H. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 16350.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-{[2-(2-Phenylethyl)phenoxy]methyl}pyridine (<b>17a</b>)</h4><div class="NLM_p last">The oil <b>17a</b> was transformed to the hydrochloride salt, a white solid (343 mg, 1.1 mmol, 56% yield). Mp: 120–122 °C. MS <i>m</i>/<i>z</i> 289 (M<sup>+</sup>, 37); 196 (40). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.89–3.08 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 5.22 (s, 2H, OCH<sub>2</sub>), 6.73–6.77 (d, 1H, <i>J</i> = 7.9 Hz, Ar), 6.97–7.26 (m, 8H, Ar), 7.86 (d, 2H, <i>J</i> = 6.2 Hz, Py), 8.77 (d, 2H, <i>J</i> = 6.2 Hz, Py). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 157.77, 154.33, 141.11, 140.36, 130.09, 129.91, 127.85, 127.71, 126.89, 125.40, 123.45, 121.71, 111.17, 66.93, 36.08, 31.37. Anal. (C<sub>20</sub>H<sub>19</sub>NO·HCl) C, H, N. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 13260.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-({2-[2-(3-Methoxyphenyl)ethyl]phenoxy}methyl)pyridine (<b>17b</b>)</h4><div class="NLM_p last">The oil <b>17b</b> was transformed to the hydrochloride salt, a white solid (158 mg, 0.44 mmol, 51% yield). Mp: 117–119 °C. MS <i>m</i>/<i>z</i> 319 (M<sup>+</sup>, 100); 240 (35). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.91–3.10 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.75 (s, 3H, OCH<sub>3</sub>), 5.25 (s, 2H, OCH<sub>2</sub>), 6.67–6.88 (m, 4H, Ar), 7.00–7.29 (m, 4H, Ar), 7.92 (d, 2H, <i>J</i> = 5.8 Hz, Py), 8.82 (d, 2H, <i>J</i> = 5.8 Hz, Py). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 160.28, 158.90, 155.62, 144.04, 141.65, 131.46, 131.27, 130.02, 128.22, 124.68, 123.15, 121.61, 115.29, 112.41, 111.76, 68.18, 55.93, 37.47, 32.55. Anal. (C<sub>21</sub>H<sub>21</sub>NO<sub>2</sub>HCl) C, H, N. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 14690.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure To Synthesize Final Compounds <b>22</b>–<b>24</b></h3><div class="NLM_p">To a solution of <b>21</b> (100 mg, 0.44 mmol) in acetonitrile (3 mL) in a microwave vial were added the appropriate methoxybenzylchloride (23 mg, 0.15 mmol) and KI (2.4 mg, 0.015 mmol). The vial was sealed and heated in a microwave at 110 °C, 150 W, 200 PSI for 10 min. The cooled reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and washed successively with H<sub>2</sub>O. Then, the organic layer was dried and evaporated to dryness.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(2-Methoxybenzyl)-2-[2-(3-methoxyphenyl)ethyl]aniline (<b>22</b>)</h4><div class="NLM_p last">The crude product was purified by chromatography, eluting with hexane/CHCl<sub>3</sub> (7:3) to give <b>22</b> (44.8 mg, 0.129 mmol, 30% yield). MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 84%); 227 (100). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.72–2.96 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.76 (s, 3H, OMe), 3.84 (s, 3H, OMe), 4.35 (s, 2H, NCH<sub>2</sub>), 6.65–7.29 (m, 12H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 159.82, 157.57, 146.0, 143.77, 129.49, 129.13, 128.43, 127.43, 125.83, 120.86, 120.71, 117.31, 114.27, 111.55, 111.10, 110.46, 55.46, 55.31, 43.98, 35.35, 33.53. Anal. (C<sub>23</sub>H<sub>25</sub>NO<sub>2</sub>) C, H, N. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 16333.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(3-Methoxybenzyl)-2-[2-(3-methoxyphenyl)ethyl]aniline (<b>23</b>)</h4><div class="NLM_p last">The crude product was purified by chromatography, eluting with hexane/CHCl<sub>3</sub> (1:1) to give <b>23</b> (29.8 mg, 0.086 mmol, 20% yield). MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 47); 227 (97). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.73–2.98 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.75 (s, 3H, OCH<sub>3</sub>), 3.80 (s, 3H, OCH<sub>3</sub>), 4.28 (s, 2H, NCH<sub>2</sub>), 6.60–6.96 (m, 8H, Ar), 7.07–7.30 (m, 4H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 160.0, 160.50, 145.77, 143.58, 141.34, 129.76, 129.53, 129.05, 127.49, 120.88, 119.86, 117.64, 114.23, 111.30, 112.77, 111.72, 110.88, 55.36, 55.29, 48.65, 35.48, 33.42. Anal. (C<sub>23</sub>H<sub>25</sub>NO<sub>2</sub>) C, H, N. UV–vis (solvent: PBS) λ = 230 nm, ϵ = 16333.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(4-Methoxybenzyl)-2-[2-(3-methoxyphenyl)ethyl]aniline (<b>24</b>)</h4><div class="NLM_p last">The crude product was purified by chromatography, eluting with hexane/CHCl<sub>3</sub> (4:6) to give an oil <b>24</b>, which was transformed to the hydrochloride salt (26.9 mg, 0.07 mmol, 15% yield). MS <i>m</i>/<i>z</i> 348 (M<sup>+</sup>, 70%); 227 (100). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.75–2.96 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.75 (s, 3H, OMe), 3.79 (s, 3H, OMe), 4.24 (s, 2H, NCH<sub>2</sub>), 6.71–6.87 (m, 6H, Ar), 7.09–7.28 (m, 6H, Ar). Anal. (C<sub>23</sub>H<sub>25</sub>NO<sub>2</sub>·HCl) C, H, N.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure To Synthesize Final Compounds <b>25</b>–<b>27</b></h3><div class="NLM_p">To a solution of <b>21</b> (200 mg, 0.88 mmol) in ethanol (10 mL) was added the appropriate dimethoxybenzylaldehyde (146 mg, 0.88 mmol), and the resulting solution was stirred and refluxed for 12 h until the disappearance of the aniline <b>21</b>. The reaction mixture was then cooled at 0 °C and treated with a solution of NaBH<sub>4</sub> (33.3 mg, 0.88 mmol) in H<sub>2</sub>O (2 mL). The suspension was stirred at room temperature for 3 h, and then it was concentrated to dryness.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-[(2,3-Dimethoxy)benzyl]-2-[2-(3-methoxyphenyl)ethyl]aniline (<b>25</b>)</h4><div class="NLM_p last">The crude product was purified by chromatography, eluting with hexane/AcOEt (8:2) to give <b>25</b> as an oil (93.8 mg, 0.25 mmol, 28% yield). MS <i>m</i>/<i>z</i> 378 (M<sup>+</sup>, 65%); 227 (100). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.72–2.97 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.76 (s, 3H, OMe), 3.87 (s, 6H, OMe), 4.36 (s, 2H, NCH<sub>2</sub>), 6.65–7.25 (m, 11H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 160.41, 153.50, 147.95, 146.70, 144.31, 133.82, 130.11, 129.60, 128.05, 126.43, 124.83, 121.62, 121.51, 118.04, 114.81, 112.43, 112.26, 111.55, 61.56, 56.58, 55.91, 44.20, 35.99, 34.06. Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>) C, H, N. UV–vis (solvent: PBS) λ = 226 nm, ϵ = 4437.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-[(3,4-Dimethoxy)benzyl]-2-[2-(3-methoxyphenyl)ethyl]aniline (<b>26</b>)</h4><div class="NLM_p last">The crude product was purified by chromatography, eluting with hexane/AcOEt (8:2) to give <b>26</b> as an oil (64.2 mg, 0.20 mmol, 22% yield). MS <i>m</i>/<i>z</i> 378 (M<sup>+</sup>, 54%); 227 (100). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.73–2.96 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.74 (s, 3H, OMe), 3.86 (s, 3H, OMe), 3.88 (s, 3H, OMe), 4.24 (s, 2H, NCH<sub>2</sub>), 6.64–6.91 (m, 8H, Ar), 7.08–7.26 (m, 3H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 159.95, 149.63, 148.72, 145.93, 143.60, 132.40, 129.53, 129.14, 127.51, 125.87, 120.90, 119.97, 117.71, 114.36, 112.01, 111.74, 111.52, 111.01, 56.30, 56.18, 55.31, 48.63, 35.57, 33.42. Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>) C, H, N. UV–vis (solvent: PBS) λ = 226 nm, ϵ = 47970.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-[(3,5-Dimethoxy)benzyl]-2-[2-(3-methoxyphenyl)ethyl]aniline (<b>27</b>)</h4><div class="NLM_p last">The crude product was purified by chromatography, eluting with hexane/AcOEt (9:1) to give <b>27</b> as an oil (81.8 mg, 0.22 mmol, 24% yield). MS <i>m</i>/<i>z</i> 378 (M<sup>+</sup>, 54%); 227 (100). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.74–2.99 (m, 4H, CH<sub>2</sub>CH<sub>2</sub>), 3.75 (s, 3H, OMe), 3.78 (s, 6H, OMe), 4.25 (s, 2H, NCH<sub>2</sub>), 6.38 (t, 1H, <i>J</i> = 2.4 Hz, Ar), 6.54 (d, 2H, <i>J</i> = 2.4 Hz, Ar), 6.61–6.84 (m, 4H, Ar), 7.02–7.24 (m, 4H, Ar). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 161.81, 160.43, 146.37, 144.18, 142.82, 130.15, 129.65, 128.12, 127.87, 126.32, 121.48, 119.62, 118.26, 116.43, 114.83, 112.30, 111.48, 106.17, 99.90, 56.09, 55.89, 49.45, 36.06, 34.06. Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>) C, H, N.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Biological Method</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Cell Lines</h4><div class="NLM_p last">The breast cancer cell line of human origin, MCF-7/Adr (resistant to adriamycin or doxorubicin), was routinely cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin in a humidified incubator at 37 °C with a 5% CO<sub>2</sub> atmosphere. Caco-2 cells were grown in DMEM medium with 10% heat-inactivated fetal bovine serum, 100 U/mL penicillin, 100 µg/mL streptomycin, and 2 mM <span class="smallcaps smallerCapital">L</span>-glutamine.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Permeability Experiments</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Preparation of the Caco-2 Monolayer</h4><div class="NLM_p last">This procedure has been previously reported by Leopoldo et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Briefly, Caco-2 cells were harvested with trypsin-EDTA and seeded onto a MultiScreen Caco-2 assay system at a density of 10 000 cells/well. The culture medium was replaced every 48 h for the first 6 days and every 24 h thereafter, and after 21 days in culture, the Caco-2 monolayer was utilized for the permeability experiments. The trans-epitelial electrical resistance (TEER) of the monolayers was measured daily before and after the experiment by using a epithelial voltohommeter (Millicell-ERS; Millipore, Billerica, MA). Generally, the TEER values obtained are greater than 1000 Ω for a 21 day culture.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Drug Transport Experiment</h4><div class="NLM_p">The apical to basolateral [<i>P</i><sub>app</sub>(A-B)] and basolateral to apical [<i>P</i><sub>app</sub>(B-A)] permeabilities of drugs were measured at 120 min and at various drug concentrations (1–100 µM).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Drugs were dissolved in Hank’s balanced salt solution (HBSS, pH 7.4) and sterile filtered. After 21 days of cell growth, the medium was removed from filter wells and from the receiver plate. The filter wells were filled with 75 µL of fresh HBSS buffer, and the receiver plate was filled with 250 µL per well of the same buffer. This procedure was repeated twice, and the plates were incubated at 37 °C for 30 min. After the incubation time, the HBSS buffer was removed, and drug solutions were added to the filter well (75 µL). HBSS without the drug was added to the receiver plate (250 µL). The plates were incubated at 37 °C for 120 min. After the incubation time, samples were removed from the apical (filter well) and basolateral (receiver plate) sides of the monolayer and then were stored in a freezer (−20 °C) pending analysis.</div><div class="NLM_p">The concentration of compounds was analyzed using UV–vis spectroscopy.</div><div class="NLM_p">The apparent permeability (<i>P</i><sub>app</sub>), in units of nanometers per second, was calculated using the following equation: <span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/jm-2007-01267q_m001.gif" alt="" /></img></span> where <i>V</i><sub>A</sub> is the volume (in mL) in the acceptor well, area is the surface area of the membrane (0.11 cm<sup>2</sup> of the well), time is the total transport time in seconds (7200 s), [drug]<sub>acceptor</sub> is the concentration of the drug measured by UV spectroscopy, and [drug]<sub>initial</sub> is the initial drug concentration (1 × 10<sup>−4</sup> M) in the apical or basolateral wells.</div><div id="sec4_6_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Cell ATP Availability Assay</h5><div class="NLM_p last">This experiment was performed as reported in the technical sheet of the ATPlite firstep Kit for luminescence ATP detection using Victor3, from PerkinElmer Life Sciences.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Caco-2 cells were seeded into a 96 well microplate in 100 µL of complete medium at a density of 2 × 10<sup>4</sup> cells/well. The plate was incubated O/N in a humidified atmosphere, 5% CO<sub>2</sub> at 37 °C. The medium was removed, and 100 µL of complete medium in the presence or absence of different concentrations of test compounds was added. The plate was incubated for 2 h in a humidified atmosphere, 5% CO<sub>2</sub> at 37 °C. Then, 50 µL of mammalian cell lysis solution was added to all wells, and the plate was stirred for 5 min in an orbital shaker. In all wells, 50 µL of substrate solution was added, and the plate was stirred for 5 min as above-reported. The plate was dark adapted for 10 min, and the luminescence was measured in Victor3.</div></div><div id="sec4_6_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> [<sup>3</sup>H]-Vinblastine Transport Inhibition</h5><div class="NLM_p">Caco-2 cells were seeded onto multiscreen plates, 10 000 cells/well for 21 days, measuring the integrity of the cell monolayers by trans-epithelial electrical resistance (TEER, Ω × cm<sup>2</sup>) with an epithelial voltohommeter. A mature Caco-2 cell monolayer exhibited a TEER > 800 Ω × cm<sup>2</sup> prior to use in transport experiments. Transport experiments for tested compounds were carried out as described by Taub et al.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p last">In each well to basolateral (BL) compartment, in the absence and in the presence of P-gp inhibitors (from 0.20 to 400 µM) was added 20 nM [<sup>3</sup>H]-vinblastine for 120 min at 37 °C, and its appearance in the apical (AP) compartment was monitored. At 120 min, a 20 µL sample was taken from the donor compartment to determine the concentration of radioligand remaining in the donor chamber at the end of the experiment. Samples were analyzed by using a LS6500 Beckman counter. For each compound, [<sup>3</sup>H]-vinblastine transport inhibition was calculated as the radioactivity difference between radioligand in the presence and absence of compound. These differences were expressed as a percentage of inhibition effect for each single drug concentration.</div></div><div id="sec4_6_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> [<sup>3</sup>H]-Mitoxantrone Transport Inhibition</h5><div class="NLM_p">Caco-2 cells were seeded onto multiscreen plates, 10 000 cells/well for 21 days, measuring the integrity of the cell monolayers by trans-epithelial electrical resistance (TEER, Ω × cm<sup>2</sup>) with an epithelial voltohommeter. A mature Caco-2 cell monolayer exhibited a TEER > 800 Ω × cm<sup>2</sup> prior to use in transport experiments. Transport experiments for tested compounds were carried out as described by Taub et al.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p last">In each well to basolateral (BL) compartment, in the absence and in the presence of P-gp inhibitors (from 0.20 to 400 µM) was added 20 nM [<sup>3</sup>H]-mitoxantrone for 120 min at 37 °C, and its appearance in the apical (AP) compartment was monitored. At 120 min, a 20 µL sample was taken from the donor compartment to determine the concentration of radioligand remaining in the donor chamber at the end of the experiment. Samples were analyzed by using a LS6500 Beckman counter. For each compound, [<sup>3</sup>H]-mitoxantrone transport inhibition was calculated as the radioactivity difference between radioligand in the presence and absence of compound. These differences were expressed as a percentage of inhibition effect for each single drug concentration.</div></div><div id="sec4_6_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Cytotoxicity Assay</h5><div class="NLM_p last">The assay was performed by using the CytoTox-One kit from the Promega Corp. (Madison, WI), as reported in a previous paper.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Cell death was determined as the release of lactate dehydrogenase (LDH) into the culture medium. The percentage of cytotoxicity was calculated relative to the LDH release from total lysis of cells in the untreated control. It is assumed here that the drug-treated wells and the control wells contained the same total number of cells (dead plus alive cells) at the end of the treatment period. Therefore, the cytotoxic effect of tested compounds was unaffected by any underestimation of cytotoxicity that could occur because of the decreased total number of cells in the treated samples as compared to that of the untreated control. Cells were seeded into 96 well plates for optical performance in the fluorescent cell-based assay in 100 µL of complete medium in the presence or absence of different concentrations of test compounds. The plate was incubated for 24 h in a humidified atmosphere, 5% CO<sub>2</sub> at 37 °C, and then 100 µL of substrate mix in assay buffer was added. Lysis solution (10 µL) was added to the untreated wells in order to estimate total LDH. Plates were kept protected from light for 10 min at room temperature, and 50 µL of stop solution was added to all wells. The fluorescence was recorded using a PerkinElmer LS55 luminescence spectrometer with a 560 nm excitation wavelength and a 590 nm emission wavelength. The cytotoxicity percentage was estimated as follows: <span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/jm-2007-01267q_m002.gif" alt="" /></img></span></div></div><div id="sec4_6_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> Statistical Analysis</h5><div class="NLM_p last">The EC<sub>50</sub> values of the compounds reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were determined by nonlinear curve fitting utilizing the GraphPad Prism program.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/jm701267q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis of compounds <b>11a</b>,<b>b</b>, <b>13a</b>,<b>b</b>, <b>14a</b>,<b>b</b>, <b>15a</b>,<b>b</b>, <b>16a</b>,<b>b</b>, <b>17a</b>,<b>b</b>, and <b>22</b>−<b>27</b> and experimental section for key intermediates <b>18</b>, <b>20</b>, and <b>21</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701267q/suppl_file/jm701267q-file002.pdf">jm701267q-file002.pdf (60.31 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701267q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45532" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45532" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola Antonio Colabufo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c4f43404d4e594a436c4a4d5e414f444541025942454e4d0245580c5e4d5c5c5f456c4a4d5e41025942455c45024558"><span class="__cf_email__" data-cfemail="43202c2f222136252c032522312e202b2a2e6d362d2a21226d2a37">[email protected]</span> <span class="__cf_email__" data-cfemail="5c2e3d2c2c2f351c3a3d2e31722932352c35723528">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simona Rapposelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ae9e5e6ebe8ffece5caecebf8e7e9e2e3e7a4ffe4e3e8eba4e3feaaf8ebfafaf9e3caecebf8e7a4ffe4e3fae3a4e3fe"><span class="__cf_email__" data-cfemail="13707c7f727166757c537572617e707b7a7e3d667d7a71723d7a67">[email protected]</span> <span class="__cf_email__" data-cfemail="4d3f2c3d3d3e240d2b2c3f20633823243d24632439">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Berardi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Perrone</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Digiacomo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Vanni</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aldo Balsamo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmacochimico, Universitá degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy, and Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno, 6, 56126 Pisa, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Klein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadi, A.</span><span> </span><span class="NLM_article-title">An inventory of the human ABC proteins</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">1461</span> <span class="NLM_fpage">237</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1461&publication_year=1999&pages=237-262&author=I.+Kleinauthor=B.+Sarkadiauthor=A.+Varadi&title=An+inventory+of+the+human+ABC+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DI.%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DVaradi%26aufirst%3DA.%26atitle%3DAn%2520inventory%2520of%2520the%2520human%2520ABC%2520proteins%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1999%26volume%3D1461%26spage%3D237%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrycyna, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Biochemical, cellular, and pharmacological aspects of the multidrug transporter</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">39</span> <span class="NLM_fpage">361</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=361-398&author=S.+V.+Ambudkarauthor=S.+Deyauthor=C.+A.+Hrycynaauthor=M.+Ramachandraauthor=I.+Pastanauthor=M.+M.+Gottesman&title=Biochemical%2C+cellular%2C+and+pharmacological+aspects+of+the+multidrug+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DRamachandra%26aufirst%3DM.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DBiochemical%252C%2520cellular%252C%2520and%2520pharmacological%2520aspects%2520of%2520the%2520multidrug%2520transporter%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1999%26volume%3D39%26spage%3D361%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ayrton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, P.</span><span> </span><span class="NLM_article-title">Role of transport proteins in drug absorption, distribution, and excretion</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">31</span> <span class="NLM_fpage">469</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=469-497&author=A.+Ayrtonauthor=P.+Morgan&title=Role+of+transport+proteins+in+drug+absorption%2C+distribution%2C+and+excretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAyrton%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DP.%26atitle%3DRole%2520of%2520transport%2520proteins%2520in%2520drug%2520absorption%252C%2520distribution%252C%2520and%2520excretion%26jtitle%3DXenobiotica%26date%3D2001%26volume%3D31%26spage%3D469%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzhetsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allikmets, R.</span><span> </span><span class="NLM_article-title">The human ATP-binding cassette (ABC) transporter superfamily</span> <span class="citation_source-journal">Genome Res.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">1156</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1101%2Fgr.GR-1649R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11435397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFaitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1156-1166&author=M.+Deanauthor=A.+Rzhetskyauthor=R.+Allikmets&title=The+human+ATP-binding+cassette+%28ABC%29+transporter+superfamily"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The human ATP-binding cassette (ABC) transporter superfamily</span></div><div class="casAuthors">Dean, Michael; Rzhetsky, Andrey; Allikmets, Rando</div><div class="citationInfo"><span class="NLM_cas:title">Genome Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1156-1166</span>CODEN:
                <span class="NLM_cas:coden">GEREFS</span>;
        ISSN:<span class="NLM_cas:issn">1088-9051</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The ATP-binding cassette (ABC) transporter superfamily contains membrane proteins that translocate a variety of substrates across extra- and intra-cellular membranes.  Genetic variation in these genes is the cause of or contributor to a wide variety of human disorders with Mendelian and complex inheritance, including cystic fibrosis, neurol. disease, retinal degeneration, cholesterol and bile transport defects, anemia, and drug response.  Conservation of the ATP-binding domains of these genes has allowed the identification of new members of the superfamily based on nucleotide and protein sequence homol.  Phylogenetic anal. is used to divide all 48 known ABC transporters into seven distinct subfamilies of proteins.  For each gene, the precise map location on human chromosomes, expression data, and localization within the superfamily has been detd.  These data allow predictions to be made as to potential functions or disease phenotypes assocd. with each protein.  In this paper, we review the current state of knowledge on all human ABC genes in inherited disease and drug resistance.  In addn., the availability of the complete Drosophila genome sequence allows the comparison of the known human ABC genes with those in the fly genome.  The combined data enable an evolutionary anal. of the superfamily.  Complete characterization of all ABC from the human genome and from model organisms will lead to important insights into the physiol. and the mol. basis of many human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8mm8uHciH1bVg90H21EOLACvtfcHk0lgvJXCzmurtHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFaitL0%253D&md5=caf7aa211f2b2603fb84c6690fe0bad5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fgr.GR-1649R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.GR-1649R%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DM.%26aulast%3DRzhetsky%26aufirst%3DA.%26aulast%3DAllikmets%26aufirst%3DR.%26atitle%3DThe%2520human%2520ATP-binding%2520cassette%2520%2528ABC%2529%2520transporter%2520superfamily%26jtitle%3DGenome%2520Res.%26date%3D2001%26volume%3D11%26spage%3D1156%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hyde, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimmack, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gileadi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, C. F.</span><span> </span><span class="NLM_article-title">Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance, and bacterial transport</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">346</span> <span class="NLM_fpage">362</span> <span class="NLM_lpage">365</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=362-365&author=S.+C.+Hydeauthor=P.+Emsleyauthor=M.+J.+Hartshornauthor=M.+M.+Mimmackauthor=U.+Gileadiauthor=S.+R.+Pearceauthor=M.+P.+Gallagherauthor=D.+R.+Gillauthor=R.+E.+Hubbardauthor=C.+F.+Higgins&title=Structural+model+of+ATP-binding+proteins+associated+with+cystic+fibrosis%2C+multidrug+resistance%2C+and+bacterial+transport"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHyde%26aufirst%3DS.%2BC.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMimmack%26aufirst%3DM.%2BM.%26aulast%3DGileadi%26aufirst%3DU.%26aulast%3DPearce%26aufirst%3DS.%2BR.%26aulast%3DGallagher%26aufirst%3DM.%2BP.%26aulast%3DGill%26aufirst%3DD.%2BR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DHiggins%26aufirst%3DC.%2BF.%26atitle%3DStructural%2520model%2520of%2520ATP-binding%2520proteins%2520associated%2520with%2520cystic%2520fibrosis%252C%2520multidrug%2520resistance%252C%2520and%2520bacterial%2520transport%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D362%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Quinton, P. M.</span><span> </span><span class="NLM_article-title">Physiological basis of cystic fibrosis: a historical perspective</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">79</span> <span class="NLM_fpage">S3</span> <span class="NLM_lpage">S22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=S3-S22&author=P.+M.+Quinton&title=Physiological+basis+of+cystic+fibrosis%3A+a+historical+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuinton%26aufirst%3DP.%2BM.%26atitle%3DPhysiological%2520basis%2520of%2520cystic%2520fibrosis%253A%2520a%2520historical%2520perspective%26jtitle%3DPhysiol.%2520Rev.%26date%3D1999%26volume%3D79%26spage%3DS3%26epage%3DS22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Remaley, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rust, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naudin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broccardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnould, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duverger, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamarina-Fojo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredrickson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denefle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, H. B.</span><span> </span><span class="NLM_article-title">Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">12685</span> <span class="NLM_lpage">12690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12685-12690&author=A.+T.+Remaleyauthor=S.+Rustauthor=M.+Rosierauthor=C.+Knapperauthor=L.+Naudinauthor=C.+Broccardoauthor=K.+M.+Petersonauthor=C.+Kochauthor=I.+Arnouldauthor=C.+Pradesauthor=N.+Duvergerauthor=H.+Funkeauthor=G.+Assmanauthor=M.+Dingerauthor=M.+Deanauthor=G.+Chiminiauthor=S.+Santamarina-Fojoauthor=D.+S.+Fredricksonauthor=P.+Denefleauthor=H.+Bryanauthor=H.+B.+Brewer&title=Human+ATP-binding+cassette+transporter+1+%28ABC1%29%3A+genomic+organization+and+identification+of+the+genetic+defect+in+the+original+Tangier+disease+kindred"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRemaley%26aufirst%3DA.%2BT.%26aulast%3DRust%26aufirst%3DS.%26aulast%3DRosier%26aufirst%3DM.%26aulast%3DKnapper%26aufirst%3DC.%26aulast%3DNaudin%26aufirst%3DL.%26aulast%3DBroccardo%26aufirst%3DC.%26aulast%3DPeterson%26aufirst%3DK.%2BM.%26aulast%3DKoch%26aufirst%3DC.%26aulast%3DArnould%26aufirst%3DI.%26aulast%3DPrades%26aufirst%3DC.%26aulast%3DDuverger%26aufirst%3DN.%26aulast%3DFunke%26aufirst%3DH.%26aulast%3DAssman%26aufirst%3DG.%26aulast%3DDinger%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DChimini%26aufirst%3DG.%26aulast%3DSantamarina-Fojo%26aufirst%3DS.%26aulast%3DFredrickson%26aufirst%3DD.%2BS.%26aulast%3DDenefle%26aufirst%3DP.%26aulast%3DBryan%26aufirst%3DH.%26aulast%3DBrewer%26aufirst%3DH.%2BB.%26atitle%3DHuman%2520ATP-binding%2520cassette%2520transporter%25201%2520%2528ABC1%2529%253A%2520genomic%2520organization%2520and%2520identification%2520of%2520the%2520genetic%2520defect%2520in%2520the%2520original%2520Tangier%2520disease%2520kindred%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D12685%26epage%3D12690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Brooks-Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roomp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molhuizen, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loubser, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouelette, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fichter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashbourne-Excoffon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martindale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohlich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koop, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimstone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastelein, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span> </span><span class="NLM_article-title">Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">22</span> <span class="NLM_fpage">336</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1038%2F11905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=10431236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADyaK1MXltVSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=336-345&author=A.+Brooks-Wilsonauthor=M.+Marcilauthor=S.+M.+Cleeauthor=L.+H.+Zhangauthor=K.+Roompauthor=M.+van+Damauthor=L.+Yuauthor=C.+Brewerauthor=J.+A.+Collinsauthor=H.+O.+Molhuizenauthor=O.+Loubserauthor=B.+F.+Oueletteauthor=K.+Fichterauthor=K.+J.+Ashbourne-Excoffonauthor=C.+W.+Sensenauthor=S.+Schererauthor=S.+Mottauthor=M.+Denisauthor=D.+Martindaleauthor=J.+Frohlichauthor=K.+Morganauthor=B.+Koopauthor=S.+Pimstoneauthor=J.+J.+Kasteleinauthor=J.+Genestauthor=M.+R.+Hayden&title=Mutations+in+ABC1+in+Tangier+disease+and+familial+high-density+lipoprotein+deficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency</span></div><div class="casAuthors">Brooks-Wilson, Angela; Marcil, Michel; Clee, Susanne M.; Zhang, Lin-Hua; Roomp, Kirsten; Van Dam, Marjel; Yu, Lu; Brewer, Carl; Collins, Jennifer A.; Molhuizen, Henri O. F.; Loubser, Odell; Ouelette, B. F. Francis; Fichter, Keith; Ashbourne-Excoffon, Katherine J. D.; Sensen, Christoph W.; Scherer, Stephen; Mott, Stephanie; Denis, Maxime; Martindale, Duane; Frohlich, Jiri; Morgan, Kenneth; Koop, Ben; Pimstone, Simon; Kastelein, John J. P.; Genest, Jacques, Jr.; Hayden, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">336-345</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Genes have a major role in the control of high-d. lipoprotein (HDL) cholesterol (HDL-C) levels.  Here the authors have identified two Tangier disease (TD) families, confirmed 9q31 linkage and refined the disease locus to a limited genomic region contg. the gene encoding the ATP-binding cassette transporter (ABC1).  Familial HDL deficiency (FHA) is a more frequent cause of low HDL levels.  On the basis of independent linkage and meiotic recombinants, the authors localized the FHA locus to the same genomic region as the TD locus.  Mutations in ABC1 were detected in both TD and FHA, indicating that TD and FHA are allelic.  This indicates that the protein encoded by ABC1 is a key gatekeeper influencing intracellular cholesterol transport, hence the authors have named it cholesterol efflux regulatory protein (CERP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMR195KgNUo7Vg90H21EOLACvtfcHk0lj-W6GQEQC8lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVSht7c%253D&md5=44506d866805006d05db772830aab871</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F11905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F11905%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks-Wilson%26aufirst%3DA.%26aulast%3DMarcil%26aufirst%3DM.%26aulast%3DClee%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DRoomp%26aufirst%3DK.%26aulast%3Dvan%2BDam%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DBrewer%26aufirst%3DC.%26aulast%3DCollins%26aufirst%3DJ.%2BA.%26aulast%3DMolhuizen%26aufirst%3DH.%2BO.%26aulast%3DLoubser%26aufirst%3DO.%26aulast%3DOuelette%26aufirst%3DB.%2BF.%26aulast%3DFichter%26aufirst%3DK.%26aulast%3DAshbourne-Excoffon%26aufirst%3DK.%2BJ.%26aulast%3DSensen%26aufirst%3DC.%2BW.%26aulast%3DScherer%26aufirst%3DS.%26aulast%3DMott%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DM.%26aulast%3DMartindale%26aufirst%3DD.%26aulast%3DFrohlich%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DK.%26aulast%3DKoop%26aufirst%3DB.%26aulast%3DPimstone%26aufirst%3DS.%26aulast%3DKastelein%26aufirst%3DJ.%2BJ.%26aulast%3DGenest%26aufirst%3DJ.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DMutations%2520in%2520ABC1%2520in%2520Tangier%2520disease%2520and%2520familial%2520high-density%2520lipoprotein%2520deficiency%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D22%26spage%3D336%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bates, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honjo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span> </span><span class="NLM_article-title">New ABC transporters in multi-drug resistance</span> <span class="citation_source-journal">Emerging Ther. Targets</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">561</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1517%2F14728222.4.5.561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2000&pages=561-580&author=E.+S.+Batesauthor=R.+Robeyauthor=T.+Knutsenauthor=Y.+Honjoauthor=T.+Litmanauthor=M.+Dean&title=New+ABC+transporters+in+multi-drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New ABC transporters in multi-drug resistance</span></div><div class="casAuthors">Bates, Susan E.; Robey, Robert; Knutsen, Turid; Honjo, Yasumasa; Litman, Thomas; Dean, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Therapeutic Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-580</span>CODEN:
                <span class="NLM_cas:coden">ETTAF7</span>;
        ISSN:<span class="NLM_cas:issn">1460-0412</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 133 refs.  ATP-binding cassette (ABC) transporters have been the subject of intense scrutiny as potential mediators of clin. drug resistance.  Since the identification of MDR1/P-glycoprotein over 15 yr ago, it has been recognized that reduced intracellular accumulation of anticancer agents can result in significant degrees of drug resistance.  The multi-drug resistance assocd. protein (MRP1) was the second ABC transporter to be assocd. with drug resistance, and in the past three years, five addnl. MRP family members have been recognized.  While studies to define the substrate specificity and normal physiol. for the new transporters is underway, it appears that the principal function for P-glycoprotein and MRP is protection of the host from xenobiotics.  The most recent addn. to the list of ABC transporters mediating drug resistance is the half-transporter, MXR/BCRP/ABCP.  Overexpression of this transporter is assocd. with mitoxantrone, anthracycline and camptothecin resistance.  The discovery of multiple distinct ABC transporters capable of conferring multi-drug resistance offers the possibility that clin. reversal of drug resistance can be achieved.  Studies with P-glycoprotein inhibitors alone have generated mixed results; one potential explanation is that other transporters may be co-expressed.  These addnl. transporters offer new therapeutic targets, as both specific and multi-specific inhibitors should be identified for clin. trials in drug resistance reversal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQcRiZ0hc-zrVg90H21EOLACvtfcHk0ljQ1Hh3zB7P6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yntrk%253D&md5=caef4054d38dd0892eb66b1324ba9951</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F14728222.4.5.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.4.5.561%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DE.%2BS.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DKnutsen%26aufirst%3DT.%26aulast%3DHonjo%26aufirst%3DY.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DM.%26atitle%3DNew%2520ABC%2520transporters%2520in%2520multi-drug%2520resistance%26jtitle%3DEmerging%2520Ther.%2520Targets%26date%3D2000%26volume%3D4%26spage%3D561%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">48</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0ljQ1Hh3zB7P6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Schneider, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, K. H.</span><span> </span><span class="NLM_article-title">Multidrug resistance</span> <span class="citation_source-journal">Cancer Chemother. Biol. Response Modif.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">152</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=10800482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVWiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=152-177&author=E.+Schneiderauthor=D.+Paulauthor=P.+Ivyauthor=K.+H.+Cowan&title=Multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance [to antitumor drugs]</span></div><div class="casAuthors">Schneider, E.; Paul, D.; Ivy, P.; Cowan, K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Biological Response Modifiers</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-177</span>CODEN:
                <span class="NLM_cas:coden">CCBAED</span>;
        ISSN:<span class="NLM_cas:issn">0921-4410</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 179 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbfju0D1x0o7Vg90H21EOLACvtfcHk0lgP0oWv1Mkrrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVWiu7k%253D&md5=47384199bfc7cdb6ae3b775952648b20</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DIvy%26aufirst%3DP.%26aulast%3DCowan%26aufirst%3DK.%2BH.%26atitle%3DMultidrug%2520resistance%26jtitle%3DCancer%2520Chemother.%2520Biol.%2520Response%2520Modif.%26date%3D1999%26volume%3D18%26spage%3D152%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Glavinas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajcsi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cserepes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkadi, B.</span><span> </span><span class="NLM_article-title">The role of ABC transporters in drug resistance, metabolism, and toxicity</span> <span class="citation_source-journal">Curr. Drug Delivery</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">27</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F1567201043480036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16305368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVSqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=27-42&author=H.+Glavinasauthor=P.+Krajcsiauthor=J.+Cserepesauthor=B.+Sarkadi&title=The+role+of+ABC+transporters+in+drug+resistance%2C+metabolism%2C+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ABC transporters in drug resistance, metabolism, and toxicity</span></div><div class="casAuthors">Glavinas, Hristos; Krajcsi, Peter; Cserepes, Judit; Sarkadi, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Delivery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">CDDUBJ</span>;
        ISSN:<span class="NLM_cas:issn">1567-2018</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP Binding Cassette (ABC) transporters form a special family of membrane proteins, characterized by homologous ATP-binding, and large, multispanning transmembrane domains.  Several members of this family are primary active transporters, which significantly modulate the absorption, metab., cellular effectivity, and toxicity of pharmacol. agents.  This review provides a general overview of the human ABC transporters, their expression, localization, and basic mechanism of action.  Then the authors shortly deal with the human ABC transporters as targets of therapeutic interventions in medicine, including cancer drug resistance, lipid and other metabolic disorders, and even gene therapy applications.  The authors place a special emphasis on the 3 major groups of ABC transporters involved in cancer multidrug resistance (MDR).  These are the classical P-glycoprotein (MDR1, ABCB1), the multidrug resistance assocd. proteins (MRPs, in the ABCC subfamily), and the ABCG2 protein, an ABC half-transporter.  All these proteins catalyze an ATP-dependent active transport of chem. unrelated compds., including anticancer drugs.  MDR1 (P-glycoprotein) and ABCG2 preferentially extrude large hydrophobic, pos. charged mols., while the members of the MRP family can extrude both hydrophobic uncharged mols. and water-sol. anionic compds.  Based on the physiol. expression and role of these transporters, the authors provide examples for their role in Absorption-Distribution-Metab.-Excretion (ADME) and toxicol., and describe several basic assays which can be applied for screening drug interactions with ABC transporters in the course of drug research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOA7ZJlJuYuLVg90H21EOLACvtfcHk0lgP0oWv1Mkrrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVSqu7Y%253D&md5=e5ea8afde47c4986d674fdc75a1dadaa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1567201043480036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567201043480036%26sid%3Dliteratum%253Aachs%26aulast%3DGlavinas%26aufirst%3DH.%26aulast%3DKrajcsi%26aufirst%3DP.%26aulast%3DCserepes%26aufirst%3DJ.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520ABC%2520transporters%2520in%2520drug%2520resistance%252C%2520metabolism%252C%2520and%2520toxicity%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2004%26volume%3D1%26spage%3D27%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Krishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, L. D.</span><span> </span><span class="NLM_article-title">Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR, and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">265</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2FS0928-0987%2800%2900114-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11033070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntF2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=265-283&author=R.+Krishnaauthor=L.+D.+Mayer&title=Multidrug+resistance+%28MDR%29+in+cancer.+Mechanisms%2C+reversal+using+modulators+of+MDR%2C+and+the+role+of+MDR+modulators+in+influencing+the+pharmacokinetics+of+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</span></div><div class="casAuthors">Krishna, R.; Mayer, L. D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-283</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 262 refs. In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-mediated pharmacokinetic interactions.  In addn., the role of P-GP in modifying the bioavailability of orally administered drugs via induction or inhibition has been also been demonstrated in various studies.  This overview presents a background on some of the commonly documented mechanisms of MDR and its reversal by modulators of MDR, followed by a discussion of the functional aspects of P-GP in the context of pharmacokinetic interactions when multiple agents are coadministered.  While adverse pharmacokinetic interactions have been documented with 1st- and 2nd-generation MDR modulators, certain newer agents of the 3rd-generation class of compds. have been less susceptible to eliciting pharmacokinetic interactions.  Although this review focuses on P-GP and the pharmacol. of MDR reversal by MDR modulators, the relevance of these drug transport proteins in the context of pharmacokinetic implications (drug absorption, distribution, clearance, and interactions) is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsAhX6vtg37Vg90H21EOLACvtfcHk0lgP0oWv1Mkrrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntF2gtLw%253D&md5=e4877ba2ce60118d96098fbaec0d4077</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2800%2900114-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252800%252900114-7%26sid%3Dliteratum%253Aachs%26aulast%3DKrishna%26aufirst%3DR.%26aulast%3DMayer%26aufirst%3DL.%2BD.%26atitle%3DMultidrug%2520resistance%2520%2528MDR%2529%2520in%2520cancer.%2520Mechanisms%252C%2520reversal%2520using%2520modulators%2520of%2520MDR%252C%2520and%2520the%2520role%2520of%2520MDR%2520modulators%2520in%2520influencing%2520the%2520pharmacokinetics%2520of%2520anticancer%2520drugs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D11%26spage%3D265%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Leslie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. P. C.</span><span> </span><span class="NLM_article-title">Multidrug resistance proteins: role of P-glycoprotein MRP1, MRP2, and BCRP (ABCG2) in tissue defense</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">204</span> <span class="NLM_fpage">216</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2Fj.taap.2004.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=15845415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFGqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2005&pages=216-237&author=E.+M.+Leslieauthor=R.+G.+Deeleyauthor=S.+P.+C.+Cole&title=Multidrug+resistance+proteins%3A+role+of+P-glycoprotein+MRP1%2C+MRP2%2C+and+BCRP+%28ABCG2%29+in+tissue+defense"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense</span></div><div class="casAuthors">Leslie, Elaine M.; Deeley, Roger G.; Cole, Susan P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-237</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  In tumor cell lines, multidrug resistance is often assocd. with an ATP-dependent decrease in cellular drug accumulation which is attributed to the overexpression of certain ATP-binding cassette (ABC) transporter proteins.  ABC proteins that confer drug resistance include (but are not limited to) P-glycoprotein (gene symbol ABCB1), the multidrug resistance protein 1 (MRP1, gene symbol ABCC1), MRP2 (gene symbol ABCC2), and the breast cancer resistance protein (BCRP, gene symbol ABCG2).  In addn. to their role in drug resistance, there is substantial evidence that these efflux pumps have overlapping functions in tissue defense.  Collectively, these proteins are capable of transporting a vast and chem. diverse array of toxicants including bulky lipophilic cationic, anionic, and neutrally charged drugs and toxins as well as conjugated org. anions that encompass dietary and environmental carcinogens, pesticides, metals, metalloids, and lipid peroxidn. products.  P-glycoprotein, MRP1, MRP2, and BCRP/ABCG2 are expressed in tissues important for absorption (e.g., lung and gut) and metab. and elimination (liver and kidney).  In addn., these transporters have an important role in maintaining the barrier function of sanctuary site tissues (e.g., blood-brain barrier, blood-cerebral spinal fluid barrier, blood-testis barrier and the maternal-fetal barrier or placenta).  Thus, these ABC transporters are increasingly recognized for their ability to modulate the absorption, distribution, metab., excretion, and toxicity of xenobiotics.  In this review, the role of these four ABC transporter proteins in protecting tissues from a variety of toxicants is discussed.  Species variations in substrate specificity and tissue distribution of these transporters are also addressed since these properties have implications for in vivo models of toxicity used for drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO1vBvwT5ZILVg90H21EOLACvtfcHk0ljvb_o2md4sNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFGqtrY%253D&md5=24d834ee8d2d30505f1e44d3eb64bc41</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2004.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2004.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%2BC.%26atitle%3DMultidrug%2520resistance%2520proteins%253A%2520role%2520of%2520P-glycoprotein%2520MRP1%252C%2520MRP2%252C%2520and%2520BCRP%2520%2528ABCG2%2529%2520in%2520tissue%2520defense%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2005%26volume%3D204%26spage%3D216%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nobili, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglioni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mini, E.</span><span> </span><span class="NLM_article-title">Pharmacological strategies for overcoming multidrug resistance</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">861</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F138945006777709593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16842217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Crsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=861-879&author=S.+Nobiliauthor=I.+Landiniauthor=B.+Giglioniauthor=E.+Mini&title=Pharmacological+strategies+for+overcoming+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological strategies for overcoming multidrug resistance</span></div><div class="casAuthors">Nobili, S.; Landini, I.; Giglioni, B.; Mini, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">861-879</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a major obstacle to the effective treatment of cancer.  One of the underlying mechanisms of MDR is cellular overprodn. of P-glycoprotein (P-gp) which acts as an efflux pump for various anticancer drugs.  P-gp is encoded by the MDR1 gene and its overexpression in cancer cells has become a therapeutic target for circumventing multidrug resistance.  A potential strategy is to co-administer efflux pump inhibitors, although such reversal agents might actually increase the side effects of chemotherapy by blocking physiol. anticancer drug efflux from normal cells.  Although many efforts to overcome MDR were made using 1st and second generation reversal agents comprising drugs already in current clin. use for other indications (e.g. verapamil, cyclosporine A, quinidine) or analogs of the first-generation drugs (e.g. dexverapamil, valspodar, cinchonine), few significant advances were made.  Clin. trials with third generation modulators (e.g. biricodar, zosuquidar, and laniquidar) specifically developed for MDR reversal are ongoing.  The results however are not encouraging and it may be that the perfect reverser does not exist.  Other approaches to multidrug resistance reversal were also considered: encapsulation of anthracyclines in liposomes or other carriers which deliver these drugs selectively to tumor tissues, the use of P-gp targeted antibodies such as UIC2 or the use of antisense strategies targeting the MDR1 mRNA.  More recently, the development of transcriptional regulators appears promising.  Also anticancer drugs that belong structurally to classes of drugs extruded from cells by P-gp but that are not substrates of this drug transporter may act as potent inhibitors of MDR tumors (e.g. epothilones, second generation taxanes).  Taking advantage of MDR has also been studied.  Bone marrow suppression, one of the major side effects of cancer chemotherapy, can compromise the potential of curative and palliative chemotherapy.  It is conceivable that drug resistance gene transfer into bone marrow stem cells may be able to reduce or abolish chemotherapy-induced myelosuppression and facilitate the use of high dose chemotherapy.  Clin. trials of retroviral vectors contg. drug resistance genes have established that the approach is safe and are now being designed to address the therapeutically relevant issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA1IVKcA00LLVg90H21EOLACvtfcHk0ljvb_o2md4sNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Crsrk%253D&md5=744fd86ed84cc8b4d9ae50e5337f487e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F138945006777709593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006777709593%26sid%3Dliteratum%253Aachs%26aulast%3DNobili%26aufirst%3DS.%26aulast%3DLandini%26aufirst%3DI.%26aulast%3DGiglioni%26aufirst%3DB.%26aulast%3DMini%26aufirst%3DE.%26atitle%3DPharmacological%2520strategies%2520for%2520overcoming%2520multidrug%2520resistance%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D861%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Thomas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coley, H. M.</span><span> </span><span class="NLM_article-title">Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein</span> <span class="citation_source-journal">Cancer Control</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">159</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1177%2F107327480301000207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=12712010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A280%3ADC%252BD3s7pt1ansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=159-165&author=H.+Thomasauthor=H.+M.+Coley&title=Overcoming+multidrug+resistance+in+cancer%3A+an+update+on+the+clinical+strategy+of+inhibiting+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein</span></div><div class="casAuthors">Thomas Hilary; Coley Helen M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer control : journal of the Moffitt Cancer Center</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-65</span>
        ISSN:<span class="NLM_cas:issn">1073-2748</span>.
    </div><div class="casAbstract">BACKGROUND:  Multidrug resistance (MDR) is a significant obstacle to providing effective chemotherapy to many patients.  Multifactorial in etiology, classic MDR is associated with the overexpression of P-glycoprotein (P-gp), resulting in increased efflux of chemotherapy from cancer cells.  Inhibiting P-gp as a method to reverse MDR in cancer patients has been studied extensively, but the results have generally been disappointing.  METHODS:  The development of P-gp inhibitors is reviewed, including a discussion of early agents that are no longer being developed and third-generation agents that are currently in clinical trials.  RESULTS:  First-generation agents (eg, cyclosporin, verapamil) were limited by unacceptable toxicity, whereas second-generation agents (eg, valspodar, biricodar) had better tolerability but were confounded by unpredictable pharmacokinetic interactions and interactions with other transporter proteins.  Third-generation inhibitors (tariquidar XR9576, zosuquidar LY335979, laniquidar R101933, and ONT-093) have high potency and specificity for P-gp.  Furthermore, pharmacokinetic studies to date have shown no appreciable impact on cytochrome P450 3A4 drug metabolism and no clinically significant drug interactions with common chemotherapy agents.  CONCLUSIONS:  Third-generation P-gp inhibitors have shown promise in clinical trials.  The continued development of these agents may establish the true therapeutic potential of P-gp-mediated MDR reversal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZbFkbBeTOf0g6wdEZmT2rfW6udTcc2ebAgtbZflYE2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7pt1ansg%253D%253D&md5=9f0f487ba641116bd397eae7ba94da32</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F107327480301000207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F107327480301000207%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%26aulast%3DColey%26aufirst%3DH.%2BM.%26atitle%3DOvercoming%2520multidrug%2520resistance%2520in%2520cancer%253A%2520an%2520update%2520on%2520the%2520clinical%2520strategy%2520of%2520inhibiting%2520P-glycoprotein%26jtitle%3DCancer%2520Control%26date%3D2003%26volume%3D10%26spage%3D159%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pérez-Tomás, R.</span><span> </span><span class="NLM_article-title">Multidrug resistance: retrospect and prospects in anti-cancer drug treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1859</span> <span class="NLM_lpage">1876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F092986706777585077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16842198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1859-1876&author=R.+P%C3%A9rez-Tom%C3%A1s&title=Multidrug+resistance%3A+retrospect+and+prospects+in+anti-cancer+drug+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance: retrospect and prospects in anti-cancer drug treatment</span></div><div class="casAuthors">Perez-Tomas, Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1859-1876</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Conventional cancer chemotherapy is seriously limited by the multidrug resistance (MDR) commonly exhibited by tumor cells.  One mechanism by which a living cell can achieve multiple resistances is via the active efflux of a broad range of anticancer drugs through the cellular membrane by MDR proteins.  Such drugs are exported in both ATP-dependent and -independent manners, and can occur despite considerable concn. gradients.  To the ATP-dependent group belongs the ATP-binding cassette (ABC) transporter family, which includes P-gp, MRP, BCRP, etc.  Another protein related to MDR, though not belonging to the ABC transporter family, is lung resistance-related protein (LRP).  All of these proteins are involved in diverse physiol. processes, and are responsible for the uptake and efflux of a multitude of substances from cancer cells.  Many inhibitors of MDR transporters have been identified over the years.  Firstly, MDR drugs were not specifically developed for inhibiting MDR: in fact, they had other pharmacol. properties, as well as a relatively low affinity for MDR transporters.  They included compds. of diverse structure and function, such as verapamil and cyclosporine, and caused side effects.  Secondly, the new drugs were more inhibitor-specific, in terms of MDR transport, and were designed to reduce such side effects (e.g., R-verapamil, dexniguldipine, etc.).  Unfortunately, they displayed poor response in clin. studies.  Recently, new compds. obtained from drug development programs conducted by the pharmaceutical industry are characterized by a high affinity to MDR transporters and are efficient at nanomolar concns.  Some of these compds. (e.g., MS-209) are currently under clin. trials for specific forms of advanced cancers.  We aim to provide an overview of the properties assocd. with those mammalian MDR transporters known to mediate significant transport of relevant drugs in cancer treatments.  We also summarize recent advances concerning resistance to cancer drug therapies with respect to the function and overexpression of ABC and LRP multidrug transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMfuV0__Y5LVg90H21EOLACvtfcHk0lgzX13decMPXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrc%253D&md5=7326324f2dd45bc14802beafaf1ee307</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986706777585077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777585077%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Tom%25C3%25A1s%26aufirst%3DR.%26atitle%3DMultidrug%2520resistance%253A%2520retrospect%2520and%2520prospects%2520in%2520anti-cancer%2520drug%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1859%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Teodori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapecchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">The functions and structure of ABC transporters: implications for the design of new inhibitors of P-gp and MRP1 to control multidrug resistance (MDR)</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">893</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F138945006777709520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16842220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Crs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=893-909&author=E.+Teodoriauthor=S.+Deiauthor=S.+Martelliauthor=F.+Scapecchiauthor=F.+Gualtieri&title=The+functions+and+structure+of+ABC+transporters%3A+implications+for+the+design+of+new+inhibitors+of+P-gp+and+MRP1+to+control+multidrug+resistance+%28MDR%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR)</span></div><div class="casAuthors">Teodori, E.; Dei, S.; Martelli, C.; Scapecchi, S.; Gualtieri, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-909</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a kind of acquired resistance of microorganisms and cancer cells to chemotherapeutic drugs that are characterized by different chem. structure and different mechanism of action.  Classic MDR is the consequence of the over-expression of a variety of proteins that extrude the chemotherapeutic from the cell, lowering its concn. below the effective one.  The ABC (ATP Binding Cassette) is a ubiquitous and important family of such transporter proteins.  Members of this super family are present in mammals as well as in prokaryotic organisms and use ATP as the energy source to activate the extrusion process.  P-glycoprotein (Pgp) and Multidrug Resistance Proteins (MRP1 and sister proteins) are the most important and widely studied members of ABC super family.  Our knowledge about the structures and functions of transporter proteins has definitely improved in recent years, following the resoln. of the structure of bacterial pumps which opened the way to the building of homol. models for the more complex Pgp and MRP.  It can be anticipated that these results will have a strong impact on the design of more potent and safer MDR reverters.  A huge no. of small mols., many of natural origin, are able to reverse multidrug resistance by inhibiting the functions of Pgp.  MRP1 and sister proteins and their action has been considered a possible way to reverse MDR.  However, while a few compds. have reached clin. trials, none of them has, so far, been cleared for therapeutic use.  Two main reasons are at the base of this difficulty: (i) MDR is a complex phenomenon that may arise from several different biochem. mechanisms, with the consequence that inhibition of transporter proteins may be insufficient to reverse it; (ii) the physiol. role of Pgp and sister proteins requires more potent modulators with proper selectivity and pharmacokinetic to avoid unwanted side effects.  This paper first reviews the most recent discoveries on the structures and functions of the ABC super family, in particular Pgp and MRP.  Then, the medicinal chem. of MDR reverters, in light of these findings, is discussed and the mols. that are presently in development are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDF8LaOY-ysLVg90H21EOLACvtfcHk0lgzX13decMPXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Crs74%253D&md5=ee253a141adf5697d901228912348185</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138945006777709520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006777709520%26sid%3Dliteratum%253Aachs%26aulast%3DTeodori%26aufirst%3DE.%26aulast%3DDei%26aufirst%3DS.%26aulast%3DMartelli%26aufirst%3DS.%26aulast%3DScapecchi%26aufirst%3DF.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DThe%2520functions%2520and%2520structure%2520of%2520ABC%2520transporters%253A%2520implications%2520for%2520the%2520design%2520of%2520new%2520inhibitors%2520of%2520P-gp%2520and%2520MRP1%2520to%2520control%2520multidrug%2520resistance%2520%2528MDR%2529%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D893%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Avendano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, J. C.</span><span> </span><span class="NLM_article-title">Inhibitors of multidrug resistance to antitumor agents (MDR)</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">159</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=159-193&author=C.+Avendanoauthor=J.+C.+Menendez&title=Inhibitors+of+multidrug+resistance+to+antitumor+agents+%28MDR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvendano%26aufirst%3DC.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26atitle%3DInhibitors%2520of%2520multidrug%2520resistance%2520to%2520antitumor%2520agents%2520%2528MDR%2529%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D159%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Planting, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneveld, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Gaast, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparreboom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burg, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luyten, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leeuw, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Boer-Dennert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purvis, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span> </span><span class="NLM_article-title">A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">55</span> <span class="NLM_fpage">91</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1007%2Fs00280-004-0854-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=15565444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWjt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=91-99&author=A.+S.+Plantingauthor=P.+Sonneveldauthor=A.+van+der+Gaastauthor=A.+Sparreboomauthor=M.+E.+van+der+Burgauthor=G.+P.+Luytenauthor=K.+de+Leeuwauthor=M.+de+Boer-Dennertauthor=P.+S.+Wisselauthor=R.+C.+Jewellauthor=E.+M.+Paulauthor=N.+B.+Purvisauthor=J.+Verweij&title=A+phase+I+and+pharmacologic+study+of+the+MDR+converter+GF120918+in+combination+with+doxorubicin+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors</span></div><div class="casAuthors">Planting, A. S. T.; Sonneveld, P.; Van Der Gaast, A.; Sparreboom, A.; Burg, M. E. L.; Luyten, G. P. M.; Leeuw, K.; De Boer-Dennert, M.; Wissel, P. S.; Jewell, R. C.; Paul, E. M.; Purvis, N. B., Jr.; Verweij, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Background: Resistance to chemotherapy can partly be explained by the activity of membrane bound P-glycoprotein.  Competitive inhibition of P-glycoprotein, by multidrug resistance (MDR) converters, may overcome this MDR.  Previously studied MDR converters either have serious intrinsic side effects or considerably influence the pharmacokinetics of cytotoxic agents at concns. theor. required to convert MDR.  GF120918 is a third-generation MDR converter with high affinity for P-glycoprotein and can be given orally.  We performed a phase 1 study with escalating doses of GF120918 in combination with doxorubicin.  Patients and methods: The study group comprised 46 patients with advanced solid tumors.  Doxorubicin was administered on day 1 (cycle 1), GF120918 on days 22-24 (cycle 2), and on days 29-33 with doxorubicin administered on day 31 (cycle 3).  Pharmacokinetics of both GF120918 and doxorubicin were studied.  The starting daily dose of GF120918 was 50 mg and was to be increased in subsequent cohorts until a steady state plasma level of 100 ng/mL was reached.  The starting dose of doxorubicin was 50 mg/m2 and was to be increased after reaching the target dose level of GF120918.  Results: In 37 of the 46 patients, full pharmacokinetic data from the three scheduled cycles were obtained.  Pharmacokinetics of GF120918 showed a less than linear increase in Cmax with increasing doses, with considerable interpatient variation.  The target steady-state plasma level for GF120918 was exceeded in 12 out of 19 patients who received 400 mg GF120918 alone twice daily and in 12 of 17 patients who received 400 mg GF120918 twice daily in combination with doxorubicin.  GF120918 pharmacokinetics were not influenced by coadministration of doxorubicin.  The doxorubicin AUC was only marginally influenced by GF120918 and only at the highest dose levels.  In these patients there was a significant increase in the AUC of doxorubicinol in cycle 3 as compared to cycle 1.  Hematol. toxicity mainly consisted of neutropenia and was more severe in cycle 3 than in cycle 1 (13 vs 5 patients with grade 4 neutropenia, P=0.003).  Neutropenic fever was the dose-limiting toxicity at a doxorubicin dose of 75 mg/m2 with 400 mg GF120918 twice daily.  The toxicity of GF120918 was limited to somnolence in eight patients and occasional gastrointestinal complaints.  Conclusion: GF120918 is an MDR converter with only minimal side effects at a dose level yielding concns. able to convert the action of P-glycoprotein in vitro.  A doxorubicin dose of 60 mg/m2 on day 3 in combination with 400 mg GF120918 twice daily on days 1-5 is an acceptable regimen for further clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv90u7DgtLn7Vg90H21EOLACvtfcHk0ljxHN_hcNskfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWjt77P&md5=a395f348bc6639576b949bbf7fdcf80b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0854-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0854-6%26sid%3Dliteratum%253Aachs%26aulast%3DPlanting%26aufirst%3DA.%2BS.%26aulast%3DSonneveld%26aufirst%3DP.%26aulast%3Dvan%2Bder%2BGaast%26aufirst%3DA.%26aulast%3DSparreboom%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBurg%26aufirst%3DM.%2BE.%26aulast%3DLuyten%26aufirst%3DG.%2BP.%26aulast%3Dde%2BLeeuw%26aufirst%3DK.%26aulast%3Dde%2BBoer-Dennert%26aufirst%3DM.%26aulast%3DWissel%26aufirst%3DP.%2BS.%26aulast%3DJewell%26aufirst%3DR.%2BC.%26aulast%3DPaul%26aufirst%3DE.%2BM.%26aulast%3DPurvis%26aufirst%3DN.%2BB.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520and%2520pharmacologic%2520study%2520of%2520the%2520MDR%2520converter%2520GF120918%2520in%2520combination%2520with%2520doxorubicin%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D55%26spage%3D91%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Morschhauser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinzani, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloots, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouafia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">48</span> <span class="NLM_fpage">708</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1080%2F10428190701190169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=17454628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVSjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=708-715&author=F.+Morschhauserauthor=P.+L.+Zinzaniauthor=M.+Burgessauthor=L.+Slootsauthor=F.+Bouafiaauthor=C.+Dumontet&title=Phase+I%2FII+trial+of+a+P-glycoprotein+inhibitor%2C+Zosuquidar.3HCl+trihydrochloride+%28LY335979%29%2C+given+orally+in+combination+with+the+CHOP+regimen+in+patients+with+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II trial of a P-glycoprotein inhibitor, zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma</span></div><div class="casAuthors">Morschhauser, Franck; Zinzani, Pier Luigi; Burgess, Michael; Sloots, Lisette; Bouafia, Fadela; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">708-715</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A phase I/II trial was performed to investigate the safety and tolerance of zosuquidar.3HCL, a potent inhibitor of P-glycoprotein (P-gp), when administered orally alone and in combination with the CHOP regimen in patients with untreated non-Hodgkin's lymphoma and to det. whether zosuquidar.3HCL affects pharmacokinetics of doxorubicin and vincristine.  Doses of CHOP remained const. and the doses of zosuquidar.3HCL were increased from 200 to 500 mg per dose.  A total of 15 patients were treated at three dose levels.  A target dose providing peak and trough levels compatible with prolonged modulation of P-gp function was obtained in patients receiving three doses of 500 mg of zosuquidar.3HCL p.o.  At this dose level, toxicity was minimal and no enhancement of CHOP-related toxicity was obsd.  Zosuquidar.3HCL did not significantly affect the pharmacokinetics of doxorubicin and had moderate effects on the pharmacokinetics of vincristine.  Zosuquidar.3HCL can be safely administered with CHOP therapy using a 24-h schedule.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAT5sarIjZbVg90H21EOLACvtfcHk0ljxHN_hcNskfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVSjurw%253D&md5=2b093e62677553432f5b7b8a1af94460</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F10428190701190169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190701190169%26sid%3Dliteratum%253Aachs%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DZinzani%26aufirst%3DP.%2BL.%26aulast%3DBurgess%26aufirst%3DM.%26aulast%3DSloots%26aufirst%3DL.%26aulast%3DBouafia%26aufirst%3DF.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DPhase%2520I%252FII%2520trial%2520of%2520a%2520P-glycoprotein%2520inhibitor%252C%2520Zosuquidar.3HCl%2520trihydrochloride%2520%2528LY335979%2529%252C%2520given%2520orally%2520in%2520combination%2520with%2520the%2520CHOP%2520regimen%2520in%2520patients%2520with%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2007%26volume%3D48%26spage%3D708%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Modok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">350</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2Fj.coph.2006.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16690355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=350-354&author=S.+Modokauthor=H.+R.+Mellorauthor=R.+Callaghan&title=Modulation+of+multidrug+resistance+efflux+pump+activity+to+overcome+chemoresistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span></div><div class="casAuthors">Modok, Szabolcs; Mellor, Howard R.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-354</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Early publications using cultured cancer cells immediately recognized the phenomenon of resistance to anticancer agents.  However, it was not until 1973 that it was first demonstrated that a major factor in the resistance of cancer cells was that of reduced drug accumulation.  This year marks the 30th anniversary of the discovery by Juliano and Ling that P-glycoprotein mediates this active efflux of chemotherapeutic drugs from cancer cells.  Since this seminal finding, the investigation of P-glycoprotein (MDR1, ATP binding cassette [ABC]B1) has proceeded with great vigour.  However, it soon became apparent that P-glycoprotein was not expressed in all drug-resistant cells that displayed an accumulation deficiency, which led to the discovery of other ABC transporters involved in drug efflux.  In 1992, the multidrug resistance-assocd. protein (MRP1, ABCC1) was identified in small cell lung cancer followed by breast cancer resistance protein (mitoxantrone resistance protein, ABCG2) in 1999.  After three decades of research, can we confidently define the contribution of multidrug resistance transporters to chemoresistance and do we have clin. useful drugs to sensitize cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEJzb35-rDLVg90H21EOLACvtfcHk0ljELulk65ALig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D&md5=9fbe122b53419fa753a006af6840c326</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DModok%26aufirst%3DS.%26aulast%3DMellor%26aufirst%3DH.%2BR.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520efflux%2520pump%2520activity%2520to%2520overcome%2520chemoresistance%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapposelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digiacomo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsamo, A.</span><span> </span><span class="NLM_article-title">Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6607</span> <span class="NLM_lpage">6613</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060639z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6607-6613&author=N.+A.+Colabufoauthor=F.+Berardiauthor=R.+Perroneauthor=S.+Rapposelliauthor=M.+Digiacomoauthor=A.+Balsamo&title=Arylmethyloxyphenyl+derivatives%3A+small+molecules+displaying+P-glycoprotein+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm060639z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060639z%26sid%3Dliteratum%253Aachs%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DRapposelli%26aufirst%3DS.%26aulast%3DDigiacomo%26aufirst%3DM.%26aulast%3DBalsamo%26aufirst%3DA.%26atitle%3DArylmethyloxyphenyl%2520derivatives%253A%2520small%2520molecules%2520displaying%2520P-glycoprotein%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6607%26epage%3D6613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. S.</span><span> </span><span class="NLM_article-title">Rational use of in vitro P-glycoprotein assays in drug discovery</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">299</span> <span class="NLM_fpage">620</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11602674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvV2qt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=620-628&author=J.+W.+Polliauthor=S.+A.+Wringauthor=J.+E.+Humphreysauthor=L.+Huangauthor=J.+B.+Morganauthor=L.+O.+Websterauthor=C.+S.+Serabjit-Singh&title=Rational+use+of+in+vitro+P-glycoprotein+assays+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Rational use of in vitro P-glycoprotein assays in drug discovery</span></div><div class="casAuthors">Polli, Joseph W.; Wring, Stephen A.; Humphreys, Joan E.; Huang, Liyue; Morgan, Jonathon B.; Webster, Lindsey O.; Serabjit-Singh, Cosette S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">620-628</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P-glycoprotein (Pgp) affects the absorption, distribution, and clearance of a variety of compds.  Thus, identification of compds. that are Pgp substrates can aid drug candidate selection and optimization.  Our goal was to evaluate three assays used to det. whether compds. are Pgp substrates.  Sixty-six compds. were tested in monolayer efflux, ATPase, and calcein-AM assays.  Assay results yielded two categories of compds.  Category I (n = 35) exhibited concordance across the assays.  Category II (n = 31) revealed differences among the assays that related to the apparent permeability (Papp) of the compds.  Within category II, two groups were discerned based on the absence (group IIA, n = 10, nontransported substrates) or presence (group IIB, n = 21, transported substrates) of monolayer efflux.  Detection of efflux (group IIB) was assocd. with compds. having low/moderate Papp values (mean = 16.6 nm/s), whereas inability to detect efflux (group IIA) was assocd. with compds. having high Papp values (mean = 535 nm/s).  The calcein-AM and ATPase assays revealed Pgp interactions for highly permeable group IIA compds. but were less responsive than monolayer efflux for low/moderate Papp compds. of group IIB.  All assays detected substrates across a broad range of Papp, but the efflux assay was more prone to fail at high Papp, whereas the calcein-AM and ATPase assays were more prone to fail at low Papp.  When Papp is low, efflux is a greater factor in the disposition of Pgp substrates.  The efflux assay is more reliable at low/moderate Papp and is the method of choice for evaluating drug candidates despite low throughput and reliance on liq. chromatog. with tandem mass spectrometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEXGQjVBl5H7Vg90H21EOLACvtfcHk0ljELulk65ALig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvV2qt78%253D&md5=77bd80ec2000fa4806bee5614c31279d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DMorgan%26aufirst%3DJ.%2BB.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BS.%26atitle%3DRational%2520use%2520of%2520in%2520vitro%2520P-glycoprotein%2520assays%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D620%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Romera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Potassium iodide catalysed monoalkylation of anilines under microwave irradiation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">45</span> <span class="NLM_fpage">8797</span> <span class="NLM_lpage">8800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=8797-8800&author=J.+L.+Romeraauthor=J.+M.+Cidauthor=A.+A.+Trabanco&title=Potassium+iodide+catalysed+monoalkylation+of+anilines+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomera%26aufirst%3DJ.%2BL.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DPotassium%2520iodide%2520catalysed%2520monoalkylation%2520of%2520anilines%2520under%2520microwave%2520irradiation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D8797%26epage%3D8800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Seelig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlik-Landwojtowicz, E.</span><span> </span><span class="NLM_article-title">Inhibitors of multidrug efflux transporters: their membrane and protein interactions</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">135</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=135-151&author=A.+Seeligauthor=E.+Gatlik-Landwojtowicz&title=Inhibitors+of+multidrug+efflux+transporters%3A+their+membrane+and+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26aulast%3DGatlik-Landwojtowicz%26aufirst%3DE.%26atitle%3DInhibitors%2520of%2520multidrug%2520efflux%2520transporters%253A%2520their%2520membrane%2520and%2520protein%2520interactions%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D135%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Pleban, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecker, G. F.</span><span> </span><span class="NLM_article-title">Inhibitors of P-glycoprotein-lead identification and optimisation</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">153</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=153-163&author=K.+Plebanauthor=G.+F.+Ecker&title=Inhibitors+of+P-glycoprotein-lead+identification+and+optimisation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPleban%26aufirst%3DK.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26atitle%3DInhibitors%2520of%2520P-glycoprotein-lead%2520identification%2520and%2520optimisation%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D153%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Balimane, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span> </span><span class="NLM_article-title">A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">301</span> <span class="NLM_fpage">80</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2Fj.ijpharm.2005.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16023314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVWhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2005&pages=80-88&author=P.+V.+Balimaneauthor=S.+Chong&title=A+combined+cell+based+approach+to+identify+P-glycoprotein+substrates+and+inhibitors+in+a+single+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay</span></div><div class="casAuthors">Balimane, Praveen V.; Chong, Saeho</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">80-88</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objective of this project was to develop a cell based in vitro exptl. procedure that can differentiate P-glycoprotein (P-gp) substrates from inhibitors in a single assay.  Caco-2 cells grown to confluency on 12-well Transwell were used for this study.  The efflux permeability (B to A) of P-gp specific probe (viz., digoxin) in the presence of test compds. (e.g. substrates, inhibitors and non-substrates of P-gp) was monitored, and the influx permeability (A to B) of test compds. was evaluated after complete P-gp blockade.  Radiolabeled digoxin was added on the basolateral side with buffer on the apical side.  The digoxin concn. appearing on the apical side represents digoxin efflux permeability during the control phase (0-1 h period).  After 1 h, a test compd. (10 uM) was added on the apical side.  The reduced efflux permeability of digoxin suggests that the added test compd. is an inhibitor.  The influx permeability of test compd. is also detd. during the 1-2 h study period by measuring the concn. of the test compd. in the basolateral side.  At the end of 2 h, a potent P-gp inhibitor (GF120918) was added.  The increased influx permeability of test compd. during the 2-3 h incubation period indicates that the added test compd. is a substrate.  Samples were taken from both sides at the end of 1-3 h and the concns. of the test compds. and digoxin were quantitated.  Digoxin efflux permeability remained unchanged when incubated with P-gp substrates (e.g., etoposide, rhodamine123, taxol).  However, when a P-gp inhibitor was added to the apical side, the digoxin efflux (B to A permeability) was significantly reduced (ketoconazole = 51% redn.) as expected.  The influx permeability of substrates increased significantly (rhodamine123=70%, taxol = 220%, digoxin = 290%) after the P-gp inhibitor (GF120918) was introduced, whereas the influx permeability of P-gp inhibitor and non-substrates was not affected by GF120918.  Thus, this combined assay provides an efficient cell based in vitro screening tool to simultaneously distinguish compds. that are P-gp substrates from P-gp inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEA2nzY6zwlbVg90H21EOLACvtfcHk0lilLnrWY4V6uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVWhtLo%253D&md5=ee2d5c4aaa06fd7708d50cb61360031f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2005.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2005.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DBalimane%26aufirst%3DP.%2BV.%26aulast%3DChong%26aufirst%3DS.%26atitle%3DA%2520combined%2520cell%2520based%2520approach%2520to%2520identify%2520P-glycoprotein%2520substrates%2520and%2520inhibitors%2520in%2520a%2520single%2520assay%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D301%26spage%3D80%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D3 receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">358</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050734s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=358-365&author=M.+Leopoldoauthor=E.+Lacivitaauthor=P.+De+Giorgioauthor=N.+A.+Colabufoauthor=M.+Nisoauthor=F.+Berardiauthor=R.+Perrone&title=Design%2C+synthesis%2C+and+binding+affinities+of+potential+positron+emission+tomography+%28PET%29+ligands+for+visualization+of+brain+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm050734s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050734s%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520binding%2520affinities%2520of%2520potential%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520for%2520visualization%2520of%2520brain%2520dopamine%2520D3%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D358%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rautio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keogh, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunta, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">786</span> <span class="NLM_lpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=786-792&author=J.+Rautioauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=A.+Balakrishnanauthor=J.+P.+Keoghauthor=J.+R.+Kuntaauthor=J.+Serabjit-Singhauthor=J.+W.+Polli&title=In+vitro+P-glycoprotein+inhibition+assays+for+assessment+of+clinical+drug+interaction+potential+of+new+drug+candidates%3A+a+recommendation+for+probe+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DBalakrishnan%26aufirst%3DA.%26aulast%3DKeogh%26aufirst%3DJ.%2BP.%26aulast%3DKunta%26aufirst%3DJ.%2BR.%26aulast%3DSerabjit-Singh%26aufirst%3DJ.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520inhibition%2520assays%2520for%2520assessment%2520of%2520clinical%2520drug%2520interaction%2520potential%2520of%2520new%2520drug%2520candidates%253A%2520a%2520recommendation%2520for%2520probe%2520substrates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D786%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kangas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grönroos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieminem, A. L.</span><span> </span><span class="NLM_article-title">Bioluminescence of cellular ATP: a new method for evaluating agents in vitro</span> <span class="citation_source-journal">Med. Biol.</span><span class="NLM_year" style="font-weight: bold;">1984</span> <span class="NLM_volume">62</span> <span class="NLM_fpage">338</span> <span class="NLM_lpage">343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=6543460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADyaL2MXltFGmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1984&pages=338-343&author=L.+Kangasauthor=M.+Gr%C3%B6nroosauthor=A.+L.+Nieminem&title=Bioluminescence+of+cellular+ATP%3A+a+new+method+for+evaluating+agents+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescence of cellular ATP:  a new method for evaluating cytotoxic agents in vitro</span></div><div class="casAuthors">Kangas, L.; Groenroos, M.; Nieminen, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Biology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">338-43</span>CODEN:
                <span class="NLM_cas:coden">MDBYAS</span>;
        ISSN:<span class="NLM_cas:issn">0302-2137</span>.
    </div><div class="casAbstract">Rat Walker 256 carcinosarcoma, human MCF-7 cell line, and a specimen of ovarian serous cystadenocarcinoma were cultured in vitro and exposed to different cytostatic drugs.  The drug effects were evaluated by bioluminescence, i.e., by measuring the levels of ATP (ATP)  [56-65-5], the basic energy source of the living cells.  The intracellular ATP was released by TCA or NRS-reagent, and the ATP levels were measured directly from an aliquot of the growth medium without any extn. or pptn. steps.  The ATP level correlated with cell no., viability, [3H]-thymidine incorporation, and stem-cell assay.  The most important advantages of the bioluminescence method were speed, tech. simplicity, and good sensitivity (about 500 cells/sample easily quantitated, the results are seen directly within a few seconds) and flexibility (any cell line and drug may be studied by many different test designs).  The ATP method obviously describes the well-being of the cultured cells.  The ATP-bioluminescence method is a powerful alternative to any other cell-growth estn. method in vitro.  It can be used esp. in primary screening of the cytostatic activity of any known or unknown substance as well as in attempts to select an individual drug therapy for patients with cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_dF9X-DhqobVg90H21EOLACvtfcHk0lh-YqeKMcoMtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltFGmsbw%253D&md5=b0e016699bd039c9d2c694a4e1ccbdad</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKangas%26aufirst%3DL.%26aulast%3DGr%25C3%25B6nroos%26aufirst%3DM.%26aulast%3DNieminem%26aufirst%3DA.%2BL.%26atitle%3DBioluminescence%2520of%2520cellular%2520ATP%253A%2520a%2520new%2520method%2520for%2520evaluating%2520agents%2520in%2520vitro%26jtitle%3DMed.%2520Biol.%26date%3D1984%26volume%3D62%26spage%3D338%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Taub, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, I.</span><span> </span><span class="NLM_article-title">Functional assessment of multiple P-glycoprotein (P-gp) probe substrate: influence of cell line and modulator concentration on P-gp activity</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">33</span> <span class="NLM_fpage">1679</span> <span class="NLM_lpage">1687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1679-1687&author=M.+E.+Taubauthor=L.+Podilaauthor=I.+Almeida&title=Functional+assessment+of+multiple+P-glycoprotein+%28P-gp%29+probe+substrate%3A+influence+of+cell+line+and+modulator+concentration+on+P-gp+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaub%26aufirst%3DM.%2BE.%26aulast%3DPodila%26aufirst%3DL.%26aulast%3DAlmeida%26aufirst%3DI.%26atitle%3DFunctional%2520assessment%2520of%2520multiple%2520P-glycoprotein%2520%2528P-gp%2529%2520probe%2520substrate%253A%2520influence%2520of%2520cell%2520line%2520and%2520modulator%2520concentration%2520on%2520P-gp%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1679%26epage%3D1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">Antiproliferative and cytotoxic effects of some σ<sub>1</sub> antagonists in tumour cell lines</span> <span class="citation_source-journal">Naunyn−Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">370</span> <span class="NLM_fpage">106</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1007%2Fs00210-004-0961-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=15322732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslyrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2004&pages=106-113&author=N.+A.+Colabufoauthor=F.+Berardiauthor=M.+Continoauthor=M.+Nisoauthor=C.+Abateauthor=R.+Perroneauthor=V.+Tortorella&title=Antiproliferative+and+cytotoxic+effects+of+some+%CF%831+antagonists+in+tumour+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and cytotoxic effects of some σ2 agonists and σ1 antagonists in tumour cell lines</span></div><div class="casAuthors">Colabufo, Nicola Antonio; Berardi, Francesco; Contino, Marialessandra; Niso, Mauro; Abate, Carmen; Perrone, Roberto; Tortorella, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-113</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">To establish the activity of σ ligands at σ1 and σ2 receptor, we chose two tumor cell lines, the human SK-N-SH neuroblastoma and the rat C6 glioma lines, which express σ2 receptors at a high d. and σ1 receptors in their high-affinity or low-affinity state.  We tested the σ2 receptor agonist PB28 and the σ2 antagonist AC927, and (+)-pentazocine and NE100 as agonist and antagonist, resp., at σ1 receptors, with regard to antiproliferative and cytotoxic effects.  In addn., 1,3-di (2-tolyl)guanidine (DTG) and haloperidol were tested as ref. compds. displaying nearly equipotent σ affinity (σ2>σ1 and σ1>σ2, resp.).  In both SK-N-SH and C6 cells, PB28 and NE100 displayed the most potent results both in antiproliferative and cytotoxic assay while AC927 and (+)-pentazocine were inactive in both assays.  The cytotoxic and antiproliferative effects of DTG and haloperidol reflected their σ1 antagonist activity and σ2 agonist activity.  Moreover, our results in the tumor cell lines correlated well with those for σ2 activity found previously in a functional assay in the guinea-pig bladder.  These findings establish a new model for evaluating both σ2 and σ1 receptor activity of σ ligands, which could be useful for developing new ligands having mixed σ2 agonist/σ1 antagonist activity as potential antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs66SL4M6j97Vg90H21EOLACvtfcHk0lii7LfZsp5IXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslyrtrg%253D&md5=3adb421f453f96086fd45096dc49366c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs00210-004-0961-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-004-0961-2%26sid%3Dliteratum%253Aachs%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DAntiproliferative%2520and%2520cytotoxic%2520effects%2520of%2520some%2520%25CF%25831%2520antagonists%2520in%2520tumour%2520cell%2520lines%26jtitle%3DNaunyn%25E2%2588%2592Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2004%26volume%3D370%26spage%3D106%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span> </span><span class="NLM_article-title">GraphPad Prism Software</span>, version for Windows; <span class="NLM_publisher-name">GraphPad Software, Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GraphPad+Prism+Software%2C+version+for+Windows%3B+GraphPad+Software%2C+Inc.%3A+San+Diego%2C+CA%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DGraphPad%2520Prism%2520Software%26pub%3DGraphPad%2520Software%252C%2520Inc%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Broccatelli</span>, <span class="hlFld-ContribAuthor ">Emanuele  Carosati</span>, <span class="hlFld-ContribAuthor ">Annalisa  Neri</span>, <span class="hlFld-ContribAuthor ">Maria  Frosini</span>, <span class="hlFld-ContribAuthor ">Laura  Goracci</span>, <span class="hlFld-ContribAuthor ">Tudor I.  Oprea</span>, and <span class="hlFld-ContribAuthor ">Gabriele  Cruciani</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (6)
                                     , 1740-1751. <a href="https://doi.org/10.1021/jm101421d" title="DOI URL">https://doi.org/10.1021/jm101421d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101421d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101421d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BApproach%252Bfor%252BPredicting%252BP-Glycoprotein%252B%252528ABCB1%252529%252BInhibition%252BUsing%252BMolecular%252BInteraction%252BFields%26aulast%3DBroccatelli%26aufirst%3DFabio%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D04112010%26date%3D22022011%26date%3D24032011%26volume%3D54%26issue%3D6%26spage%3D1740%26epage%3D1751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola Antonio  Colabufo</span>, <span class="hlFld-ContribAuthor ">Francesco  Berardi</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>, <span class="hlFld-ContribAuthor ">Simona  Rapposelli</span>, <span class="hlFld-ContribAuthor ">Maria  Digiacomo</span>, <span class="hlFld-ContribAuthor ">Michael  Vanni</span> and <span class="hlFld-ContribAuthor ">Aldo  Balsamo</span>  . </span><span class="cited-content_cbyCitation_article-title">2-[(3-Methoxyphenylethyl)phenoxy]-Based ABCB1 Inhibitors: Effect of Different Basic Side-Chains on Their Biological Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (23)
                                     , 7602-7613. <a href="https://doi.org/10.1021/jm800928j" title="DOI URL">https://doi.org/10.1021/jm800928j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800928j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800928j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-%25255B%2525283-Methoxyphenylethyl%252529phenoxy%25255D-Based%252BABCB1%252BInhibitors%25253A%252BEffect%252Bof%252BDifferent%252BBasic%252BSide-Chains%252Bon%252BTheir%252BBiological%252BProperties%26aulast%3DColabufo%26aufirst%3DNicola%2BAntonio%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D11%252012%25202008%26date%3D17%252011%25202008%26date%3D24%252007%25202008%26volume%3D51%26issue%3D23%26spage%3D7602%26epage%3D7613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana  Costa</span>, <span class="hlFld-ContribAuthor ">Vanessa  Almonti</span>, <span class="hlFld-ContribAuthor ">Ludovica  Cacopardo</span>, <span class="hlFld-ContribAuthor ">Daniele  Poli</span>, <span class="hlFld-ContribAuthor ">Simona  Rapposelli</span>, <span class="hlFld-ContribAuthor ">Arti  Ahluwalia</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating Curcumin/Intestinal Epithelium Interaction in a Millifluidic Bioreactor. </span><span class="cited-content_cbyCitation_journal-name">Bioengineering</span><span> <strong>2020,</strong> <em>7 </em>
                                    (3)
                                     , 100. <a href="https://doi.org/10.3390/bioengineering7030100" title="DOI URL">https://doi.org/10.3390/bioengineering7030100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/bioengineering7030100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbioengineering7030100%26sid%3Dliteratum%253Aachs%26jtitle%3DBioengineering%26atitle%3DInvestigating%252BCurcumin%25252FIntestinal%252BEpithelium%252BInteraction%252Bin%252Ba%252BMillifluidic%252BBioreactor%26aulast%3DCosta%26aufirst%3DJoana%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D3%26spage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clarissa  Willers</span>, <span class="hlFld-ContribAuthor ">Hanna  Svitina</span>, <span class="hlFld-ContribAuthor ">Michael J.  Rossouw</span>, <span class="hlFld-ContribAuthor ">Roan A.  Swanepoel</span>, <span class="hlFld-ContribAuthor ">Josias H.  Hamman</span>, <span class="hlFld-ContribAuthor ">Chrisna  Gouws</span>. </span><span class="cited-content_cbyCitation_article-title">Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Research and Clinical Oncology</span><span> <strong>2019,</strong> <em>145 </em>
                                    (8)
                                     , 1949-1976. <a href="https://doi.org/10.1007/s00432-019-02973-5" title="DOI URL">https://doi.org/10.1007/s00432-019-02973-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00432-019-02973-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00432-019-02973-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Research%2520and%2520Clinical%2520Oncology%26atitle%3DModels%252Bused%252Bto%252Bscreen%252Bfor%252Bthe%252Btreatment%252Bof%252Bmultidrug%252Bresistant%252Bcancer%252Bfacilitated%252Bby%252Btransporter-based%252Befflux%26aulast%3DWillers%26aufirst%3DClarissa%26date%3D2019%26date%3D2019%26volume%3D145%26issue%3D8%26spage%3D1949%26epage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debora  Petroni</span>, <span class="hlFld-ContribAuthor ">Antonietta  Bartoli</span>, <span class="hlFld-ContribAuthor ">Simona  Rapposelli</span>, <span class="hlFld-ContribAuthor ">Maria  Digiacomo</span>, <span class="hlFld-ContribAuthor ">Silvia  Burchielli</span>, <span class="hlFld-ContribAuthor ">Giulia  Nesi</span>, <span class="hlFld-ContribAuthor ">Annalina  Lapucci</span>, <span class="hlFld-ContribAuthor ">Silvia  Pardini</span>, <span class="hlFld-ContribAuthor ">Sabrina  Fucci</span>, <span class="hlFld-ContribAuthor ">Marco  Macchia</span>, <span class="hlFld-ContribAuthor ">Piero A.  Salvadori</span>, <span class="hlFld-ContribAuthor ">Luca  Menichetti</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2016,</strong> <em>18 </em>
                                    (6)
                                     , 916-923. <a href="https://doi.org/10.1007/s11307-016-0965-6" title="DOI URL">https://doi.org/10.1007/s11307-016-0965-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-016-0965-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-016-0965-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DSynthesis%252Band%252BIn%252BVivo%252BImaging%252Bof%252BN-%2525283-%25255B11C%25255DMethoxybenzyl%252529-2-%2525283-Methoxyphenyl%252529ethylaniline%252Bas%252Ba%252BPotential%252BTargeting%252BAgent%252Bfor%252BP-glycoprotein%26aulast%3DPetroni%26aufirst%3DDebora%26date%3D2016%26date%3D2016%26volume%3D18%26issue%3D6%26spage%3D916%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Theresa  Schwarz</span>, <span class="hlFld-ContribAuthor ">Floriane  Montanari</span>, <span class="hlFld-ContribAuthor ">Anna  Cseke</span>, <span class="hlFld-ContribAuthor ">Katrin  Wlcek</span>, <span class="hlFld-ContribAuthor ">Lene  Visvader</span>, <span class="hlFld-ContribAuthor ">Sarah  Palme</span>, <span class="hlFld-ContribAuthor ">Peter  Chiba</span>, <span class="hlFld-ContribAuthor ">Karl  Kuchler</span>, <span class="hlFld-ContribAuthor ">Ernst  Urban</span>, <span class="hlFld-ContribAuthor ">Gerhard F.  Ecker</span>. </span><span class="cited-content_cbyCitation_article-title">Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P-Glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , 1380-1394. <a href="https://doi.org/10.1002/cmdc.201500592" title="DOI URL">https://doi.org/10.1002/cmdc.201500592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500592%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSubtle%252BStructural%252BDifferences%252BTrigger%252BInhibitory%252BActivity%252Bof%252BPropafenone%252BAnalogues%252Bat%252Bthe%252BTwo%252BPolyspecific%252BABC%252BTransporters%25253A%252BP-Glycoprotein%252B%252528P-gp%252529%252Band%252BBreast%252BCancer%252BResistance%252BProtein%252B%252528BCRP%252529%26aulast%3DSchwarz%26aufirst%3DTheresa%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D1380%26epage%3D1394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.-M.  Thai</span>, <span class="hlFld-ContribAuthor ">N.-T.  Huynh</span>, <span class="hlFld-ContribAuthor ">T.-D.  Ngo</span>, <span class="hlFld-ContribAuthor ">T.-T.  Mai</span>, <span class="hlFld-ContribAuthor ">T.-H.  Nguyen</span>, <span class="hlFld-ContribAuthor ">T.-D.  Tran</span>. </span><span class="cited-content_cbyCitation_article-title">Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2015,</strong> <em>26 </em>
                                    (2)
                                     , 139-163. <a href="https://doi.org/10.1080/1062936X.2014.995701" title="DOI URL">https://doi.org/10.1080/1062936X.2014.995701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2014.995701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2014.995701%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DThree-%252Band%252Bfour-class%252Bclassification%252Bmodels%252Bfor%252BP-glycoprotein%252Binhibitors%252Busing%252Bcounter-propagation%252Bneural%252Bnetworks%26aulast%3DThai%26aufirst%3DK.-M.%26date%3D2015%26date%3D2015%26volume%3D26%26issue%3D2%26spage%3D139%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Floriane  Montanari</span>, <span class="hlFld-ContribAuthor ">Gerhard F.  Ecker</span>. </span><span class="cited-content_cbyCitation_article-title">BCRP Inhibition: from Data Collection to Ligand-Based Modeling. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2014,</strong> <em>33 </em>
                                    (5)
                                     , 322-331. <a href="https://doi.org/10.1002/minf.201400012" title="DOI URL">https://doi.org/10.1002/minf.201400012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201400012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201400012%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DBCRP%252BInhibition%25253A%252Bfrom%252BData%252BCollection%252Bto%252BLigand-Based%252BModeling%26aulast%3DMontanari%26aufirst%3DFloriane%26date%3D2014%26date%3D2014%26volume%3D33%26issue%3D5%26spage%3D322%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Nesi</span>, <span class="hlFld-ContribAuthor ">Nicola Antonio  Colabufo</span>, <span class="hlFld-ContribAuthor ">Marialessandra  Contino</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Perrone</span>, <span class="hlFld-ContribAuthor ">Maria  Digiacomo</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>, <span class="hlFld-ContribAuthor ">Annalina  Lapucci</span>, <span class="hlFld-ContribAuthor ">Marco  Macchia</span>, <span class="hlFld-ContribAuthor ">Simona  Rapposelli</span>. </span><span class="cited-content_cbyCitation_article-title">SAR study on arylmethyloxyphenyl scaffold: Looking for a P-gp nanomolar affinity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>76 </em>, 558-566. <a href="https://doi.org/10.1016/j.ejmech.2014.02.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.02.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.02.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.02.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSAR%252Bstudy%252Bon%252Barylmethyloxyphenyl%252Bscaffold%25253A%252BLooking%252Bfor%252Ba%252BP-gp%252Bnanomolar%252Baffinity%26aulast%3DNesi%26aufirst%3DGiulia%26date%3D2014%26volume%3D76%26spage%3D558%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>, <span class="hlFld-ContribAuthor ">Changdev G.  Gadhe</span>, <span class="hlFld-ContribAuthor ">Gugan  Kothandan</span>, <span class="hlFld-ContribAuthor ">Seung Joo  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancement of P-gylcoprotein modulators of arylmethylamine-phenyl derivatives: an integrative modeling approach. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (5)
                                     , 2511-2523. <a href="https://doi.org/10.1007/s00044-012-0246-0" title="DOI URL">https://doi.org/10.1007/s00044-012-0246-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0246-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0246-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DEnhancement%252Bof%252BP-gylcoprotein%252Bmodulators%252Bof%252Barylmethylamine-phenyl%252Bderivatives%25253A%252Ban%252Bintegrative%252Bmodeling%252Bapproach%26aulast%3DMadhavan%26aufirst%3DThirumurthy%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D5%26spage%3D2511%26epage%3D2523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simona  Rapposelli</span>, <span class="hlFld-ContribAuthor ">Alessio  Coi</span>, <span class="hlFld-ContribAuthor ">Marcello  Imbriani</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Bianucci</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Classification Models for Identifying “True” P-glycoprotein (P-gp) Inhibitors Through Inhibition, ATPase Activation and Monolayer Efflux Assays. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2012,</strong> <em>13 </em>
                                    (6)
                                     , 6924-6943. <a href="https://doi.org/10.3390/ijms13066924" title="DOI URL">https://doi.org/10.3390/ijms13066924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms13066924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms13066924%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDevelopment%252Bof%252BClassification%252BModels%252Bfor%252BIdentifying%252B%2525E2%252580%25259CTrue%2525E2%252580%25259D%252BP-glycoprotein%252B%252528P-gp%252529%252BInhibitors%252BThrough%252BInhibition%25252C%252BATPase%252BActivation%252Band%252BMonolayer%252BEfflux%252BAssays%26aulast%3DRapposelli%26aufirst%3DSimona%26date%3D2012%26date%3D2012%26volume%3D13%26issue%3D6%26spage%3D6924%26epage%3D6943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola Antonio  Colabufo</span>, <span class="hlFld-ContribAuthor ">Marialessandra  Contino</span>, <span class="hlFld-ContribAuthor ">Francesco  Berardi</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>, <span class="hlFld-ContribAuthor ">Maria Antonietta  Panaro</span>, <span class="hlFld-ContribAuthor ">Antonia  Cianciulli</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Mitolo</span>, <span class="hlFld-ContribAuthor ">Amalia  Azzariti</span>, <span class="hlFld-ContribAuthor ">Annelisa  Quatrale</span>, <span class="hlFld-ContribAuthor ">Angelo  Paradiso</span>. </span><span class="cited-content_cbyCitation_article-title">A new generation of MDR modulating agents with dual activity: P-gp inhibitor and iNOS inducer agents. </span><span class="cited-content_cbyCitation_journal-name">Toxicology in Vitro</span><span> <strong>2011,</strong> <em>25 </em>
                                    (1)
                                     , 222-230. <a href="https://doi.org/10.1016/j.tiv.2010.11.004" title="DOI URL">https://doi.org/10.1016/j.tiv.2010.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tiv.2010.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tiv.2010.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520in%2520Vitro%26atitle%3DA%252Bnew%252Bgeneration%252Bof%252BMDR%252Bmodulating%252Bagents%252Bwith%252Bdual%252Bactivity%25253A%252BP-gp%252Binhibitor%252Band%252BiNOS%252Binducer%252Bagents%26aulast%3DColabufo%26aufirst%3DNicola%2BAntonio%26date%3D2011%26volume%3D25%26issue%3D1%26spage%3D222%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Xia</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Multidrug Resistance with Small Molecules for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules and Therapeutics</span><span> <strong>2010,</strong> <em>18 </em>
                                    (4)
                                     , 375-385. <a href="https://doi.org/10.4062/biomolther.2010.18.4.375" title="DOI URL">https://doi.org/10.4062/biomolther.2010.18.4.375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4062/biomolther.2010.18.4.375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4062%2Fbiomolther.2010.18.4.375%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%2520and%2520Therapeutics%26atitle%3DTargeting%252BMultidrug%252BResistance%252Bwith%252BSmall%252BMolecules%252Bfor%252BCancer%252BTherapy%26aulast%3DXia%26aufirst%3DYan%26date%3D2010%26volume%3D18%26issue%3D4%26spage%3D375%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent Multidrug Resistance (MDR) Reversal Agents: Aminosulfonylaryl Isoxazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2009,</strong>,, 779-780. <a href="https://doi.org/10.5012/bkcs.2009.30.4.779" title="DOI URL">https://doi.org/10.5012/bkcs.2009.30.4.779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2009.30.4.779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2009.30.4.779%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%252BMultidrug%252BResistance%252B%252528MDR%252529%252BReversal%252BAgents%25253A%252BAminosulfonylaryl%252BIsoxazole%252BDerivatives%26date%3D2009%26volume%3D30%26issue%3D4%26spage%3D779%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola A.  Colabufo</span>, <span class="hlFld-ContribAuthor ">Francesco  Berardi</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Perrone</span>, <span class="hlFld-ContribAuthor ">Mariangela  Cantore</span>, <span class="hlFld-ContribAuthor ">Marialessandra  Contino</span>, <span class="hlFld-ContribAuthor ">Carmela  Inglese</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-Drug-Resistance-Reverting Agents: 2-Aryloxazole and 2-Arylthiazole Derivatives as Potent BCRP or MRP1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2009,</strong> <em>4 </em>
                                    (2)
                                     , 188-195. <a href="https://doi.org/10.1002/cmdc.200800329" title="DOI URL">https://doi.org/10.1002/cmdc.200800329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.200800329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.200800329%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMulti-Drug-Resistance-Reverting%252BAgents%25253A%252B2-Aryloxazole%252Band%252B2-Arylthiazole%252BDerivatives%252Bas%252BPotent%252BBCRP%252Bor%252BMRP1%252BInhibitors%26aulast%3DColabufo%26aufirst%3DNicola%25E2%2580%2585A.%26date%3D2009%26volume%3D4%26issue%3D2%26spage%3D188%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Third Generation P-gp Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compounds <b>12b</b> and <b>28b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0003.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents: (A) KOH, Δ, DMSO.</p><p class="last"><span class="fn-label">Scheme b</span>Physical properties reported in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0004.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (A) DBU (1,8-diazabicyclic[5.4.0]undec-7-ene), CH<sub>3</sub>CN; (B) H<sub>2</sub>, Pd/C 10%, EtOH; (C) appropriate methoxybenzylchloride, KI, CH<sub>3</sub>CN, microwave; (D) (i) appropriate dimethoxybenzaldehyde, EtOH, reflux, (ii) NaBH<sub>4</sub>, EtOH/H<sub>2</sub>O.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cytotoxic effect of P-gp inhibitors on the MCF-7/Adr cell line at 48 h. The effect of compound <b>17b</b> has been determined at 1 µM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/medium/jm-2007-01267q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison between P-gp (gray bars) and BCRP (white bars) inhibition activity of oxygen derivatives (A) and amino derivatives (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-5/jm701267q/production/images/large/jm-2007-01267q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701267q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Klein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadi, A.</span><span> </span><span class="NLM_article-title">An inventory of the human ABC proteins</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">1461</span> <span class="NLM_fpage">237</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1461&publication_year=1999&pages=237-262&author=I.+Kleinauthor=B.+Sarkadiauthor=A.+Varadi&title=An+inventory+of+the+human+ABC+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DI.%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DVaradi%26aufirst%3DA.%26atitle%3DAn%2520inventory%2520of%2520the%2520human%2520ABC%2520proteins%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1999%26volume%3D1461%26spage%3D237%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrycyna, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Biochemical, cellular, and pharmacological aspects of the multidrug transporter</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">39</span> <span class="NLM_fpage">361</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=361-398&author=S.+V.+Ambudkarauthor=S.+Deyauthor=C.+A.+Hrycynaauthor=M.+Ramachandraauthor=I.+Pastanauthor=M.+M.+Gottesman&title=Biochemical%2C+cellular%2C+and+pharmacological+aspects+of+the+multidrug+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DRamachandra%26aufirst%3DM.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DBiochemical%252C%2520cellular%252C%2520and%2520pharmacological%2520aspects%2520of%2520the%2520multidrug%2520transporter%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1999%26volume%3D39%26spage%3D361%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ayrton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, P.</span><span> </span><span class="NLM_article-title">Role of transport proteins in drug absorption, distribution, and excretion</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">31</span> <span class="NLM_fpage">469</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=469-497&author=A.+Ayrtonauthor=P.+Morgan&title=Role+of+transport+proteins+in+drug+absorption%2C+distribution%2C+and+excretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAyrton%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DP.%26atitle%3DRole%2520of%2520transport%2520proteins%2520in%2520drug%2520absorption%252C%2520distribution%252C%2520and%2520excretion%26jtitle%3DXenobiotica%26date%3D2001%26volume%3D31%26spage%3D469%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzhetsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allikmets, R.</span><span> </span><span class="NLM_article-title">The human ATP-binding cassette (ABC) transporter superfamily</span> <span class="citation_source-journal">Genome Res.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">1156</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1101%2Fgr.GR-1649R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11435397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFaitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1156-1166&author=M.+Deanauthor=A.+Rzhetskyauthor=R.+Allikmets&title=The+human+ATP-binding+cassette+%28ABC%29+transporter+superfamily"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The human ATP-binding cassette (ABC) transporter superfamily</span></div><div class="casAuthors">Dean, Michael; Rzhetsky, Andrey; Allikmets, Rando</div><div class="citationInfo"><span class="NLM_cas:title">Genome Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1156-1166</span>CODEN:
                <span class="NLM_cas:coden">GEREFS</span>;
        ISSN:<span class="NLM_cas:issn">1088-9051</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The ATP-binding cassette (ABC) transporter superfamily contains membrane proteins that translocate a variety of substrates across extra- and intra-cellular membranes.  Genetic variation in these genes is the cause of or contributor to a wide variety of human disorders with Mendelian and complex inheritance, including cystic fibrosis, neurol. disease, retinal degeneration, cholesterol and bile transport defects, anemia, and drug response.  Conservation of the ATP-binding domains of these genes has allowed the identification of new members of the superfamily based on nucleotide and protein sequence homol.  Phylogenetic anal. is used to divide all 48 known ABC transporters into seven distinct subfamilies of proteins.  For each gene, the precise map location on human chromosomes, expression data, and localization within the superfamily has been detd.  These data allow predictions to be made as to potential functions or disease phenotypes assocd. with each protein.  In this paper, we review the current state of knowledge on all human ABC genes in inherited disease and drug resistance.  In addn., the availability of the complete Drosophila genome sequence allows the comparison of the known human ABC genes with those in the fly genome.  The combined data enable an evolutionary anal. of the superfamily.  Complete characterization of all ABC from the human genome and from model organisms will lead to important insights into the physiol. and the mol. basis of many human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8mm8uHciH1bVg90H21EOLACvtfcHk0lj3piBhEq47Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFaitL0%253D&md5=caf7aa211f2b2603fb84c6690fe0bad5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fgr.GR-1649R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.GR-1649R%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DM.%26aulast%3DRzhetsky%26aufirst%3DA.%26aulast%3DAllikmets%26aufirst%3DR.%26atitle%3DThe%2520human%2520ATP-binding%2520cassette%2520%2528ABC%2529%2520transporter%2520superfamily%26jtitle%3DGenome%2520Res.%26date%3D2001%26volume%3D11%26spage%3D1156%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hyde, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimmack, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gileadi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, C. F.</span><span> </span><span class="NLM_article-title">Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance, and bacterial transport</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">346</span> <span class="NLM_fpage">362</span> <span class="NLM_lpage">365</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=362-365&author=S.+C.+Hydeauthor=P.+Emsleyauthor=M.+J.+Hartshornauthor=M.+M.+Mimmackauthor=U.+Gileadiauthor=S.+R.+Pearceauthor=M.+P.+Gallagherauthor=D.+R.+Gillauthor=R.+E.+Hubbardauthor=C.+F.+Higgins&title=Structural+model+of+ATP-binding+proteins+associated+with+cystic+fibrosis%2C+multidrug+resistance%2C+and+bacterial+transport"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHyde%26aufirst%3DS.%2BC.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMimmack%26aufirst%3DM.%2BM.%26aulast%3DGileadi%26aufirst%3DU.%26aulast%3DPearce%26aufirst%3DS.%2BR.%26aulast%3DGallagher%26aufirst%3DM.%2BP.%26aulast%3DGill%26aufirst%3DD.%2BR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DHiggins%26aufirst%3DC.%2BF.%26atitle%3DStructural%2520model%2520of%2520ATP-binding%2520proteins%2520associated%2520with%2520cystic%2520fibrosis%252C%2520multidrug%2520resistance%252C%2520and%2520bacterial%2520transport%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D362%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Quinton, P. M.</span><span> </span><span class="NLM_article-title">Physiological basis of cystic fibrosis: a historical perspective</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">79</span> <span class="NLM_fpage">S3</span> <span class="NLM_lpage">S22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=S3-S22&author=P.+M.+Quinton&title=Physiological+basis+of+cystic+fibrosis%3A+a+historical+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuinton%26aufirst%3DP.%2BM.%26atitle%3DPhysiological%2520basis%2520of%2520cystic%2520fibrosis%253A%2520a%2520historical%2520perspective%26jtitle%3DPhysiol.%2520Rev.%26date%3D1999%26volume%3D79%26spage%3DS3%26epage%3DS22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Remaley, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rust, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naudin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broccardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnould, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duverger, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamarina-Fojo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredrickson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denefle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, H. B.</span><span> </span><span class="NLM_article-title">Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">96</span> <span class="NLM_fpage">12685</span> <span class="NLM_lpage">12690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12685-12690&author=A.+T.+Remaleyauthor=S.+Rustauthor=M.+Rosierauthor=C.+Knapperauthor=L.+Naudinauthor=C.+Broccardoauthor=K.+M.+Petersonauthor=C.+Kochauthor=I.+Arnouldauthor=C.+Pradesauthor=N.+Duvergerauthor=H.+Funkeauthor=G.+Assmanauthor=M.+Dingerauthor=M.+Deanauthor=G.+Chiminiauthor=S.+Santamarina-Fojoauthor=D.+S.+Fredricksonauthor=P.+Denefleauthor=H.+Bryanauthor=H.+B.+Brewer&title=Human+ATP-binding+cassette+transporter+1+%28ABC1%29%3A+genomic+organization+and+identification+of+the+genetic+defect+in+the+original+Tangier+disease+kindred"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRemaley%26aufirst%3DA.%2BT.%26aulast%3DRust%26aufirst%3DS.%26aulast%3DRosier%26aufirst%3DM.%26aulast%3DKnapper%26aufirst%3DC.%26aulast%3DNaudin%26aufirst%3DL.%26aulast%3DBroccardo%26aufirst%3DC.%26aulast%3DPeterson%26aufirst%3DK.%2BM.%26aulast%3DKoch%26aufirst%3DC.%26aulast%3DArnould%26aufirst%3DI.%26aulast%3DPrades%26aufirst%3DC.%26aulast%3DDuverger%26aufirst%3DN.%26aulast%3DFunke%26aufirst%3DH.%26aulast%3DAssman%26aufirst%3DG.%26aulast%3DDinger%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DChimini%26aufirst%3DG.%26aulast%3DSantamarina-Fojo%26aufirst%3DS.%26aulast%3DFredrickson%26aufirst%3DD.%2BS.%26aulast%3DDenefle%26aufirst%3DP.%26aulast%3DBryan%26aufirst%3DH.%26aulast%3DBrewer%26aufirst%3DH.%2BB.%26atitle%3DHuman%2520ATP-binding%2520cassette%2520transporter%25201%2520%2528ABC1%2529%253A%2520genomic%2520organization%2520and%2520identification%2520of%2520the%2520genetic%2520defect%2520in%2520the%2520original%2520Tangier%2520disease%2520kindred%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D12685%26epage%3D12690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Brooks-Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roomp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molhuizen, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loubser, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouelette, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fichter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashbourne-Excoffon, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martindale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohlich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koop, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimstone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastelein, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span> </span><span class="NLM_article-title">Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">22</span> <span class="NLM_fpage">336</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1038%2F11905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=10431236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADyaK1MXltVSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=336-345&author=A.+Brooks-Wilsonauthor=M.+Marcilauthor=S.+M.+Cleeauthor=L.+H.+Zhangauthor=K.+Roompauthor=M.+van+Damauthor=L.+Yuauthor=C.+Brewerauthor=J.+A.+Collinsauthor=H.+O.+Molhuizenauthor=O.+Loubserauthor=B.+F.+Oueletteauthor=K.+Fichterauthor=K.+J.+Ashbourne-Excoffonauthor=C.+W.+Sensenauthor=S.+Schererauthor=S.+Mottauthor=M.+Denisauthor=D.+Martindaleauthor=J.+Frohlichauthor=K.+Morganauthor=B.+Koopauthor=S.+Pimstoneauthor=J.+J.+Kasteleinauthor=J.+Genestauthor=M.+R.+Hayden&title=Mutations+in+ABC1+in+Tangier+disease+and+familial+high-density+lipoprotein+deficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency</span></div><div class="casAuthors">Brooks-Wilson, Angela; Marcil, Michel; Clee, Susanne M.; Zhang, Lin-Hua; Roomp, Kirsten; Van Dam, Marjel; Yu, Lu; Brewer, Carl; Collins, Jennifer A.; Molhuizen, Henri O. F.; Loubser, Odell; Ouelette, B. F. Francis; Fichter, Keith; Ashbourne-Excoffon, Katherine J. D.; Sensen, Christoph W.; Scherer, Stephen; Mott, Stephanie; Denis, Maxime; Martindale, Duane; Frohlich, Jiri; Morgan, Kenneth; Koop, Ben; Pimstone, Simon; Kastelein, John J. P.; Genest, Jacques, Jr.; Hayden, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">336-345</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Genes have a major role in the control of high-d. lipoprotein (HDL) cholesterol (HDL-C) levels.  Here the authors have identified two Tangier disease (TD) families, confirmed 9q31 linkage and refined the disease locus to a limited genomic region contg. the gene encoding the ATP-binding cassette transporter (ABC1).  Familial HDL deficiency (FHA) is a more frequent cause of low HDL levels.  On the basis of independent linkage and meiotic recombinants, the authors localized the FHA locus to the same genomic region as the TD locus.  Mutations in ABC1 were detected in both TD and FHA, indicating that TD and FHA are allelic.  This indicates that the protein encoded by ABC1 is a key gatekeeper influencing intracellular cholesterol transport, hence the authors have named it cholesterol efflux regulatory protein (CERP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMR195KgNUo7Vg90H21EOLACvtfcHk0lh4CQT10Nz-Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVSht7c%253D&md5=44506d866805006d05db772830aab871</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F11905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F11905%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks-Wilson%26aufirst%3DA.%26aulast%3DMarcil%26aufirst%3DM.%26aulast%3DClee%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DL.%2BH.%26aulast%3DRoomp%26aufirst%3DK.%26aulast%3Dvan%2BDam%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DBrewer%26aufirst%3DC.%26aulast%3DCollins%26aufirst%3DJ.%2BA.%26aulast%3DMolhuizen%26aufirst%3DH.%2BO.%26aulast%3DLoubser%26aufirst%3DO.%26aulast%3DOuelette%26aufirst%3DB.%2BF.%26aulast%3DFichter%26aufirst%3DK.%26aulast%3DAshbourne-Excoffon%26aufirst%3DK.%2BJ.%26aulast%3DSensen%26aufirst%3DC.%2BW.%26aulast%3DScherer%26aufirst%3DS.%26aulast%3DMott%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DM.%26aulast%3DMartindale%26aufirst%3DD.%26aulast%3DFrohlich%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DK.%26aulast%3DKoop%26aufirst%3DB.%26aulast%3DPimstone%26aufirst%3DS.%26aulast%3DKastelein%26aufirst%3DJ.%2BJ.%26aulast%3DGenest%26aufirst%3DJ.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DMutations%2520in%2520ABC1%2520in%2520Tangier%2520disease%2520and%2520familial%2520high-density%2520lipoprotein%2520deficiency%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D22%26spage%3D336%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bates, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honjo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span> </span><span class="NLM_article-title">New ABC transporters in multi-drug resistance</span> <span class="citation_source-journal">Emerging Ther. Targets</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">561</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1517%2F14728222.4.5.561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2000&pages=561-580&author=E.+S.+Batesauthor=R.+Robeyauthor=T.+Knutsenauthor=Y.+Honjoauthor=T.+Litmanauthor=M.+Dean&title=New+ABC+transporters+in+multi-drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New ABC transporters in multi-drug resistance</span></div><div class="casAuthors">Bates, Susan E.; Robey, Robert; Knutsen, Turid; Honjo, Yasumasa; Litman, Thomas; Dean, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Therapeutic Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-580</span>CODEN:
                <span class="NLM_cas:coden">ETTAF7</span>;
        ISSN:<span class="NLM_cas:issn">1460-0412</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 133 refs.  ATP-binding cassette (ABC) transporters have been the subject of intense scrutiny as potential mediators of clin. drug resistance.  Since the identification of MDR1/P-glycoprotein over 15 yr ago, it has been recognized that reduced intracellular accumulation of anticancer agents can result in significant degrees of drug resistance.  The multi-drug resistance assocd. protein (MRP1) was the second ABC transporter to be assocd. with drug resistance, and in the past three years, five addnl. MRP family members have been recognized.  While studies to define the substrate specificity and normal physiol. for the new transporters is underway, it appears that the principal function for P-glycoprotein and MRP is protection of the host from xenobiotics.  The most recent addn. to the list of ABC transporters mediating drug resistance is the half-transporter, MXR/BCRP/ABCP.  Overexpression of this transporter is assocd. with mitoxantrone, anthracycline and camptothecin resistance.  The discovery of multiple distinct ABC transporters capable of conferring multi-drug resistance offers the possibility that clin. reversal of drug resistance can be achieved.  Studies with P-glycoprotein inhibitors alone have generated mixed results; one potential explanation is that other transporters may be co-expressed.  These addnl. transporters offer new therapeutic targets, as both specific and multi-specific inhibitors should be identified for clin. trials in drug resistance reversal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQcRiZ0hc-zrVg90H21EOLACvtfcHk0lh4CQT10Nz-Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yntrk%253D&md5=caef4054d38dd0892eb66b1324ba9951</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F14728222.4.5.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.4.5.561%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DE.%2BS.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DKnutsen%26aufirst%3DT.%26aulast%3DHonjo%26aufirst%3DY.%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DDean%26aufirst%3DM.%26atitle%3DNew%2520ABC%2520transporters%2520in%2520multi-drug%2520resistance%26jtitle%3DEmerging%2520Ther.%2520Targets%26date%3D2000%26volume%3D4%26spage%3D561%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">48</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lg3-UmsC_oZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Schneider, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, K. H.</span><span> </span><span class="NLM_article-title">Multidrug resistance</span> <span class="citation_source-journal">Cancer Chemother. Biol. Response Modif.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">152</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=10800482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVWiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=152-177&author=E.+Schneiderauthor=D.+Paulauthor=P.+Ivyauthor=K.+H.+Cowan&title=Multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance [to antitumor drugs]</span></div><div class="casAuthors">Schneider, E.; Paul, D.; Ivy, P.; Cowan, K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Biological Response Modifiers</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-177</span>CODEN:
                <span class="NLM_cas:coden">CCBAED</span>;
        ISSN:<span class="NLM_cas:issn">0921-4410</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 179 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbfju0D1x0o7Vg90H21EOLACvtfcHk0lg3-UmsC_oZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVWiu7k%253D&md5=47384199bfc7cdb6ae3b775952648b20</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DIvy%26aufirst%3DP.%26aulast%3DCowan%26aufirst%3DK.%2BH.%26atitle%3DMultidrug%2520resistance%26jtitle%3DCancer%2520Chemother.%2520Biol.%2520Response%2520Modif.%26date%3D1999%26volume%3D18%26spage%3D152%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Glavinas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajcsi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cserepes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkadi, B.</span><span> </span><span class="NLM_article-title">The role of ABC transporters in drug resistance, metabolism, and toxicity</span> <span class="citation_source-journal">Curr. Drug Delivery</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">27</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F1567201043480036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16305368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVSqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=27-42&author=H.+Glavinasauthor=P.+Krajcsiauthor=J.+Cserepesauthor=B.+Sarkadi&title=The+role+of+ABC+transporters+in+drug+resistance%2C+metabolism%2C+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ABC transporters in drug resistance, metabolism, and toxicity</span></div><div class="casAuthors">Glavinas, Hristos; Krajcsi, Peter; Cserepes, Judit; Sarkadi, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Delivery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">CDDUBJ</span>;
        ISSN:<span class="NLM_cas:issn">1567-2018</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP Binding Cassette (ABC) transporters form a special family of membrane proteins, characterized by homologous ATP-binding, and large, multispanning transmembrane domains.  Several members of this family are primary active transporters, which significantly modulate the absorption, metab., cellular effectivity, and toxicity of pharmacol. agents.  This review provides a general overview of the human ABC transporters, their expression, localization, and basic mechanism of action.  Then the authors shortly deal with the human ABC transporters as targets of therapeutic interventions in medicine, including cancer drug resistance, lipid and other metabolic disorders, and even gene therapy applications.  The authors place a special emphasis on the 3 major groups of ABC transporters involved in cancer multidrug resistance (MDR).  These are the classical P-glycoprotein (MDR1, ABCB1), the multidrug resistance assocd. proteins (MRPs, in the ABCC subfamily), and the ABCG2 protein, an ABC half-transporter.  All these proteins catalyze an ATP-dependent active transport of chem. unrelated compds., including anticancer drugs.  MDR1 (P-glycoprotein) and ABCG2 preferentially extrude large hydrophobic, pos. charged mols., while the members of the MRP family can extrude both hydrophobic uncharged mols. and water-sol. anionic compds.  Based on the physiol. expression and role of these transporters, the authors provide examples for their role in Absorption-Distribution-Metab.-Excretion (ADME) and toxicol., and describe several basic assays which can be applied for screening drug interactions with ABC transporters in the course of drug research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOA7ZJlJuYuLVg90H21EOLACvtfcHk0lg46UDli2s2Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVSqu7Y%253D&md5=e5ea8afde47c4986d674fdc75a1dadaa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1567201043480036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567201043480036%26sid%3Dliteratum%253Aachs%26aulast%3DGlavinas%26aufirst%3DH.%26aulast%3DKrajcsi%26aufirst%3DP.%26aulast%3DCserepes%26aufirst%3DJ.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520ABC%2520transporters%2520in%2520drug%2520resistance%252C%2520metabolism%252C%2520and%2520toxicity%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2004%26volume%3D1%26spage%3D27%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Krishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, L. D.</span><span> </span><span class="NLM_article-title">Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR, and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">265</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2FS0928-0987%2800%2900114-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11033070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntF2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=265-283&author=R.+Krishnaauthor=L.+D.+Mayer&title=Multidrug+resistance+%28MDR%29+in+cancer.+Mechanisms%2C+reversal+using+modulators+of+MDR%2C+and+the+role+of+MDR+modulators+in+influencing+the+pharmacokinetics+of+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</span></div><div class="casAuthors">Krishna, R.; Mayer, L. D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-283</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 262 refs. In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-mediated pharmacokinetic interactions.  In addn., the role of P-GP in modifying the bioavailability of orally administered drugs via induction or inhibition has been also been demonstrated in various studies.  This overview presents a background on some of the commonly documented mechanisms of MDR and its reversal by modulators of MDR, followed by a discussion of the functional aspects of P-GP in the context of pharmacokinetic interactions when multiple agents are coadministered.  While adverse pharmacokinetic interactions have been documented with 1st- and 2nd-generation MDR modulators, certain newer agents of the 3rd-generation class of compds. have been less susceptible to eliciting pharmacokinetic interactions.  Although this review focuses on P-GP and the pharmacol. of MDR reversal by MDR modulators, the relevance of these drug transport proteins in the context of pharmacokinetic implications (drug absorption, distribution, clearance, and interactions) is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsAhX6vtg37Vg90H21EOLACvtfcHk0lg46UDli2s2Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntF2gtLw%253D&md5=e4877ba2ce60118d96098fbaec0d4077</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2800%2900114-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252800%252900114-7%26sid%3Dliteratum%253Aachs%26aulast%3DKrishna%26aufirst%3DR.%26aulast%3DMayer%26aufirst%3DL.%2BD.%26atitle%3DMultidrug%2520resistance%2520%2528MDR%2529%2520in%2520cancer.%2520Mechanisms%252C%2520reversal%2520using%2520modulators%2520of%2520MDR%252C%2520and%2520the%2520role%2520of%2520MDR%2520modulators%2520in%2520influencing%2520the%2520pharmacokinetics%2520of%2520anticancer%2520drugs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D11%26spage%3D265%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Leslie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. P. C.</span><span> </span><span class="NLM_article-title">Multidrug resistance proteins: role of P-glycoprotein MRP1, MRP2, and BCRP (ABCG2) in tissue defense</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">204</span> <span class="NLM_fpage">216</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2Fj.taap.2004.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=15845415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFGqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2005&pages=216-237&author=E.+M.+Leslieauthor=R.+G.+Deeleyauthor=S.+P.+C.+Cole&title=Multidrug+resistance+proteins%3A+role+of+P-glycoprotein+MRP1%2C+MRP2%2C+and+BCRP+%28ABCG2%29+in+tissue+defense"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense</span></div><div class="casAuthors">Leslie, Elaine M.; Deeley, Roger G.; Cole, Susan P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-237</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  In tumor cell lines, multidrug resistance is often assocd. with an ATP-dependent decrease in cellular drug accumulation which is attributed to the overexpression of certain ATP-binding cassette (ABC) transporter proteins.  ABC proteins that confer drug resistance include (but are not limited to) P-glycoprotein (gene symbol ABCB1), the multidrug resistance protein 1 (MRP1, gene symbol ABCC1), MRP2 (gene symbol ABCC2), and the breast cancer resistance protein (BCRP, gene symbol ABCG2).  In addn. to their role in drug resistance, there is substantial evidence that these efflux pumps have overlapping functions in tissue defense.  Collectively, these proteins are capable of transporting a vast and chem. diverse array of toxicants including bulky lipophilic cationic, anionic, and neutrally charged drugs and toxins as well as conjugated org. anions that encompass dietary and environmental carcinogens, pesticides, metals, metalloids, and lipid peroxidn. products.  P-glycoprotein, MRP1, MRP2, and BCRP/ABCG2 are expressed in tissues important for absorption (e.g., lung and gut) and metab. and elimination (liver and kidney).  In addn., these transporters have an important role in maintaining the barrier function of sanctuary site tissues (e.g., blood-brain barrier, blood-cerebral spinal fluid barrier, blood-testis barrier and the maternal-fetal barrier or placenta).  Thus, these ABC transporters are increasingly recognized for their ability to modulate the absorption, distribution, metab., excretion, and toxicity of xenobiotics.  In this review, the role of these four ABC transporter proteins in protecting tissues from a variety of toxicants is discussed.  Species variations in substrate specificity and tissue distribution of these transporters are also addressed since these properties have implications for in vivo models of toxicity used for drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO1vBvwT5ZILVg90H21EOLACvtfcHk0lg46UDli2s2Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFGqtrY%253D&md5=24d834ee8d2d30505f1e44d3eb64bc41</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2004.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2004.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%2BC.%26atitle%3DMultidrug%2520resistance%2520proteins%253A%2520role%2520of%2520P-glycoprotein%2520MRP1%252C%2520MRP2%252C%2520and%2520BCRP%2520%2528ABCG2%2529%2520in%2520tissue%2520defense%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2005%26volume%3D204%26spage%3D216%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nobili, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglioni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mini, E.</span><span> </span><span class="NLM_article-title">Pharmacological strategies for overcoming multidrug resistance</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">861</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F138945006777709593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16842217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Crsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=861-879&author=S.+Nobiliauthor=I.+Landiniauthor=B.+Giglioniauthor=E.+Mini&title=Pharmacological+strategies+for+overcoming+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological strategies for overcoming multidrug resistance</span></div><div class="casAuthors">Nobili, S.; Landini, I.; Giglioni, B.; Mini, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">861-879</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a major obstacle to the effective treatment of cancer.  One of the underlying mechanisms of MDR is cellular overprodn. of P-glycoprotein (P-gp) which acts as an efflux pump for various anticancer drugs.  P-gp is encoded by the MDR1 gene and its overexpression in cancer cells has become a therapeutic target for circumventing multidrug resistance.  A potential strategy is to co-administer efflux pump inhibitors, although such reversal agents might actually increase the side effects of chemotherapy by blocking physiol. anticancer drug efflux from normal cells.  Although many efforts to overcome MDR were made using 1st and second generation reversal agents comprising drugs already in current clin. use for other indications (e.g. verapamil, cyclosporine A, quinidine) or analogs of the first-generation drugs (e.g. dexverapamil, valspodar, cinchonine), few significant advances were made.  Clin. trials with third generation modulators (e.g. biricodar, zosuquidar, and laniquidar) specifically developed for MDR reversal are ongoing.  The results however are not encouraging and it may be that the perfect reverser does not exist.  Other approaches to multidrug resistance reversal were also considered: encapsulation of anthracyclines in liposomes or other carriers which deliver these drugs selectively to tumor tissues, the use of P-gp targeted antibodies such as UIC2 or the use of antisense strategies targeting the MDR1 mRNA.  More recently, the development of transcriptional regulators appears promising.  Also anticancer drugs that belong structurally to classes of drugs extruded from cells by P-gp but that are not substrates of this drug transporter may act as potent inhibitors of MDR tumors (e.g. epothilones, second generation taxanes).  Taking advantage of MDR has also been studied.  Bone marrow suppression, one of the major side effects of cancer chemotherapy, can compromise the potential of curative and palliative chemotherapy.  It is conceivable that drug resistance gene transfer into bone marrow stem cells may be able to reduce or abolish chemotherapy-induced myelosuppression and facilitate the use of high dose chemotherapy.  Clin. trials of retroviral vectors contg. drug resistance genes have established that the approach is safe and are now being designed to address the therapeutically relevant issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA1IVKcA00LLVg90H21EOLACvtfcHk0ljbC_vKFDDKvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Crsrk%253D&md5=744fd86ed84cc8b4d9ae50e5337f487e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F138945006777709593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006777709593%26sid%3Dliteratum%253Aachs%26aulast%3DNobili%26aufirst%3DS.%26aulast%3DLandini%26aufirst%3DI.%26aulast%3DGiglioni%26aufirst%3DB.%26aulast%3DMini%26aufirst%3DE.%26atitle%3DPharmacological%2520strategies%2520for%2520overcoming%2520multidrug%2520resistance%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D861%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Thomas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coley, H. M.</span><span> </span><span class="NLM_article-title">Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein</span> <span class="citation_source-journal">Cancer Control</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">159</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1177%2F107327480301000207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=12712010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A280%3ADC%252BD3s7pt1ansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=159-165&author=H.+Thomasauthor=H.+M.+Coley&title=Overcoming+multidrug+resistance+in+cancer%3A+an+update+on+the+clinical+strategy+of+inhibiting+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein</span></div><div class="casAuthors">Thomas Hilary; Coley Helen M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer control : journal of the Moffitt Cancer Center</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-65</span>
        ISSN:<span class="NLM_cas:issn">1073-2748</span>.
    </div><div class="casAbstract">BACKGROUND:  Multidrug resistance (MDR) is a significant obstacle to providing effective chemotherapy to many patients.  Multifactorial in etiology, classic MDR is associated with the overexpression of P-glycoprotein (P-gp), resulting in increased efflux of chemotherapy from cancer cells.  Inhibiting P-gp as a method to reverse MDR in cancer patients has been studied extensively, but the results have generally been disappointing.  METHODS:  The development of P-gp inhibitors is reviewed, including a discussion of early agents that are no longer being developed and third-generation agents that are currently in clinical trials.  RESULTS:  First-generation agents (eg, cyclosporin, verapamil) were limited by unacceptable toxicity, whereas second-generation agents (eg, valspodar, biricodar) had better tolerability but were confounded by unpredictable pharmacokinetic interactions and interactions with other transporter proteins.  Third-generation inhibitors (tariquidar XR9576, zosuquidar LY335979, laniquidar R101933, and ONT-093) have high potency and specificity for P-gp.  Furthermore, pharmacokinetic studies to date have shown no appreciable impact on cytochrome P450 3A4 drug metabolism and no clinically significant drug interactions with common chemotherapy agents.  CONCLUSIONS:  Third-generation P-gp inhibitors have shown promise in clinical trials.  The continued development of these agents may establish the true therapeutic potential of P-gp-mediated MDR reversal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZbFkbBeTOf0g6wdEZmT2rfW6udTcc2eZp4N9vhPO1t7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7pt1ansg%253D%253D&md5=9f0f487ba641116bd397eae7ba94da32</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F107327480301000207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F107327480301000207%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%26aulast%3DColey%26aufirst%3DH.%2BM.%26atitle%3DOvercoming%2520multidrug%2520resistance%2520in%2520cancer%253A%2520an%2520update%2520on%2520the%2520clinical%2520strategy%2520of%2520inhibiting%2520P-glycoprotein%26jtitle%3DCancer%2520Control%26date%3D2003%26volume%3D10%26spage%3D159%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pérez-Tomás, R.</span><span> </span><span class="NLM_article-title">Multidrug resistance: retrospect and prospects in anti-cancer drug treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1859</span> <span class="NLM_lpage">1876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F092986706777585077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16842198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1859-1876&author=R.+P%C3%A9rez-Tom%C3%A1s&title=Multidrug+resistance%3A+retrospect+and+prospects+in+anti-cancer+drug+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance: retrospect and prospects in anti-cancer drug treatment</span></div><div class="casAuthors">Perez-Tomas, Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1859-1876</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Conventional cancer chemotherapy is seriously limited by the multidrug resistance (MDR) commonly exhibited by tumor cells.  One mechanism by which a living cell can achieve multiple resistances is via the active efflux of a broad range of anticancer drugs through the cellular membrane by MDR proteins.  Such drugs are exported in both ATP-dependent and -independent manners, and can occur despite considerable concn. gradients.  To the ATP-dependent group belongs the ATP-binding cassette (ABC) transporter family, which includes P-gp, MRP, BCRP, etc.  Another protein related to MDR, though not belonging to the ABC transporter family, is lung resistance-related protein (LRP).  All of these proteins are involved in diverse physiol. processes, and are responsible for the uptake and efflux of a multitude of substances from cancer cells.  Many inhibitors of MDR transporters have been identified over the years.  Firstly, MDR drugs were not specifically developed for inhibiting MDR: in fact, they had other pharmacol. properties, as well as a relatively low affinity for MDR transporters.  They included compds. of diverse structure and function, such as verapamil and cyclosporine, and caused side effects.  Secondly, the new drugs were more inhibitor-specific, in terms of MDR transport, and were designed to reduce such side effects (e.g., R-verapamil, dexniguldipine, etc.).  Unfortunately, they displayed poor response in clin. studies.  Recently, new compds. obtained from drug development programs conducted by the pharmaceutical industry are characterized by a high affinity to MDR transporters and are efficient at nanomolar concns.  Some of these compds. (e.g., MS-209) are currently under clin. trials for specific forms of advanced cancers.  We aim to provide an overview of the properties assocd. with those mammalian MDR transporters known to mediate significant transport of relevant drugs in cancer treatments.  We also summarize recent advances concerning resistance to cancer drug therapies with respect to the function and overexpression of ABC and LRP multidrug transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMfuV0__Y5LVg90H21EOLACvtfcHk0ljGuhk7NnFRtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Cltrc%253D&md5=7326324f2dd45bc14802beafaf1ee307</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986706777585077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777585077%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Tom%25C3%25A1s%26aufirst%3DR.%26atitle%3DMultidrug%2520resistance%253A%2520retrospect%2520and%2520prospects%2520in%2520anti-cancer%2520drug%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1859%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Teodori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapecchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">The functions and structure of ABC transporters: implications for the design of new inhibitors of P-gp and MRP1 to control multidrug resistance (MDR)</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">893</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.2174%2F138945006777709520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16842220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Crs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=893-909&author=E.+Teodoriauthor=S.+Deiauthor=S.+Martelliauthor=F.+Scapecchiauthor=F.+Gualtieri&title=The+functions+and+structure+of+ABC+transporters%3A+implications+for+the+design+of+new+inhibitors+of+P-gp+and+MRP1+to+control+multidrug+resistance+%28MDR%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR)</span></div><div class="casAuthors">Teodori, E.; Dei, S.; Martelli, C.; Scapecchi, S.; Gualtieri, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-909</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a kind of acquired resistance of microorganisms and cancer cells to chemotherapeutic drugs that are characterized by different chem. structure and different mechanism of action.  Classic MDR is the consequence of the over-expression of a variety of proteins that extrude the chemotherapeutic from the cell, lowering its concn. below the effective one.  The ABC (ATP Binding Cassette) is a ubiquitous and important family of such transporter proteins.  Members of this super family are present in mammals as well as in prokaryotic organisms and use ATP as the energy source to activate the extrusion process.  P-glycoprotein (Pgp) and Multidrug Resistance Proteins (MRP1 and sister proteins) are the most important and widely studied members of ABC super family.  Our knowledge about the structures and functions of transporter proteins has definitely improved in recent years, following the resoln. of the structure of bacterial pumps which opened the way to the building of homol. models for the more complex Pgp and MRP.  It can be anticipated that these results will have a strong impact on the design of more potent and safer MDR reverters.  A huge no. of small mols., many of natural origin, are able to reverse multidrug resistance by inhibiting the functions of Pgp.  MRP1 and sister proteins and their action has been considered a possible way to reverse MDR.  However, while a few compds. have reached clin. trials, none of them has, so far, been cleared for therapeutic use.  Two main reasons are at the base of this difficulty: (i) MDR is a complex phenomenon that may arise from several different biochem. mechanisms, with the consequence that inhibition of transporter proteins may be insufficient to reverse it; (ii) the physiol. role of Pgp and sister proteins requires more potent modulators with proper selectivity and pharmacokinetic to avoid unwanted side effects.  This paper first reviews the most recent discoveries on the structures and functions of the ABC super family, in particular Pgp and MRP.  Then, the medicinal chem. of MDR reverters, in light of these findings, is discussed and the mols. that are presently in development are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDF8LaOY-ysLVg90H21EOLACvtfcHk0ljGuhk7NnFRtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Crs74%253D&md5=ee253a141adf5697d901228912348185</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138945006777709520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006777709520%26sid%3Dliteratum%253Aachs%26aulast%3DTeodori%26aufirst%3DE.%26aulast%3DDei%26aufirst%3DS.%26aulast%3DMartelli%26aufirst%3DS.%26aulast%3DScapecchi%26aufirst%3DF.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DThe%2520functions%2520and%2520structure%2520of%2520ABC%2520transporters%253A%2520implications%2520for%2520the%2520design%2520of%2520new%2520inhibitors%2520of%2520P-gp%2520and%2520MRP1%2520to%2520control%2520multidrug%2520resistance%2520%2528MDR%2529%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D893%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Avendano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, J. C.</span><span> </span><span class="NLM_article-title">Inhibitors of multidrug resistance to antitumor agents (MDR)</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">9</span> <span class="NLM_fpage">159</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=159-193&author=C.+Avendanoauthor=J.+C.+Menendez&title=Inhibitors+of+multidrug+resistance+to+antitumor+agents+%28MDR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvendano%26aufirst%3DC.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26atitle%3DInhibitors%2520of%2520multidrug%2520resistance%2520to%2520antitumor%2520agents%2520%2528MDR%2529%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D159%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Planting, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneveld, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Gaast, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparreboom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burg, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luyten, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leeuw, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Boer-Dennert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purvis, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span> </span><span class="NLM_article-title">A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">55</span> <span class="NLM_fpage">91</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1007%2Fs00280-004-0854-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=15565444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWjt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=91-99&author=A.+S.+Plantingauthor=P.+Sonneveldauthor=A.+van+der+Gaastauthor=A.+Sparreboomauthor=M.+E.+van+der+Burgauthor=G.+P.+Luytenauthor=K.+de+Leeuwauthor=M.+de+Boer-Dennertauthor=P.+S.+Wisselauthor=R.+C.+Jewellauthor=E.+M.+Paulauthor=N.+B.+Purvisauthor=J.+Verweij&title=A+phase+I+and+pharmacologic+study+of+the+MDR+converter+GF120918+in+combination+with+doxorubicin+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors</span></div><div class="casAuthors">Planting, A. S. T.; Sonneveld, P.; Van Der Gaast, A.; Sparreboom, A.; Burg, M. E. L.; Luyten, G. P. M.; Leeuw, K.; De Boer-Dennert, M.; Wissel, P. S.; Jewell, R. C.; Paul, E. M.; Purvis, N. B., Jr.; Verweij, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Background: Resistance to chemotherapy can partly be explained by the activity of membrane bound P-glycoprotein.  Competitive inhibition of P-glycoprotein, by multidrug resistance (MDR) converters, may overcome this MDR.  Previously studied MDR converters either have serious intrinsic side effects or considerably influence the pharmacokinetics of cytotoxic agents at concns. theor. required to convert MDR.  GF120918 is a third-generation MDR converter with high affinity for P-glycoprotein and can be given orally.  We performed a phase 1 study with escalating doses of GF120918 in combination with doxorubicin.  Patients and methods: The study group comprised 46 patients with advanced solid tumors.  Doxorubicin was administered on day 1 (cycle 1), GF120918 on days 22-24 (cycle 2), and on days 29-33 with doxorubicin administered on day 31 (cycle 3).  Pharmacokinetics of both GF120918 and doxorubicin were studied.  The starting daily dose of GF120918 was 50 mg and was to be increased in subsequent cohorts until a steady state plasma level of 100 ng/mL was reached.  The starting dose of doxorubicin was 50 mg/m2 and was to be increased after reaching the target dose level of GF120918.  Results: In 37 of the 46 patients, full pharmacokinetic data from the three scheduled cycles were obtained.  Pharmacokinetics of GF120918 showed a less than linear increase in Cmax with increasing doses, with considerable interpatient variation.  The target steady-state plasma level for GF120918 was exceeded in 12 out of 19 patients who received 400 mg GF120918 alone twice daily and in 12 of 17 patients who received 400 mg GF120918 twice daily in combination with doxorubicin.  GF120918 pharmacokinetics were not influenced by coadministration of doxorubicin.  The doxorubicin AUC was only marginally influenced by GF120918 and only at the highest dose levels.  In these patients there was a significant increase in the AUC of doxorubicinol in cycle 3 as compared to cycle 1.  Hematol. toxicity mainly consisted of neutropenia and was more severe in cycle 3 than in cycle 1 (13 vs 5 patients with grade 4 neutropenia, P=0.003).  Neutropenic fever was the dose-limiting toxicity at a doxorubicin dose of 75 mg/m2 with 400 mg GF120918 twice daily.  The toxicity of GF120918 was limited to somnolence in eight patients and occasional gastrointestinal complaints.  Conclusion: GF120918 is an MDR converter with only minimal side effects at a dose level yielding concns. able to convert the action of P-glycoprotein in vitro.  A doxorubicin dose of 60 mg/m2 on day 3 in combination with 400 mg GF120918 twice daily on days 1-5 is an acceptable regimen for further clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv90u7DgtLn7Vg90H21EOLACvtfcHk0ljETkUilciwWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWjt77P&md5=a395f348bc6639576b949bbf7fdcf80b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0854-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0854-6%26sid%3Dliteratum%253Aachs%26aulast%3DPlanting%26aufirst%3DA.%2BS.%26aulast%3DSonneveld%26aufirst%3DP.%26aulast%3Dvan%2Bder%2BGaast%26aufirst%3DA.%26aulast%3DSparreboom%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBurg%26aufirst%3DM.%2BE.%26aulast%3DLuyten%26aufirst%3DG.%2BP.%26aulast%3Dde%2BLeeuw%26aufirst%3DK.%26aulast%3Dde%2BBoer-Dennert%26aufirst%3DM.%26aulast%3DWissel%26aufirst%3DP.%2BS.%26aulast%3DJewell%26aufirst%3DR.%2BC.%26aulast%3DPaul%26aufirst%3DE.%2BM.%26aulast%3DPurvis%26aufirst%3DN.%2BB.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520and%2520pharmacologic%2520study%2520of%2520the%2520MDR%2520converter%2520GF120918%2520in%2520combination%2520with%2520doxorubicin%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D55%26spage%3D91%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Morschhauser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinzani, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloots, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouafia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">48</span> <span class="NLM_fpage">708</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1080%2F10428190701190169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=17454628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVSjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=708-715&author=F.+Morschhauserauthor=P.+L.+Zinzaniauthor=M.+Burgessauthor=L.+Slootsauthor=F.+Bouafiaauthor=C.+Dumontet&title=Phase+I%2FII+trial+of+a+P-glycoprotein+inhibitor%2C+Zosuquidar.3HCl+trihydrochloride+%28LY335979%29%2C+given+orally+in+combination+with+the+CHOP+regimen+in+patients+with+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II trial of a P-glycoprotein inhibitor, zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma</span></div><div class="casAuthors">Morschhauser, Franck; Zinzani, Pier Luigi; Burgess, Michael; Sloots, Lisette; Bouafia, Fadela; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">708-715</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A phase I/II trial was performed to investigate the safety and tolerance of zosuquidar.3HCL, a potent inhibitor of P-glycoprotein (P-gp), when administered orally alone and in combination with the CHOP regimen in patients with untreated non-Hodgkin's lymphoma and to det. whether zosuquidar.3HCL affects pharmacokinetics of doxorubicin and vincristine.  Doses of CHOP remained const. and the doses of zosuquidar.3HCL were increased from 200 to 500 mg per dose.  A total of 15 patients were treated at three dose levels.  A target dose providing peak and trough levels compatible with prolonged modulation of P-gp function was obtained in patients receiving three doses of 500 mg of zosuquidar.3HCL p.o.  At this dose level, toxicity was minimal and no enhancement of CHOP-related toxicity was obsd.  Zosuquidar.3HCL did not significantly affect the pharmacokinetics of doxorubicin and had moderate effects on the pharmacokinetics of vincristine.  Zosuquidar.3HCL can be safely administered with CHOP therapy using a 24-h schedule.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAT5sarIjZbVg90H21EOLACvtfcHk0ljETkUilciwWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVSjurw%253D&md5=2b093e62677553432f5b7b8a1af94460</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F10428190701190169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190701190169%26sid%3Dliteratum%253Aachs%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DZinzani%26aufirst%3DP.%2BL.%26aulast%3DBurgess%26aufirst%3DM.%26aulast%3DSloots%26aufirst%3DL.%26aulast%3DBouafia%26aufirst%3DF.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DPhase%2520I%252FII%2520trial%2520of%2520a%2520P-glycoprotein%2520inhibitor%252C%2520Zosuquidar.3HCl%2520trihydrochloride%2520%2528LY335979%2529%252C%2520given%2520orally%2520in%2520combination%2520with%2520the%2520CHOP%2520regimen%2520in%2520patients%2520with%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2007%26volume%3D48%26spage%3D708%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Modok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">350</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2Fj.coph.2006.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16690355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=350-354&author=S.+Modokauthor=H.+R.+Mellorauthor=R.+Callaghan&title=Modulation+of+multidrug+resistance+efflux+pump+activity+to+overcome+chemoresistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span></div><div class="casAuthors">Modok, Szabolcs; Mellor, Howard R.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-354</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Early publications using cultured cancer cells immediately recognized the phenomenon of resistance to anticancer agents.  However, it was not until 1973 that it was first demonstrated that a major factor in the resistance of cancer cells was that of reduced drug accumulation.  This year marks the 30th anniversary of the discovery by Juliano and Ling that P-glycoprotein mediates this active efflux of chemotherapeutic drugs from cancer cells.  Since this seminal finding, the investigation of P-glycoprotein (MDR1, ATP binding cassette [ABC]B1) has proceeded with great vigour.  However, it soon became apparent that P-glycoprotein was not expressed in all drug-resistant cells that displayed an accumulation deficiency, which led to the discovery of other ABC transporters involved in drug efflux.  In 1992, the multidrug resistance-assocd. protein (MRP1, ABCC1) was identified in small cell lung cancer followed by breast cancer resistance protein (mitoxantrone resistance protein, ABCG2) in 1999.  After three decades of research, can we confidently define the contribution of multidrug resistance transporters to chemoresistance and do we have clin. useful drugs to sensitize cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEJzb35-rDLVg90H21EOLACvtfcHk0lhs5QRU-NhH6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D&md5=9fbe122b53419fa753a006af6840c326</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DModok%26aufirst%3DS.%26aulast%3DMellor%26aufirst%3DH.%2BR.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520efflux%2520pump%2520activity%2520to%2520overcome%2520chemoresistance%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapposelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digiacomo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsamo, A.</span><span> </span><span class="NLM_article-title">Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6607</span> <span class="NLM_lpage">6613</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060639z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6607-6613&author=N.+A.+Colabufoauthor=F.+Berardiauthor=R.+Perroneauthor=S.+Rapposelliauthor=M.+Digiacomoauthor=A.+Balsamo&title=Arylmethyloxyphenyl+derivatives%3A+small+molecules+displaying+P-glycoprotein+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm060639z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060639z%26sid%3Dliteratum%253Aachs%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DRapposelli%26aufirst%3DS.%26aulast%3DDigiacomo%26aufirst%3DM.%26aulast%3DBalsamo%26aufirst%3DA.%26atitle%3DArylmethyloxyphenyl%2520derivatives%253A%2520small%2520molecules%2520displaying%2520P-glycoprotein%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6607%26epage%3D6613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. S.</span><span> </span><span class="NLM_article-title">Rational use of in vitro P-glycoprotein assays in drug discovery</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">299</span> <span class="NLM_fpage">620</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=11602674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvV2qt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=620-628&author=J.+W.+Polliauthor=S.+A.+Wringauthor=J.+E.+Humphreysauthor=L.+Huangauthor=J.+B.+Morganauthor=L.+O.+Websterauthor=C.+S.+Serabjit-Singh&title=Rational+use+of+in+vitro+P-glycoprotein+assays+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Rational use of in vitro P-glycoprotein assays in drug discovery</span></div><div class="casAuthors">Polli, Joseph W.; Wring, Stephen A.; Humphreys, Joan E.; Huang, Liyue; Morgan, Jonathon B.; Webster, Lindsey O.; Serabjit-Singh, Cosette S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">620-628</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P-glycoprotein (Pgp) affects the absorption, distribution, and clearance of a variety of compds.  Thus, identification of compds. that are Pgp substrates can aid drug candidate selection and optimization.  Our goal was to evaluate three assays used to det. whether compds. are Pgp substrates.  Sixty-six compds. were tested in monolayer efflux, ATPase, and calcein-AM assays.  Assay results yielded two categories of compds.  Category I (n = 35) exhibited concordance across the assays.  Category II (n = 31) revealed differences among the assays that related to the apparent permeability (Papp) of the compds.  Within category II, two groups were discerned based on the absence (group IIA, n = 10, nontransported substrates) or presence (group IIB, n = 21, transported substrates) of monolayer efflux.  Detection of efflux (group IIB) was assocd. with compds. having low/moderate Papp values (mean = 16.6 nm/s), whereas inability to detect efflux (group IIA) was assocd. with compds. having high Papp values (mean = 535 nm/s).  The calcein-AM and ATPase assays revealed Pgp interactions for highly permeable group IIA compds. but were less responsive than monolayer efflux for low/moderate Papp compds. of group IIB.  All assays detected substrates across a broad range of Papp, but the efflux assay was more prone to fail at high Papp, whereas the calcein-AM and ATPase assays were more prone to fail at low Papp.  When Papp is low, efflux is a greater factor in the disposition of Pgp substrates.  The efflux assay is more reliable at low/moderate Papp and is the method of choice for evaluating drug candidates despite low throughput and reliance on liq. chromatog. with tandem mass spectrometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEXGQjVBl5H7Vg90H21EOLACvtfcHk0lhs5QRU-NhH6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvV2qt78%253D&md5=77bd80ec2000fa4806bee5614c31279d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DMorgan%26aufirst%3DJ.%2BB.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BS.%26atitle%3DRational%2520use%2520of%2520in%2520vitro%2520P-glycoprotein%2520assays%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D620%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Romera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Potassium iodide catalysed monoalkylation of anilines under microwave irradiation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">45</span> <span class="NLM_fpage">8797</span> <span class="NLM_lpage">8800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=8797-8800&author=J.+L.+Romeraauthor=J.+M.+Cidauthor=A.+A.+Trabanco&title=Potassium+iodide+catalysed+monoalkylation+of+anilines+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomera%26aufirst%3DJ.%2BL.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DPotassium%2520iodide%2520catalysed%2520monoalkylation%2520of%2520anilines%2520under%2520microwave%2520irradiation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D8797%26epage%3D8800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Seelig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlik-Landwojtowicz, E.</span><span> </span><span class="NLM_article-title">Inhibitors of multidrug efflux transporters: their membrane and protein interactions</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">135</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=135-151&author=A.+Seeligauthor=E.+Gatlik-Landwojtowicz&title=Inhibitors+of+multidrug+efflux+transporters%3A+their+membrane+and+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26aulast%3DGatlik-Landwojtowicz%26aufirst%3DE.%26atitle%3DInhibitors%2520of%2520multidrug%2520efflux%2520transporters%253A%2520their%2520membrane%2520and%2520protein%2520interactions%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D135%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Pleban, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecker, G. F.</span><span> </span><span class="NLM_article-title">Inhibitors of P-glycoprotein-lead identification and optimisation</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">153</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=153-163&author=K.+Plebanauthor=G.+F.+Ecker&title=Inhibitors+of+P-glycoprotein-lead+identification+and+optimisation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPleban%26aufirst%3DK.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26atitle%3DInhibitors%2520of%2520P-glycoprotein-lead%2520identification%2520and%2520optimisation%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D153%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Balimane, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span> </span><span class="NLM_article-title">A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">301</span> <span class="NLM_fpage">80</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1016%2Fj.ijpharm.2005.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=16023314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVWhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2005&pages=80-88&author=P.+V.+Balimaneauthor=S.+Chong&title=A+combined+cell+based+approach+to+identify+P-glycoprotein+substrates+and+inhibitors+in+a+single+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay</span></div><div class="casAuthors">Balimane, Praveen V.; Chong, Saeho</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">80-88</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objective of this project was to develop a cell based in vitro exptl. procedure that can differentiate P-glycoprotein (P-gp) substrates from inhibitors in a single assay.  Caco-2 cells grown to confluency on 12-well Transwell were used for this study.  The efflux permeability (B to A) of P-gp specific probe (viz., digoxin) in the presence of test compds. (e.g. substrates, inhibitors and non-substrates of P-gp) was monitored, and the influx permeability (A to B) of test compds. was evaluated after complete P-gp blockade.  Radiolabeled digoxin was added on the basolateral side with buffer on the apical side.  The digoxin concn. appearing on the apical side represents digoxin efflux permeability during the control phase (0-1 h period).  After 1 h, a test compd. (10 uM) was added on the apical side.  The reduced efflux permeability of digoxin suggests that the added test compd. is an inhibitor.  The influx permeability of test compd. is also detd. during the 1-2 h study period by measuring the concn. of the test compd. in the basolateral side.  At the end of 2 h, a potent P-gp inhibitor (GF120918) was added.  The increased influx permeability of test compd. during the 2-3 h incubation period indicates that the added test compd. is a substrate.  Samples were taken from both sides at the end of 1-3 h and the concns. of the test compds. and digoxin were quantitated.  Digoxin efflux permeability remained unchanged when incubated with P-gp substrates (e.g., etoposide, rhodamine123, taxol).  However, when a P-gp inhibitor was added to the apical side, the digoxin efflux (B to A permeability) was significantly reduced (ketoconazole = 51% redn.) as expected.  The influx permeability of substrates increased significantly (rhodamine123=70%, taxol = 220%, digoxin = 290%) after the P-gp inhibitor (GF120918) was introduced, whereas the influx permeability of P-gp inhibitor and non-substrates was not affected by GF120918.  Thus, this combined assay provides an efficient cell based in vitro screening tool to simultaneously distinguish compds. that are P-gp substrates from P-gp inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEA2nzY6zwlbVg90H21EOLACvtfcHk0lgvlpSlQEirzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVWhtLo%253D&md5=ee2d5c4aaa06fd7708d50cb61360031f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2005.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2005.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DBalimane%26aufirst%3DP.%2BV.%26aulast%3DChong%26aufirst%3DS.%26atitle%3DA%2520combined%2520cell%2520based%2520approach%2520to%2520identify%2520P-glycoprotein%2520substrates%2520and%2520inhibitors%2520in%2520a%2520single%2520assay%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D301%26spage%3D80%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D3 receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">358</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050734s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=358-365&author=M.+Leopoldoauthor=E.+Lacivitaauthor=P.+De+Giorgioauthor=N.+A.+Colabufoauthor=M.+Nisoauthor=F.+Berardiauthor=R.+Perrone&title=Design%2C+synthesis%2C+and+binding+affinities+of+potential+positron+emission+tomography+%28PET%29+ligands+for+visualization+of+brain+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm050734s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050734s%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520binding%2520affinities%2520of%2520potential%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520for%2520visualization%2520of%2520brain%2520dopamine%2520D3%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D358%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rautio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keogh, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunta, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">786</span> <span class="NLM_lpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=786-792&author=J.+Rautioauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=A.+Balakrishnanauthor=J.+P.+Keoghauthor=J.+R.+Kuntaauthor=J.+Serabjit-Singhauthor=J.+W.+Polli&title=In+vitro+P-glycoprotein+inhibition+assays+for+assessment+of+clinical+drug+interaction+potential+of+new+drug+candidates%3A+a+recommendation+for+probe+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DBalakrishnan%26aufirst%3DA.%26aulast%3DKeogh%26aufirst%3DJ.%2BP.%26aulast%3DKunta%26aufirst%3DJ.%2BR.%26aulast%3DSerabjit-Singh%26aufirst%3DJ.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520inhibition%2520assays%2520for%2520assessment%2520of%2520clinical%2520drug%2520interaction%2520potential%2520of%2520new%2520drug%2520candidates%253A%2520a%2520recommendation%2520for%2520probe%2520substrates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D786%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kangas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grönroos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieminem, A. L.</span><span> </span><span class="NLM_article-title">Bioluminescence of cellular ATP: a new method for evaluating agents in vitro</span> <span class="citation_source-journal">Med. Biol.</span><span class="NLM_year" style="font-weight: bold;">1984</span> <span class="NLM_volume">62</span> <span class="NLM_fpage">338</span> <span class="NLM_lpage">343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=6543460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADyaL2MXltFGmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1984&pages=338-343&author=L.+Kangasauthor=M.+Gr%C3%B6nroosauthor=A.+L.+Nieminem&title=Bioluminescence+of+cellular+ATP%3A+a+new+method+for+evaluating+agents+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescence of cellular ATP:  a new method for evaluating cytotoxic agents in vitro</span></div><div class="casAuthors">Kangas, L.; Groenroos, M.; Nieminen, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Biology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">338-43</span>CODEN:
                <span class="NLM_cas:coden">MDBYAS</span>;
        ISSN:<span class="NLM_cas:issn">0302-2137</span>.
    </div><div class="casAbstract">Rat Walker 256 carcinosarcoma, human MCF-7 cell line, and a specimen of ovarian serous cystadenocarcinoma were cultured in vitro and exposed to different cytostatic drugs.  The drug effects were evaluated by bioluminescence, i.e., by measuring the levels of ATP (ATP)  [56-65-5], the basic energy source of the living cells.  The intracellular ATP was released by TCA or NRS-reagent, and the ATP levels were measured directly from an aliquot of the growth medium without any extn. or pptn. steps.  The ATP level correlated with cell no., viability, [3H]-thymidine incorporation, and stem-cell assay.  The most important advantages of the bioluminescence method were speed, tech. simplicity, and good sensitivity (about 500 cells/sample easily quantitated, the results are seen directly within a few seconds) and flexibility (any cell line and drug may be studied by many different test designs).  The ATP method obviously describes the well-being of the cultured cells.  The ATP-bioluminescence method is a powerful alternative to any other cell-growth estn. method in vitro.  It can be used esp. in primary screening of the cytostatic activity of any known or unknown substance as well as in attempts to select an individual drug therapy for patients with cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_dF9X-DhqobVg90H21EOLACvtfcHk0lgROWmQlvhCoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltFGmsbw%253D&md5=b0e016699bd039c9d2c694a4e1ccbdad</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKangas%26aufirst%3DL.%26aulast%3DGr%25C3%25B6nroos%26aufirst%3DM.%26aulast%3DNieminem%26aufirst%3DA.%2BL.%26atitle%3DBioluminescence%2520of%2520cellular%2520ATP%253A%2520a%2520new%2520method%2520for%2520evaluating%2520agents%2520in%2520vitro%26jtitle%3DMed.%2520Biol.%26date%3D1984%26volume%3D62%26spage%3D338%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Taub, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, I.</span><span> </span><span class="NLM_article-title">Functional assessment of multiple P-glycoprotein (P-gp) probe substrate: influence of cell line and modulator concentration on P-gp activity</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">33</span> <span class="NLM_fpage">1679</span> <span class="NLM_lpage">1687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1679-1687&author=M.+E.+Taubauthor=L.+Podilaauthor=I.+Almeida&title=Functional+assessment+of+multiple+P-glycoprotein+%28P-gp%29+probe+substrate%3A+influence+of+cell+line+and+modulator+concentration+on+P-gp+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaub%26aufirst%3DM.%2BE.%26aulast%3DPodila%26aufirst%3DL.%26aulast%3DAlmeida%26aufirst%3DI.%26atitle%3DFunctional%2520assessment%2520of%2520multiple%2520P-glycoprotein%2520%2528P-gp%2529%2520probe%2520substrate%253A%2520influence%2520of%2520cell%2520line%2520and%2520modulator%2520concentration%2520on%2520P-gp%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1679%26epage%3D1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">Antiproliferative and cytotoxic effects of some σ<sub>1</sub> antagonists in tumour cell lines</span> <span class="citation_source-journal">Naunyn−Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">370</span> <span class="NLM_fpage">106</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm701267q&amp;key=10.1007%2Fs00210-004-0961-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm701267q&amp;key=15322732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm701267q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslyrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2004&pages=106-113&author=N.+A.+Colabufoauthor=F.+Berardiauthor=M.+Continoauthor=M.+Nisoauthor=C.+Abateauthor=R.+Perroneauthor=V.+Tortorella&title=Antiproliferative+and+cytotoxic+effects+of+some+%CF%831+antagonists+in+tumour+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and cytotoxic effects of some σ2 agonists and σ1 antagonists in tumour cell lines</span></div><div class="casAuthors">Colabufo, Nicola Antonio; Berardi, Francesco; Contino, Marialessandra; Niso, Mauro; Abate, Carmen; Perrone, Roberto; Tortorella, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-113</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">To establish the activity of σ ligands at σ1 and σ2 receptor, we chose two tumor cell lines, the human SK-N-SH neuroblastoma and the rat C6 glioma lines, which express σ2 receptors at a high d. and σ1 receptors in their high-affinity or low-affinity state.  We tested the σ2 receptor agonist PB28 and the σ2 antagonist AC927, and (+)-pentazocine and NE100 as agonist and antagonist, resp., at σ1 receptors, with regard to antiproliferative and cytotoxic effects.  In addn., 1,3-di (2-tolyl)guanidine (DTG) and haloperidol were tested as ref. compds. displaying nearly equipotent σ affinity (σ2>σ1 and σ1>σ2, resp.).  In both SK-N-SH and C6 cells, PB28 and NE100 displayed the most potent results both in antiproliferative and cytotoxic assay while AC927 and (+)-pentazocine were inactive in both assays.  The cytotoxic and antiproliferative effects of DTG and haloperidol reflected their σ1 antagonist activity and σ2 agonist activity.  Moreover, our results in the tumor cell lines correlated well with those for σ2 activity found previously in a functional assay in the guinea-pig bladder.  These findings establish a new model for evaluating both σ2 and σ1 receptor activity of σ ligands, which could be useful for developing new ligands having mixed σ2 agonist/σ1 antagonist activity as potential antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs66SL4M6j97Vg90H21EOLACvtfcHk0lgROWmQlvhCoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslyrtrg%253D&md5=3adb421f453f96086fd45096dc49366c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs00210-004-0961-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-004-0961-2%26sid%3Dliteratum%253Aachs%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DAntiproliferative%2520and%2520cytotoxic%2520effects%2520of%2520some%2520%25CF%25831%2520antagonists%2520in%2520tumour%2520cell%2520lines%26jtitle%3DNaunyn%25E2%2588%2592Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2004%26volume%3D370%26spage%3D106%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span> </span><span class="NLM_article-title">GraphPad Prism Software</span>, version for Windows; <span class="NLM_publisher-name">GraphPad Software, Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GraphPad+Prism+Software%2C+version+for+Windows%3B+GraphPad+Software%2C+Inc.%3A+San+Diego%2C+CA%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DGraphPad%2520Prism%2520Software%26pub%3DGraphPad%2520Software%252C%2520Inc%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/jm701267q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_68400"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis of compounds <b>11a</b>,<b>b</b>, <b>13a</b>,<b>b</b>, <b>14a</b>,<b>b</b>, <b>15a</b>,<b>b</b>, <b>16a</b>,<b>b</b>, <b>17a</b>,<b>b</b>, and <b>22</b>−<b>27</b> and experimental section for key intermediates <b>18</b>, <b>20</b>, and <b>21</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701267q/suppl_file/jm701267q-file002.pdf">jm701267q-file002.pdf (60.31 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701267q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm701267q%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701267q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                255KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999ef7ab402374","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
